
<html lang="en"     class="pb-page"  data-request-id="520b976f-ab95-4ac7-ba2a-5f02261710ad"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-20;article:article:10.1021/acs.jmedchem.8b00542;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter" /></meta><meta name="dc.Creator" content="Brian A.  Provencher" /></meta><meta name="dc.Creator" content="Amy J.  Eshleman" /></meta><meta name="dc.Creator" content="Robert A.  Johnson" /></meta><meta name="dc.Creator" content="Xiao  Shi" /></meta><meta name="dc.Creator" content="Olga  Kryatova" /></meta><meta name="dc.Creator" content="Jared  Nelson" /></meta><meta name="dc.Creator" content="Jianhua  Tian" /></meta><meta name="dc.Creator" content="Mario  Gonzalez" /></meta><meta name="dc.Creator" content="Peter C.  Meltzer" /></meta><meta name="dc.Creator" content="Aaron  Janowsky" /></meta><meta name="dc.Description" content="Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reve..." /></meta><meta name="Description" content="Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reve..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00542" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00542" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00542" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00542" /></link>
        
    
    

<title>Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00542" /></meta><meta property="og:title" content="Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0011.jpeg" /></meta><meta property="og:description" content="Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reverse transport by the monoamine transporters to increase extracellular neurotransmitters. Currently available radioligands for VMAT2 have considerable liabilities: The binding of [3H]dihydrotetrabenazine ([3H]DHTB) to a site on VMAT2 is not dependent on ATP, and [3H]reserpine binds almost irreversibly to VMAT2. Herein we demonstrate that several arylpiperidinylquinazolines (APQs) are potent inhibitors of [3H]reserpine binding at recombinant human VMAT2 expressed in HEK-293 cells. These compounds are biodiastereoselective and bioenantioselective. The lead radiolabeled APQ is unique because it binds reversibly to VMAT2 but does not bind the [3H]DHTB binding site. Furthermore, experimentation shows that several novel APQ ligands have high potency for inhibition of uptake by both HEK-VMAT2 cells and mouse striatal vesicles and may be useful tools for characterizing drug-induced effects on human VMAT2 expression and function." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00542"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00542">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00542&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00542&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00542&amp;href=/doi/10.1021/acs.jmedchem.8b00542" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9121-9131</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00049" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00559" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Brian A. Provencher</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian A. Provencher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Merrimack College, North Andover, Massachusetts 01845, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#77270518011219141f120535371a1205051e1a16141c59121302"><span class="__cf_email__" data-cfemail="fdad8f928b98939e95988fbfbd90988f8f94909c9e96d3989988">[emailÂ protected]</span></a>. Phone: (978) 837-5296.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+A.++Provencher">Brian A. Provencher</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2607-9530" title="Orcid link">http://orcid.org/0000-0003-2607-9530</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Amy J. Eshleman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amy J. Eshleman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Service, VA Portland Health Care System, Portland, Oregon 97239, United States</div><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amy+J.++Eshleman">Amy J. Eshleman</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Robert A. Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert A. Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Service, VA Portland Health Care System, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+A.++Johnson">Robert A. Johnson</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Xiao Shi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao Shi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Service, VA Portland Health Care System, Portland, Oregon 97239, United States</div><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Shi">Xiao Shi</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Olga Kryatova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olga Kryatova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Kryatova">Olga Kryatova</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jared Nelson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jared Nelson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jared++Nelson">Jared Nelson</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jianhua Tian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianhua Tian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianhua++Tian">Jianhua Tian</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mario Gonzalez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mario Gonzalez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Gonzalez">Mario Gonzalez</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Peter C. Meltzer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter C. Meltzer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organix Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+C.++Meltzer">Peter C. Meltzer</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Aaron Janowsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aaron Janowsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Service, VA Portland Health Care System, Portland, Oregon 97239, United States</div><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</div><div class="loa-info-affiliations-info">The Methamphetamine Abuse Research Center, Oregon Health and Science University, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Janowsky">Aaron Janowsky</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00542&amp;href=/doi/10.1021%2Facs.jmedchem.8b00542" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9121â9131</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 April 2018</li><li><span class="item_label"><b>Published</b> online</span>21 September 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00542" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00542</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9121%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrian%2BA.%2BProvencher%252C%2BAmy%2BJ.%2BEshleman%252C%2BRobert%2BA.%2BJohnson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D20%26contentID%3Dacs.jmedchem.8b00542%26title%3DSynthesis%2Band%2BDiscovery%2Bof%2BArylpiperidinylquinazolines%253A%2BNew%2BInhibitors%2Bof%2Bthe%2BVesicular%2BMonoamine%2BTransporter%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9131%26publicationDate%3DOctober%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00542"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1621</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00542" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;A. Provencher&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;J. Eshleman&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;A. Johnson&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Kryatova&quot;},{&quot;first_name&quot;:&quot;Jared&quot;,&quot;last_name&quot;:&quot;Nelson&quot;},{&quot;first_name&quot;:&quot;Jianhua&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Gonzalez&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;C. Meltzer&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Janowsky&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9121-9131&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00542&quot;},&quot;abstract&quot;:&quot;Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reverse transport by the monoamine transporters to increase extracellular neurotransmitters. Currently available radioligands for VMAT2 have considerable liabilities: The binding of [3H]dihydrotetrabenazine ([3H]DHTB) to a site on VMAT2 is not dependent on ATP, and [3H]reserpine binds almost irreversibly to VMAT2. Herein we demonstrate that several arylpiperidinylquinazolines (APQs) are potent inhibitors of [3H]reserpine binding at recombinant human VMAT2 expressed in HEK-293 cells. These compounds are biodiastereoselective and bioenantioselective. The lead radiolabeled APQ is unique because it binds reversibly to VMAT2 but does not bind the [3H]DHTB binding site. Furthermore, experimentation shows that several novel APQ ligands have high potency for inhibition of uptake by both HEK-VMAT2 cells and mouse striatal vesicl&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00542&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00542" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00542&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00542" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00542&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00542" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00542&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00542&amp;href=/doi/10.1021/acs.jmedchem.8b00542" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00542" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00542" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00542%26sid%3Dliteratum%253Aachs%26pmid%3D30240563%26genre%3Darticle%26aulast%3DProvencher%26date%3D2018%26atitle%3DSynthesis%2Band%2BDiscovery%2Bof%2BArylpiperidinylquinazolines%253A%2BNew%2BInhibitors%2Bof%2Bthe%2BVesicular%2BMonoamine%2BTransporter%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D20%26spage%3D9121%26epage%3D9131%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/jmcmar.2018.61.issue-20/20181025/jmcmar.2018.61.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reverse transport by the monoamine transporters to increase extracellular neurotransmitters. Currently available radioligands for VMAT2 have considerable liabilities: The binding of [<sup>3</sup>H]dihydrotetrabenazine ([<sup>3</sup>H]DHTB) to a site on VMAT2 is not dependent on ATP, and [<sup>3</sup>H]reserpine binds almost irreversibly to VMAT2. Herein we demonstrate that several arylpiperidinylquinazolines (APQs) are potent inhibitors of [<sup>3</sup>H]reserpine binding at recombinant human VMAT2 expressed in HEK-293 cells. These compounds are biodiastereoselective and bioenantioselective. The lead radiolabeled APQ is unique because it binds reversibly to VMAT2 but does not bind the [<sup>3</sup>H]DHTB binding site. Furthermore, experimentation shows that several novel APQ ligands have high potency for inhibition of uptake by both HEK-VMAT2 cells and mouse striatal vesicles and may be useful tools for characterizing drug-induced effects on human VMAT2 expression and function.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Methamphetamine is a highly addictive stimulant.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The abuse of methamphetamine is prevalent and escalates with time for many individuals.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Stimulant-induced psychosis and long-term neuronal loss are indications of methamphetamine-induced neurotoxicity.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3â5)</a> Currently, there are no approved pharmacotherapies for treatment of methamphetamine addiction and behavioral therapy has had limited success.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Among the primary initial neuronal targets for methamphetamine is the human vesicular monoamine transporter 2 (VMAT2).<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7â10)</a> Expressed in monoaminergic presynaptic neurons, as well as in peripheral tissues, VMAT2 transports cytosolic dopamine (DA), serotonin (5-HT), or norepinephrine (NE) into storage vesicles.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> By transporting neurotransmitters into vesicles, VMAT2 participates in the regulation of cytosolic levels and vesicular stores of biogenic amines.</div><div class="NLM_p">Methamphetamine competes with the endogenous neurotransmitters for binding sites and uptake into VMAT2. When VMAT2 binds methamphetamine, vesicular degradation resulting in dopamine efflux into the cytosol of presynaptic neurons is observed.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This can cause reverse transport by the dopamine transporter to increase dopamine in the extracellular space. Therefore, VMAT2 is a possible target for therapeutics to treat methamphetamine abuse.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6,8)</a> The VMAT2, while expressed in vivo on the vesicular membranes of neurons, is also functional when expressed in mammalian cell lines, with the energy source for transport provided by the native V-type H<sup>+</sup>-ATPase.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">Recent work reveals that in drosophila brain, amphetamine redistributes vesicle contents, diminishes the vesicle pH-gradient needed for biogenic amine uptake, and requires VMAT2 function.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Current therapy for methamphetamine abuse consists primarily of cognitive behavioral interventions; however, pharmacological interventions could improve the treatment of methamphetamine abuse. Vocci and Appel, when reviewing possible targets for methamphetamine pharmacotherapies, identified the VMAT2 as having an obligatory role in methamphetamine activity.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Some strategies for pharmacotherapy development have focused on altering psychostimulant interaction with the VMAT2 or with altering VMAT2 function. Lobeline, a lipophilic alkaloid of Indian tobacco, alters VMAT2-mediated DA uptake and release and alters methamphetamine-induced DA release,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> and lobeline and its analogs are being investigated as possible therapeutics for methamphetamine abuse.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18â20)</a> Reserpine, a high affinity VMAT2 blocker, has been used to treat hypertension but essentially irreversibly binds to VMAT2 which results in depletion of biogenic amines including dopamine and epinephrine. Thus, recovery of biogenic amine storage requires synthesis of new storage vesicles.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, reserpine binds to both the VMAT2 and the peripheral VMAT1, with side effects including sedation, inability to concentrate or perform complex tasks, and sometimes psychotic depression that appears over many weeks or months.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Tetrabenazine (TBZ) and its analog, dihydrotetrabenazine (DHTB), inhibit VMAT2 function, bind reversibly to the VMAT2 at an allosteric binding site, and have shown effectiveness in treatment of hyperkinesias characterized by abnormal involuntary movements as observed in Huntingtonâs disease, Touretteâs syndrome, and tardive dyskinesia.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22,24)</a> However, TBZ has side effects similar to reserpine including sedation, depression, akathisia, and Parkinsonism.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Ketanserin binds to VMAT2 with relatively high affinity (â¼6â45 nM)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> but is nonselective, displaying high affinity for the 5-HT2A receptor and moderate affinities for the histamine H1 and 5-HT2C receptors.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26â28)</a></div><div class="NLM_p">There are a number of radioligands and drugs that bind to the VMAT2 and affect its function. Currently, available radioligands for labeling VMAT2, such as [<sup>3</sup>H]DHTB and [<sup>3</sup>H]reserpine, have considerable liabilities. [<sup>3</sup>H]DHTB binding is not ATP-dependent and thus mechanistically is less similar to ATP-dependent VMAT2 function, and [<sup>3</sup>H]reserpine binds almost irreversibly to VMAT2 and does not lend itself to high-throughput screening.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> One model of the binding sites on VMAT2 suggests that the reserpine site has high affinity for substrates and is directed toward the cytosol; in contrast, after the binding of the substrate to VMAT2, a conformational change results in the TBZ-binding conformation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Furthermore, it was found that TBZ does not require a proton gradient for binding and that TBZ binding locks the transporter into a confirmation which no longer allows the substrate to bind to VMAT2 by inhibiting the cytoplasmic gate.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">With few available radioligands, the search for novel ligands to serve as chemical probes that bind reversibly and specifically to the VMAT2, and are associated with VMAT2 function, can provide a springboard for the development of pharmacotherapies for symptoms related to methamphetamine addiction. Herein we describe the discovery of new arylpiperidinylquinazoline (APQ) ligands and their biological activity in VMAT2 assays.<named-content content-type="anchor" rid="sch1" type="simple"></named-content><named-content content-type="anchor" rid="sch2" type="simple"></named-content></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Novel APQ ligands (Â±)-<b>5</b> were synthesized from commercially available ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride <b>1</b>. Conversion from the ketone to triflate <b>2</b> was accomplished using <i>N</i>-phenyl bistrifluorsulfonamide. Suzuki coupling followed by reduction afforded substituted aryl-piperidine (<b>4</b>). N-Alkylation with the known quinazoline <b>6</b> afforded racemic, <i>syn</i>-APQ ligands (Â±)-<b>5</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> To ensure water solubility, the APQs were converted to the HCl salt with HCl in ether. The precipitate was filtered, dissolved in water, and freeze-dried to afford the APQ-HCl salt which was confirmed by elemental analysis. Enantiomers could be resolved by crystallizing <b>4</b> with tartaric acid. Once purified, single enantiomers were subjected to the same N-alkylation and salt procedure as stated above.</div><div class="NLM_p last"><i>anti</i>-APQ isomer <b>9</b> was prepared from intermediate <b>4b</b>. Protection of the free amine with Boc anhydride yielded <b>7</b>. Heating <b>7</b> in the presence of sodium ethoxide converted the <i>cis</i>-diastereomer to the more stable <i>trans</i>-diastereomer. Deprotection followed by N-alkylation with the known quinazoline afforded (Â±)-<b>9</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To begin, the binding affinities of 13 APQ derivatives and reference compounds (ketanserin, DHTB, methamphetamine, reserpine, Ro4-1284, serotonin, and lobeline) for VMAT2 were assessed by inhibition of radioligand binding using [<sup>3</sup>H]reserpine and [<sup>3</sup>H]DHTB (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Methamphetamine had micromolar affinity for the reserpine binding site but had 60-fold lower affinity for the DHTB site. Ketanserin displays some affinity for the reserpine binding site albeit 5-fold lower than for the DHTB binding site (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 1). Interestingly, APQs displayed a wide range of binding affinities across both sites and were generally more selective for the reserpine site. <i>syn</i>-APQ (Â±)-<b>5a</b> bound to the reserpine site with a <i>K</i><sub>i</sub> = 70 nM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 9). The para-fluoro analog (Â±)-<b>5b</b>, which contains the same aryl moiety of ketanserin, was found to bind with essentially the same <i>K</i><sub>i</sub> at the reserpine site (74 vs 70 nM). Neither compound showed much affinity for the DHTB site. To explore the diastereoselectivity of the APQ ligand on the receptors, <i>anti</i>-isomer (Â±)-<b>9</b> was tested. APQ ligand <b>9</b> had less affinity for the reserpine site than the <i>syn</i>-analog, (Â±)-<b>5b</b>. Additionally, (Â±)-<b>9</b> was not as selective for the reserpine site and competed at the DHTB site with <i>K</i><sub>i</sub> = 750 nM.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>syn</i>-APQ Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (1) K<sub>2</sub>CO<sub>3</sub>, DCM; (2) NaH, PhN(Tf)<sub>2</sub>, DMF, 0Â° C; (b) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH, 85 Â°C; (c) Pd/C, H<sub>2</sub>, rt; (d) <b>6</b>, toluene or DMF/1,4-dioxane or CH<sub>3</sub>CN, 90â110 Â°C.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>anti</i>-APQ Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 60 Â°C; (b) EtONa, EtOH, 70 Â°C; (c) 4 M HCl; (d) <b>6</b>, toluene, 100 Â°C.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities for the VMAT2 Binding Sites of [<sup>3</sup>H]Reserpine and [<sup>3</sup>H]DHTB<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0009.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The core APQ structure is given in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Experiments were conducted as detailed in the Experimental Section. <i>n</i> â¥ 3 except when the <i>K</i><sub>i</sub> was greater than 10 Î¼M, in which case <i>n</i> = 2. If some experiments yielded IC<sub>50</sub> or <i>K</i><sub>i</sub> values less than 10 Î¼M and other experiments yielded IC<sub>50</sub> or <i>K</i><sub>i</sub> values greater than 10 Î¼M, the latter experiments were assigned a value of 10 Î¼M and averages calculated. The actual value is greater than that average and no standard error is reported. APQ compounds were tested at concentrations ranging from 1 nM to 10 Î¼M. Data are provided as <i>K</i><sub>i</sub>= nM Â± SEM unless otherwise noted.</p></div></div><div></div></div><div class="NLM_p">With the knowledge that the <i>syn</i>-isomers (<b>5</b>) were more selective for reserpine over DHTB, we explored the structureâactivity relationship of the APQ ligands. Compound (Â±)-<b>5c</b> lost affinity for the reserpine site while 3-trifluorophenyl analog (Â±)-<b>5d</b> retained some affinity for the reserpine site, albeit much lower than (Â±)-<b>5b</b>. Other analogs in this series did not bind at the reserpine or DHTB sites (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 15â18). Thiophene analog (Â±)-<b>5i</b> and dioxane analog (Â±)-<b>5j</b> were found to bind with moderate affinity to the reserpine site, <i>K</i><sub>i</sub> = 450 and 652 nM respectively.</div><div class="NLM_p">To explore the enantioselectivity of the ligands, (+)-<b>5b</b> and (â)-<b>5b</b> were isolated and subjected to the reserpine and DHTB binding assays. (+)-<b>5b</b> had higher affinity than (Â±)-<b>5b</b> in the reserpine binding assay with <i>K</i><sub>i</sub> = 62 nM (<i>p</i> < 0.001, one-way ANOVA followed by Tukeyâs multiple comparison test) and was essentially inactive in the DHTB binding assay. (â)-<b>5b</b> displayed similar affinity as racemic (Â±)-<b>5b</b> (<i>p</i> > 0.05) but lower affinity than the enantiomer (+)<b>-5b</b> (<i>p</i> < 0.01) (<i>K</i><sub>i</sub> = 179 nM) for the reserpine site while remaining inactive in the DHTB binding assay. To further study the effect of the APQ ligand on VMAT2, compound (+)-<b>5b</b>, with the highest affinity for the reserpine site, was selected for tritium radiolabeling.</div><div class="NLM_p">The effect of Mg-ATP on radiolabeled [<sup>3</sup>H](+)-<b>5b</b> binding was determined. The binding of [<sup>3</sup>H]reserpine and [<sup>3</sup>H](+)-<b>5b</b> to VMAT2 was ATP-dependent. Mg-ATP (2 mM) enhanced specific binding to recombinant VMAT2 approximately 8- and 15-fold for [<sup>3</sup>H]reserpine and [<sup>3</sup>H](+)-<b>5b</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). In contrast, the binding of [<sup>3</sup>H]DHTB was not changed by the addition of 2 mM ATP (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Thus, ATP increases [<sup>3</sup>H](+)-<b>5b</b> and [<sup>3</sup>H]reserpine binding but not [<sup>3</sup>H]DHTB binding. The ATP enhancement of [<sup>3</sup>H](+)-<b>5b</b> binding suggests that the binding is energy-dependent and may also be dependent on one or more proton(s) being countertransported. ATP is required for the proton pump that regulates the vesicle-cytoplasm proton-gradient that is required for substrate transport by various vesicular transporters.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Additionally, this finding corroborates data suggesting that reserpine and the APQs, but not DHTB, bind to a site that is coupled to VMAT2 function.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of Mg-ATP on (A) [<sup>3</sup>H]reserpine, (B) [<sup>3</sup>H](+)-<b>5b</b>, and (C) [<sup>3</sup>H]DHTB. The effects of Mg-ATP on radioligand binding were conducted as described in the Experimental Section. Error bars (SEMs) were derived from multiple experiments conducted with duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The rates of association and dissociation for [<sup>3</sup>H](+)-<b>5b</b> and [<sup>3</sup>H]reserpine binding were determined in the presence of 2 mM Mg-ATP. Kinetic analysis of [<sup>3</sup>H]reserpine (14â22 nM) and [<sup>3</sup>H](+)-<b>5b</b> (24â28 nM) binding to VMAT2 indicates that the observed association rates (<i>k</i><sub>obs</sub>) were similar (0.028 Â± 0.01, 0.051 Â± 0.01, respectively, <i>n</i> = 5, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). By contrast, the dissociation half-lives for [<sup>3</sup>H]reserpine and [<sup>3</sup>H](+)-<b>5b</b> are significantly different (<i>p</i> < 0.05), with [<sup>3</sup>H]reserpine having a dissociation half-life greater than 3 h (data did not fit a one phase exponential decay) and [<sup>3</sup>H](+)-<b>5b</b> having a dissociation half-life of less than 1 min, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). The kinetic characteristics of [<sup>3</sup>H](+)-<b>5b</b> binding to VMAT2 are quite unlike [<sup>3</sup>H]reserpine, which binds essentially irreversibly (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Saturation binding of [<sup>3</sup>H]reserpine, [<sup>3</sup>H](+)-<b>5b</b>, and [<sup>3</sup>H]DHTB was also conducted, with the caveat that the nearly irreversible [<sup>3</sup>H]reserpine binding does not obey the reversibility requirement for true equilibrium. Saturation binding of [<sup>3</sup>H]reserpine, [<sup>3</sup>H](+)-<b>5b</b>, and [<sup>3</sup>H]DHTB yielded <i>K</i><sub>d</sub> values of 8.0 Â± 1.2 nM, 93 Â± 13 nM, and 71 Â± 15 nM and <i>B</i><sub>max</sub> values of 0.942 Â± 0.085, 13.5 Â± 1.4, and 41.2 Â± 2.2 pmol/mg protein, respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). [<sup>3</sup>H]Reserpine binding to VMAT2 had a higher affinity but much lower density of binding sites compared to the other two ligands.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Kinetics of [<sup>3</sup>H]reserpine and [<sup>3</sup>H](+)-<b>5b</b> binding to human VMAT2. (A, B) [<sup>3</sup>H]Reserpine association and dissociation time curves, respectively. (C, D) [<sup>3</sup>H](+)-<b>5b</b> association and dissociation time curves, respectively. Note the different <i>X</i> axis time ranges in (B) and (D). Assays were conducted as described in theÂ <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, with excess concentration of respective nonradiolabeled ligand. <i>n</i> = 3â5 independent experiments conducted in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Saturation binding of [<sup>3</sup>H]reserpine, [<sup>3</sup>H](+)-<b>5b</b>, and [<sup>3</sup>H]DHTB binding to HEK-VMAT2 cell membranes: (A) [<sup>3</sup>H]reserpine, (B) [<sup>3</sup>H](+)-<b>5b</b>, and (C) [<sup>3</sup>H]DHTB saturation binding. Assays were conducted as described in theÂ <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Saturation curves are the average and SEM of 3â4 independent experiments each conducted in duplicate. A representative Scatchard plot is shown for each radioligand. In the Scatchard analysis, the (â) reciprocal of the slope of the line is an estimate of the <i>K</i><sub>d</sub> value for the radioligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The fast off rate of [<sup>3</sup>H](+)-<b>5b</b> compared to the off-rate for [<sup>3</sup>H]reserpine indicates that binding is reversible, an important characteristic for screening possible therapeutics with high throughput radioligand binding. Likewise, [<sup>3</sup>H]DHTB binding is reversible,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> with a relatively fast off-rate, but the binding characteristics are not ATP dependent.</div><div class="NLM_p">While APQ ligands did not appear to bind with great affinity for the reserpine or DHTB binding sites, further experimentation with (+)-<b>5b</b> showed evidence that the ligands were binding and affecting VMAT2 function. We lastly screened the APQ ligands in a binding assay competing with [<sup>3</sup>H](+)-<b>5b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Enantiomeric APQ ligand (â)-<b>5b</b> displayed moderate affinity in this assay with <i>K</i><sub>i</sub> = 290 nM, whereas the racemate (Â±)-<b>5b</b> was found to bind with <i>K</i><sub>i</sub> = 161 nM.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities of APQ Ligands versus [<sup>3</sup>H](+)-<b>5b</b> at the Human VMAT2, versus [<sup>125</sup>I]DOI at the 5HT2A Receptor and versus [<sup>125</sup>I]RTI-55 at the DAT, and Potencies for Inhibition of [<sup>3</sup>H]5-HT Uptake by Human VMAT2 Expressed in HEK Cells and by Mouse Striatal VMAT2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0010.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Experiments were conducted as detailed in the Experimental Section.Â <i>n</i> â¥ 3, except when the <i>K</i><sub>i</sub> or IC<sub>50</sub> was greater than 10 Î¼M, in which case <i>n</i> = 2. If some experiments yielded IC<sub>50</sub> or <i>K</i><sub>i</sub> values less than 10 Î¼M and other experiments yielded IC<sub>50</sub> or <i>K</i><sub>i</sub> values greater than 10 Î¼M, the latter experiments were assigned a value of 10 Î¼M and averages calculated. The actual value is greater than that average, and no standard error is reported. APQ compounds were tested at concentrations ranging from 0.01 nM to 10 Î¼M. Data is reported as <i>K</i><sub>i</sub> = nM Â± SEM unless otherwise noted. <sup><i>b</i></sup>IC<sub>50</sub> = nM Â± SEM. <sup><i>c</i></sup><i>K</i><sub>d</sub>= nM Â± SEM. ND = not determined.</p></div></div><div></div></div><div class="NLM_p">The other racemic APQ ligands were tested against [<sup>3</sup>H](+)-<b>5b</b> as well. APQ ligand (Â±)-<b>5a</b>, displayed moderate binding affinity albeit only two times less potent than (Â±)-<b>5b</b>. Other APQ ligands with electron withdrawing substituents displayed moderate binding affinity with (Â±)-<b>5d</b> showing the best results out of the group (entries 13, 14, and 18; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). SAR investigations into electron donating groups also resulted in loss of potency in the [<sup>3</sup>H](Â±)-<b>5b</b> binding assay (entries 15â17; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">The potency of the APQ compounds at inhibition of [<sup>3</sup>H]5-HT uptake via human VMAT2 expressed in HEK cells was assessed. APQ ligands (Â±)-<b>5a</b> and all stereoisomers of <b>5b</b> had similar potencies, ranging from 16 to 51 nM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The next most potent compounds ((Â±)-<b>5d</b>, (Â±)-<b>5i</b>, (Â±)-<b>5j</b>) had potencies ranging from 101 nM to 142 nM. Interestingly, APQ (Â±)-<b>5d</b> with a meta-trifluormethyl group had greater than 20-fold higher potency than (Â±)-<b>5c</b> with a para-trifluormethyl. APQ ligands (Â±)-<b>5e</b>, (Â±)-<b>5f</b>, (Â±)-<b>5g</b>, and (Â±)-<b>5h</b> demonstrated little potency in the [<sup>3</sup>H]5-HT uptake assay. The potencies of a subset of APQ compounds and standards for inhibition of [<sup>3</sup>H]5-HT uptake via endogenous VMAT2 in mouse striatal vesicular membranes were assessed (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The potencies of all standard compounds were higher in the mouse vesicular preparations (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The subset of APQ ligands tested in this preparation had higher potencies compared to potencies in the HEK-VMAT2 uptake assay. APQ ligands (Â±)-<b>5a</b> and all stereoisomers of <b>5b</b> were very potent, with IC<sub>50</sub> values below 10 nM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). (Â±)-<b>5d</b>, (+)-<b>9</b>, and (Â±)-<b>5i</b> had moderate potencies ranging from 12.8 to 31.5 nM. All APQ compounds tested completely inhibited specific [<sup>3</sup>H]5-HT uptake, defined with 1 Î¼M reserpine.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentrationâresponse curves of inhibition of [<sup>3</sup>H]5-HT uptake into mouse striatal vesicular membranes. Six APQ compounds and three standards are shown. <i>n</i> = 3â6. All APQ compounds were more potent than ketanserin in this assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the 14 APQ compounds and the seven standard compounds, a good correlation was observed between the logÂ IC<sub>50</sub> value for [<sup>3</sup>H]5-HT uptake and the logÂ <i>K</i><sub>i</sub> value for inhibition of [<sup>3</sup>H](+)-<b>5b</b> binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, Spearmanâs <i>r</i> = 0.63, <i>p</i> < 0.01). With this same set of compounds, there was an excellent correlation between the logÂ IC<sub>50</sub> value for [<sup>3</sup>H]5-HT uptake and the logÂ <i>K</i><sub>i</sub> value for inhibition of [<sup>3</sup>H]reserpine binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, Spearmanâs <i>r</i> = 0.90, <i>p</i> < 0.0001). There was also a good correlation between the logÂ IC<sub>50</sub> value for [<sup>3</sup>H]5-HT uptake and the logÂ <i>K</i><sub>i</sub> value for inhibition of [<sup>3</sup>H]DHTB binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C, Spearmanâs <i>r</i> = 0.57, <i>p</i> < 0.01), although the correlation was driven mainly by the control compounds, as the APQs generally had micromolar to no measurable affinity for this site.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlations of binding affinities and uptake potencies for HEK-VMAT2 for select compounds: drug-induced inhibition of (A) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H](+)-<b>5b</b> binding versus log(IC<sub>50</sub>) for inhibition of [<sup>3</sup>H]5-HT uptake, (B) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H]reserpine binding versus log(IC<sub>50</sub>) for [<sup>3</sup>H]5-HT uptake, and (C) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H]DHTB binding versus log(IC<sub>50</sub>) for [<sup>3</sup>H]5-HT uptake. Fourteen APQ compounds and seven standard compounds were included in the analysis. Data were analyzed using Spearmanâs nonparametric correlation analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Affinities for several other neuronal proteins were assessed (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). At the 5-HT2A receptor, (Â±)-<b>9</b> had nanomolar affinity similar to ketanserin. All other APQ ligands had little to no measurable affinity for this receptor. Furthermore, (+)-<b>5b</b> and (Â±)-<b>5a</b> had <i>K</i><sub>i</sub> values of 2440 nM and 1610 nM, respectively, for displacement of [<sup>125</sup>I]RTI-55 binding to the DAT; all other APQs tested had <i>K</i><sub>i</sub> values greater than 4 Î¼M (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). From assessment of the affinity of the lead compound for other transporters, (+)-<b>5b</b> and the parent compound ketanserin had very low affinities (>10 Î¼M) for the [<sup>125</sup>I]RTI-55 binding site on the human serotonin transporter and human norepinephrine transporter while cocaine had <i>K</i><sub>i</sub> values of 632 Â± 21 and 2,357 Â± 39 nM, respectively. No APQs had measurable affinity for 5-HT1A receptor (data not shown).</div><div class="NLM_p">In addition, a subset of APQs was tested in the MTT cell viability assay. (Â±)-<b>5a</b>, (Â±)<b>5b</b>, (+)-<b>5b</b>, (â)-<b>5b</b>, (Â±)-<b>5d</b>, (Â±)-<b>5i</b>, (Â±)-<b>9</b>, ketanserin, DHTB, RO4-1284, and methamphetamine at 10 Î¼M and reserpine at 1 Î¼M had no significant effect on HEK-VMAT2 cell viability (one-way ANOVA followed by Tukeyâs post hoc test, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). By contrast, staurosporine, the positive control, decreased cell viability by 45% and 60% at 1 and 3 Î¼M, respectively.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of APQ compounds, standards, and staurosporine (SP) on cell viability in the MTT assay. APQ compounds, RO4-1284, ketanserin, METH, and DHTB were tested at 10 Î¼M, and reserpine was tested at 1 Î¼M. The positive control SP was tested at 0.1, 0.3, 1, and 3 Î¼M. Inset: test for linearity of HEK-hVMAT2 cell number vs OD at 590 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lastly, CNS MPO scores were calculated for the APQ compounds to determine viability of the ligands moving forward.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Ligands scored from 2.2 to 4.4 in the MPO calculation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Generally scores greater than 4 are desired, and of note, (Â±)-<b>5b</b> displayed one of the best MPO scores of 4.1. The moderate MPO values obtained for the APQ ligands lend credence to the viability of APQs as potential CNS therapeutics. The CNS MPO scores will help guide future investigations of the APQ ligands.</div><div class="NLM_p last">There are numerous radioligands and drugs that bind to the VMAT2 and affect its function. The results presented here suggest that the novel APQ compounds bind to a new, heretofore unidentified site on the VMAT2. This site is associated with the region of VMAT2 involved in transport activity, a claim supported by the correlation between binding affinity for this site and inhibition of [<sup>3</sup>H]5-HT uptake (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The modifications of the ketanserin core structure have eliminated affinity for the 5-HT2A receptor and increased selectivity for the [<sup>3</sup>H]reserpine site for most of the compounds reported. In addition, there is very low affinity for the DAT, an off-target site for some compounds that bind to the VMAT2, such as lobeline.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The low affinities of the compounds at the two off-target sites indicate that the APQs have high specificity for VMAT2 compared to ketanserin, a ligand for VMAT2, as well as for 5HT receptors. Whether the APQs also lack affinity for other receptors and transporters has not been determined. An important question for additional studies is whether the APQs interact with the vesicular monoamine transporter 1 (VMAT1), expressed in the intestine, stomach, and sympathetic nervous system.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Ketanserin has slightly higher potency for inhibition of transport by VMAT2 than VMAT1.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> An interesting finding is that the structural changes made to ketanserin have modified the binding preference for the DHTB binding site; APQ ligands prefer to bind to the reserpine site. Additional detailed structureâactivity studies using APQs with varying affinities for VMAT2 may help to characterize the relationships between radioligand binding sites and VMAT2 function, an important precursor to the development of pharmacotherapeutic compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Information and Materials</h3><div class="NLM_p last">All reactions were magnetically stirred and monitored by analytical thin-layer chromatography (TLC) silica gel 60 F254 plates using UV light to visualize the compounds. Column chromatography was carried out on Teledyne ISCO Combiflash automated chromatography units using standard silica gel cartridges. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a JEOL Eclipse 300 MHz spectrometer using tetramethylsilane (TMS) as an internal reference. All target compounds were determined to be >95% pure by HPLC/MS analysis using an Agilent 1200 HPLC apparatus with an ESI mass spectrometer. Melting points were obtained using a Mel-Temp capillary melting-point apparatus and are uncorrected. Reagents and solvents were purchased from commercial suppliers and used without further purification unless otherwise noted.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Ethyl 1-Benzyl-4-(trifluoromethylsulfonyloxy)-1,2,5,6-tetrahydropyridine-3-carboxylate (<b>2</b>)</h3><div class="NLM_p last">To a suspension of ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride (3.32 g, 11.1 mmol) in H<sub>2</sub>O (30 mL) was added potassium carbonate (2.76 g, 20.0 mmol), and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 40 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give the free base (100%) as an oil which was used without further purification. This keto ester was dissolved in anhydrous DMF (20 mL), fitted with a septum, nitrogen inlet, and cooled to 0 Â°C. NaH (60% in mineral oil, 668 mg, 16.7 mmol) was added in one portion, and the solution was stirred at 0 Â°C for 10 min. <i>N</i>-Phenylbis(trifluoromethanesulfonimide) (4.36 g, 12.2 mmol) was added in one portion, and the solution was stirred at 0 Â°C for 1.5 h. Water (50 mL) was then added and the resulting mixture was extracted with EtOAc (3 Ã 50 mL). The combined organic layers were washed with H<sub>2</sub>O (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by flash chromatography eluting with 0â15% EtOAc/hexanes to give <b>2</b> (3.60 g, 83%) as a yellow oil: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.34â7.25 (comp, 5H), 4.27 (q, <i>J</i> = 7.2 Hz, 2H), 3.67 (s, 2H), 3.42 (t, <i>J</i> = 2.7 Hz, 2H), 2.71 (t, <i>J</i> = 5.4 Hz, 2H), 2.53â2.49 (m, 2H), 1.31 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure for the Synthesis of Ethyl 1-Benzyl-4-(aryl)-1,2,5,6-tetrahydropyridine-3-carboxylate (<b>3</b>)</h3><div class="NLM_p last">A 250 mL round-bottom flask was charged with triflate <b>2</b> (6.9 mmol), boronic acid (15.1 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.21 mmol), LiCl (20.6 mmol), and K<sub>2</sub>CO<sub>3</sub> (41.3 mmol). The flask was evacuated and back-flushed with argon three times, anhydrous dioxane (100 mL) was added, and the flask was heated to 95 Â°C overnight. The flask was cooled to room temperature, and CHCl<sub>3</sub> (500 mL) was added. The mixture was then washed with water (2 Ã 150 mL), brine (150 mL), dried (MgSO<sub>4</sub>), and concentrated. The residue was purified by flash chromatography eluting with 0â30% EtOAc/hexanes to give pure <b>3</b>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Procedure for the Synthesis of (Â±)-<i>syn</i>-Ethyl 4-Arylpiperidine-3-carboxylate (<b>4</b>)</h3><div class="NLM_p last">To a 50 mL round-bottom flask was added 10% Pd/C (225 mg, 0.10 mmol, 50% wet) followed by the addition of a solution of <b>3</b> (1 mmol) in EtOH (10 mL). The flask was evacuated and back-flushed with H<sub>2</sub> three times, and the reaction mixture was stirred under a static atmosphere of H<sub>2</sub> at room temperature (unless otherwise noted) for 24â72 h. The suspension was filtered through a pad of Celite, washing with EtOH. The combined filtrate and washings were concentrated and purified by flash chromatography eluting with 0â10% MeOH/EtOAc (1% Et<sub>3</sub>N) to give pure <b>4</b>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of (Â±)-<i>syn</i>-Ethyl 1-(2-(2,4-Dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)ethyl)-4-arylpiperidine-3-carboxylate (<b>5</b>)</h3><div class="NLM_p last">A 25 mL high-pressure tube was charged with <b>4</b> (0.4 mmol), <b>6</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (0.42 mmol), and toluene or CH<sub>3</sub>CN (3 mL). The tube was sealed and heated to 110 Â°C for 2 days. The reaction mixture was concentrated and the residue was purified by flash chromatography, eluting with 0â100% CH<sub>2</sub>Cl<sub>2</sub>/EtOAc [<i>R<sub>f</sub></i> â 0.3 (50% CH<sub>2</sub>Cl<sub>2</sub>/EtOAc)] to give <b>5</b> as an off-white solid. The ligands were then converted to their hydrochloride salts prior to biological testing. Compounds were dissolved in CHCl<sub>3</sub> (1 mL), and 1 N HCl (2 equiv) was then added, and the solution was stirred for 5 min. The solvent was removed under reduced pressure, and the crude solid was dissolved in water. After filtration and removal of the solvent by lyophilization, pure salts could be obtained in good yields.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Tritium Labeled [<sup>3</sup>H](+)-<i>syn</i>-Ethyl 1-(2-(2,4-Dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)ethyl)-4-(4-fluorophenyl)piperidine-3-carboxylate ([<sup>3</sup>H]-<b>5b</b>)</h3><div class="NLM_p last">The title compound was prepared via direct tritiation of <b>5b</b> by Morevek Bochemical. Specific activity: 12.8 Ci/mmol. Radiochemical purity: 99.8%.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of (Â±)-<i>anti</i>-Ethyl 1-<i>tert</i>-Butyl-4-(4-fluorophenyl)piperidine-1,3-dicarboxylate (<b>7</b>)</h3><div class="NLM_p">A 50 mL round-bottom flask was charged with <b>4b</b> (215 mg, 0.86 mmol), MeOH (5 mL), triethylamine (240 Î¼L, 1.72 mmol), and a magnetic stir bar. Boc<sub>2</sub>O (375 mg, 1.72 mmol) was added with vigorous stirring, and the mixture was heated to 60 Â°C for 30 min. Volatiles were removed in vacuo, and the residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and brine (5 mL). The layers were separated, and the aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 10 mL). The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and concentrated, then purified by flash chromatography, eluting with 0â100% EtOAc/hexanes to give boc protected <b>4b</b> (214 mg, 71%): <i>R<sub>f</sub></i> = 0.75 (50% EtOAc/hexanes, 1% Et<sub>3</sub>N); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.19 (dd, <i>J</i> = 5.5, 8.8 Hz, 1H), 6.95 (t, <i>J</i> = 8.8 Hz, 2H), 4.09â4.64 (m, 2H), 3.92 (q, <i>J</i> = 7.2 Hz, 2H), 3.01â3.29 (m, 1H), 2.71â3.02 (m, 2H), 2.48â2.71 (m, 1H), 1.54â1.85 (m, 2H), 1.47 (s, 9H), 1.04 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) Î´ 171.6, 163.3, 160.0, 154.5, 138.3, 129.1, 129.0, 115.2, 115.0, 79.7, 60.2, 49.1, 45.7, 43.6, 42.5, 28.5, 25.9, 14.1.</div><div class="NLM_p last">A 50 mL round-bottom flask was charged with the previous product (194 mg, 0.55 mmol), EtOH (5 mL), and NaOEt (56 mg, 0.83 mmol), then heated to 70 Â°C for 3 h in an oil bath. The solution was concentrated in vacuo and purified by flash chromatography, eluting with 0â30% EtOAc/hexanes to give pure <b>7</b> (137 mg, 71%): <i>R<sub>f</sub></i> = 0.87 (50% EtOAc/hexanes, +1% Et<sub>3</sub>N); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.13 (dd, <i>J</i> = 5.2, 8.8 Hz, 2H), 6.96 (t, <i>J</i> = 8.8 Hz, 2H), 4.35 (br s, 1H), 4.24 (br s, 1H), 3.89 (q, <i>J</i> = 7.2 Hz, 2H), 2.72â3.04 (m, 3H), 2.47â2.71 (m, 1H), 1.69â1.87 (m, 1H), 1.56â1.69 (m, H), 1.48 (s, 9H), 0.95 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) Î´ 172.5, 163.4, 160.2, 154.5, 138.6, 129.0, 128.9, 115.5, 115.2, 80.2, 60.4, 49.1, 46.3, 45.1, 44.1, 32.9, 28.5, 14.0.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of (Â±)-<i>anti</i>-Ethyl 4-(4-Fluorophenyl)piperidine-3-carboxylate (<b>8</b>)</h3><div class="NLM_p last">Compound <b>7</b> (126 mg, 0.36 mmol) was taken up in HCl (4 M in dioxane, 6.3 mL) under N<sub>2</sub>. The solution was stirred 45 min and neutralized with solid NaHCO<sub>3</sub> (4.60 g). The reaction mixture was diluted with water (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 20 mL). The combined organic layers were dried (MgSO<sub>4</sub>), concentrated. The residue was purified by flash chromatography, eluting with 0â10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1% Et<sub>3</sub>N) to give <b>9</b> (90 mg, 100%); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.15 (dd, <i>J</i> = 5.2, 8.8 Hz, 2H), 6.94 (t, <i>J</i> = 8.8 Hz, 2H), 3.87 (q, <i>J</i> = 7.2 Hz, 2H), 3.33 (dd, <i>J</i> = 3.6, 11.8 Hz, 1H), 3.10â3.25 (m, 1H), 2.62â2.95 (m, 4H), 2.25 (br s, 1H), 1.74â1.92 (m, 1H), 1.62 (dq, <i>J</i> = 4.1, 12.6 Hz, 1H), 0.95 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (Â±)-<i>anti</i>-Ethyl 1-(2-(2,4-Dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)ethyl)-4-(4-fluorophenyl)piperidine-3-carboxylate (<b>9</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>8</b> and <b>6</b> as an off-white solid (68 mg, 47%) using the general procedure described above for the synthesis of 5. Mp = 195.0â197.0 Â°C; <i>R</i><sub><i>f</i></sub> = 0.54 (10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.47 (s, 1H), 7.94 (dd, <i>J</i> = 1.1, 8.0 Hz, 1H), 7.66 (ddd, <i>J</i> = 1.4, 7.4, 8.0 Hz, 1H), 7.14â7.30 (m, 4H), 7.07 (t, <i>J</i> = 8.8 Hz, 2H), 4.04 (t, <i>J</i> = 6.9 Hz, 2H), 3.82 (qd, <i>J</i> = 1.7, 7.2 Hz, 2H), 3.18 (d, <i>J</i> = 10.7 Hz, 1H), 3.02 (d, <i>J</i> = 10.7 Hz, 1H), 2.65â2.78 (m, 2H), 2.60 (t, <i>J</i> = 6.9 Hz, 2H), 2.07â2.27 (m, 2H), 1.51â1.75 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 172.9, 163.0, 162.5, 159.8, 150.7, 140.2, 140.0, 135.6, 129.7, 129.6, 127.9, 123.1, 115.7, 115.6, 115.3, 114.3, 60.1, 56.2, 55.2, 53.9, 49.1, 44.7, 38.0, 33.3, 14.3. Anal. Calcd for C<sub>24</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>F: C, 65.59; H, 5.96; N, 9.56; F, 4.32. Found: C, 65.52; H, 6.09; N, 9.42; F, 4.24. MS (APCI, [M + H]<sup>+</sup>, <i>m</i>/<i>z</i>) 440.2.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cell Culture</h3><div class="NLM_p last">The human VMAT2 cDNA was generously supplied by Dr. Robert Edwards (University of California, San Francisco, CA) and subcloned into pcDNA3.1 with G418 resistance. HEK-293 cells were transfected with the human VMAT2 and characterized as described previously.<a onclick="showRef(event, 'ref16 ref41'); return false;" href="javascript:void(0);" class="ref ref16 ref41">(16,41)</a> Cells were maintained in Dulbeccoâs modified Eagleâs medium (DMEM) supplemented with 10% FetalClone and 0.05 U of penicillin/streptomycin. Stock plates were grown on 150 mm diameter tissue culture dishes in 10% CO<sub>2</sub> at 37 Â°C.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> [<sup>3</sup>H](+)-<b>5b</b> Binding Assay</h3><div class="NLM_p last">Conditions were optimized for [<sup>3</sup>H](+)-<b>5b</b> binding, and [<sup>3</sup>H](+)-<b>5b</b> binding to the human VMAT2 in HEK-VMAT2 cells was performed as follows. Cells were grown to confluence and washed with Tris buffer (25 mM, pH 7.4). Cells were scraped from plates in 5 mL of Tris buffer, resuspended, and centrifuged at 30â¯900<i>g</i> for 20 min at 4 Â°C. The resulting pellet was resuspended in 2 mL of H<sub>2</sub>O and homogenized with a Polytron homogenizer at setting 6 for 5â10 s. After 10 min incubation on ice, osmolarity was reestablished with the addition of 338 Î¼L of 250 mM Tris (pH 7.4), 338 Î¼L of 1 M potassium tartrate, and 10 Î¼L of 0.9 M MgSO<sub>4</sub>. The binding assays contained approximately 50â75 Î¼g of membrane protein (less than 15% of the radioactivity added was bound) and [<sup>3</sup>H](+)-<b>5b</b> (50â100 nM final concentration) in a final volume of 250 Î¼L. Tris assay buffer [25 mM Tris, 5 mM KCl, 2.5 mM MgSO<sub>4</sub>, 0.32 M sucrose, 2 mM Mg-ATP, pH 7.4] was used for all assays except as indicated. Specific binding was defined as the difference in binding observed in the absence and presence of 10 Î¼M O-7443 (an analog of (+)-<b>5b</b>). The membranes were incubated for 60 min (equilibrium) at 4 Â°C in the dark except where indicated. Assays were terminated by filtration through Filtermat A filters (PerkinElmer) using a 96-well Tomtec cell harvester. Scintillation fluid (50 Î¼L) was added to each filtered spot, and the radioactivity remaining on the filters was determined using a Wallac 1205 Beta plate scintillation counter. Saturation binding experiments were conducted with duplicate determinations at each ligand concentration, which included radiolabeled and nonradiolabeled ligand for final concentrations ranging from 5 to 600 nM for (+)-<b>5b</b>. Protein concentrations were determined using a modified bicinchoninic acid (BCA) protein assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> [<sup>3</sup>H]Reserpine Binding Assay</h3><div class="NLM_p last">The [<sup>3</sup>H]reserpine binding assay was modified from the literature procedure.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> [<sup>3</sup>H]Reserpine binding to the human VMAT2 in HEK-VMAT2 cells was performed as follows. Membranes were prepared as for [<sup>3</sup>H](+)-<b>5b</b> binding (above). The assays contained approximately 200â300 Î¼g of membrane protein for [<sup>3</sup>H]reserpine binding (less than 15% of the radioactivity added was bound) and [<sup>3</sup>H]reserpine (6â8 nM final concentration) in a final volume of 1 mL. Tris assay buffer was used for all assays except as indicated. Specific binding was defined as the difference in binding observed in the absence and presence of 1 Î¼M reserpine. The membranes were incubated for 60 min (equilibrium) at 30 Â°C. Assays were terminated by addition of 1 mL of ice-cold Tris buffer containing 2 Î¼M nonradiolabeled reserpine and filtration over Whatman 25 mm GF/C filters presoaked in 0.05% polyethylenimine through a 12-channel Millipore filtration chamber. Filters were washed three times with 10 mL of ice-cold Tris buffer. Remaining radioactivity on the filters was counted on a Beckman LS6500 scintillation counter. Saturation binding experiments were conducted with duplicate determinations at each ligand concentration, which included radiolabeled and nonradiolabeled ligand for final concentrations ranging from 1 to 22 nM for reserpine. Protein concentrations were determined using a modified BCA protein assay.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> [<sup>3</sup>H]DHTB Binding Assay</h3><div class="NLM_p last">[<sup>3</sup>H]DHTB binding to the human VMAT2 in HEK-VMAT2 cells was performed as described previously, with minor modifications.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Cells were grown to confluence and washed with calciumâmagnesium-free phosphate-buffered saline (cmf-PBS). Cells were scraped from plates in 0.32 M sucrose (4 mL), homogenized with a Polytron homogenizer at setting 6 for 5â10 s, and centrifuged at 30â¯900<i>g</i> for 20 min at 4 Â°C. The resulting pellet was resuspended in 2 mL of H<sub>2</sub>O, homogenized with a Polytron homogenizer, incubated for 10 min on ice, and osmolarity was reestablished by addition of 338 Î¼L of 250 mM Tris, 338 Î¼L of 1 M potassium tartrate, and 10 Î¼L of 0.9 M MgSO<sub>4</sub>. The assays contained approximately 75â150 Î¼g of membrane protein for [<sup>3</sup>H]DHTB binding (less than 15% of the radioactivity added was bound) and [<sup>3</sup>H]DHTB (6â8 nM final concentration) in a final volume of 250 Î¼L. Tris assay buffer without ATP was used for all assays except as indicated. Specific binding was defined as the difference in binding observed in the absence and presence of 2 Î¼M DHTB. The membranes were incubated for 90 min, unless otherwise indicated, at room temperature. Assays were terminated by filtration through Filtermat A filters using a 96-well Tomtec cell harvester, and radioactivity was determined as for [<sup>3</sup>H](+)-<b>5b</b> using a PerkinElmer 1405 microBeta scintillation counter. Saturation binding experiments were conducted with duplicate determinations at each ligand concentration, which included radiolabeled and nonradiolabeled ligand for final concentrations ranging from 6 to 200 nM for DHTB. Protein concentrations were determined using a modified BCA protein assay.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> [<sup>3</sup>H]5HT Uptake Assay, HEK-Human VMAT2</h3><div class="NLM_p last">The HEK-VMAT2 [<sup>3</sup>H]5HT uptake assay was performed as described previously, with minor modifications.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> [<sup>3</sup>H]5HT was used for the uptake assay because it had slightly higher potency than DA or NE in preliminary uptake experiments (data not shown) and has been used as [<sup>3</sup>H]substrate to characterize VMAT2 activity.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44â46)</a> HEK-human VMAT2 cells were grown until confluent. After removal of medium, cells were scraped from plates and homogenized with 12 strokes of a glass/glass homogenizer in sucrose (0.32 M supplemented with protease inhibitors). After centrifugation at 800<i>g</i> for 10 min, the supernatant was removed and centrifuged at 10â¯000<i>g</i> for 20 min. The pellet was resuspended in sucrose (0.32 M with protease inhibitors). The membranes were osmotically shocked by addition of 3.5 volumes of water (4 Â°C) and homogenized with a glass/Teflon homogenizer. Osmolarity was reestablished with addition of Tris (25 mM final), potassium tartrate (100 mM), and MgSO<sub>4</sub> (0.9 mM), and the membranes were centrifuged at 20â¯000<i>g</i> for 20 min. After centrifugations, the pellet was resuspended in VMAT2 uptake buffer (100 mM potassium tartrate, 25 mM Tris, 4 mM KCl, 2 mM MgSO<sub>4</sub>, 1.7 mM ascorbic acid, 100 Î¼M tropolone, and 1 Î¼M pargyline, pH 7.4, at 25 Â°C with MgATP, 2 mM) using 2 gentle strokes of a Teflon/glass homogenizer. The uptake assay was conducted in duplicate and included membrane preparation, drug, [<sup>3</sup>H]5-HT (40 nM), and VMAT2 uptake buffer in a final volume of 0.25 mL. [<sup>3</sup>H]5-HT uptake by HEK-VMAT2 membranes is ATP dependent (data not shown). Membranes were preincubated with drugs for 10 min at 30 Â°C. After addition of [<sup>3</sup>H]5HT, uptake was conducted at 30 Â°C for 6 min and terminated by filtration as described for [<sup>3</sup>H]DHTB binding, using filters presoaked in 0.05% polyethylenimine. Specific uptake was defined as the difference in uptake observed in the absence and presence of reserpine (1 Î¼M).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> [<sup>3</sup>H]5HT Uptake Assay, Vesicular Preparation of Mouse Striata</h3><div class="NLM_p last">The method was adapted from the literature.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> C57Bl/6J mice (males and females, 44 total, ages 121â152 days) were used. All procedures were performed in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the VA Portland Health Care System. Mice were sacrificed by cervical dislocation, striata were dissected, placed on ice, and homogenized with 12 strokes of a glass/Teflon homogenizer in sucrose (0.32 M supplemented with protease inhibitors). After centrifugation at 800<i>g</i> for 10 min, the supernatant was decanted, the pellet was resuspended in sucrose solution and centrifuged at 800<i>g</i> for 10 min. The supernatants were combined and centrifuged at 10â¯000<i>g</i> for 20 min. The pellet was resuspended in sucrose (0.32 M with protease inhibitors). The membranes were osmotically shocked by addition of 3.5 volumes of water (4 Â°C) and homogenized with a glass/Teflon homogenizer. Osmolarity was reestablished with addition of Tris (25 mM final), potassium tartrate (100 mM), and MgSO<sub>4</sub> (0.9 mM), and the membranes were centrifuged at 20â¯000<i>g</i> for 20 min. The supernatant was decanted and centrifuged at 100â¯000<i>g</i> for 60 min in a Beckman Optima TLX Ultracentrifuge. Uptake was conducted at 30 Â°C for 8 min and terminated as described above. Specific uptake was defined as the difference in uptake observed in the absence and presence of the VMAT2-selective compound reserpine (1 Î¼M) and was 81â84% of total [<sup>3</sup>H]5-HT uptake.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Because reserpine does not bind to the DAT, NET, or SERT, uptake by those transporters in the presence of the VMAT2 blocker, reserpine, is nonspecific uptake.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50â52)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> [<sup>125</sup>I]RTI-55 Binding to hDAT and [<sup>125</sup>I]DOI Binding to Human Serotonin Receptor (5HT2A)</h3><div class="NLM_p last">[<sup>125</sup>I]RTI-55 binding to the hDAT stably expressed in HEK-293 cells was conducted as previously described using a total particulate membrane preparation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The binding assay included test compound or buffer, membranes, [<sup>125</sup>I]RTI-55 (40â60 pM), and buffer in a final volume of 250 Î¼L. Specific binding was defined as the difference between total binding and binding in the presence of 5 Î¼M mazindol. [<sup>125</sup>I]RTI-55 binding to the human norepinephrine transporter and the human serotonin transporter was conducted as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> [<sup>125</sup>I]DOI binding to the h5-HT<sub>2A</sub> receptor stably expressed in HEK-293 cells was conducted as previously described.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The binding assay included test compound or buffer, well-washed cell homogenate, [<sup>125</sup>I]DOI (50 pM), and buffer in a final volume of 250 Î¼L. Specific binding was defined as the difference between total binding and binding in the presence of 10 Î¼M 5HT.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> MTT Cell Viability Assay</h3><div class="NLM_p last">Compounds were tested for effects on cell viability using a MTT cell proliferation assay kit (Abcam, Cambridge, MA), HEK-VMAT2 cells (5 Ã 10<sup>4</sup>) were plated in 96-well plates in 100 Î¼L of DMEM supplemented with 10% FetalClone, 0.05 U of penicillin/streptomycin, and G418. This density of cells was in the linear response range for the assay (data not shown). On day 2, drugs (100 Î¼L) in unsupplemented DMEM or DMEM were added to triplicate wells. The medium was removed 24 h later, and unsupplemented medium and MTT reagent were added. The plate was incubated for 2 h. at 37 Â°C, medium was removed, and MTT solvent was added. After 15 min on a shaker, the plate was read at 590 nm. Data were normalized to the response of control cells. Data were analyzed with one-way ANOVA followed with Dunnettâs test. All conditions had 0.1% DMSO. As a positive control, staurosporine, which induces programmed cell death, decreased cell viability at 1 and 3 Î¼M (data not shown).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Statistical Analysis</h3><div class="NLM_p last">GraphPad Prism 7.02 software (GraphPad Inc., La Jolla, CA) was used to analyze all kinetic, saturation, and competition binding data and was used for analysis of variance (ANOVA) with Bonferroni post-tests. Association experiments with a single concentration of radioligand were analyzed using one phase exponential association nonlinear fit to determine <i>k</i><sub>obs</sub>. Dissociation experiments were analyzed using a one phase exponential decay nonlinear fit to determine the dissociation rate constant and half-life. Data shown are the mean Â± SEM except as indicated. <i>t</i> tests (two-tailed, unpaired) were performed using Microsoft Excel (Microsoft, Redmond, WA). Correlations were assessed with Spearmanâs nonparametric correlation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00542" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00542" class="ext-link">10.1021/acs.jmedchem.8b00542</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed experimental procedures,Â spectroscopic data (<sup>1</sup>H NMR) and MPO calculations for the APQ ligands (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf">jm8b00542_si_001.pdf (4.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_002.csv">jm8b00542_si_002.csv (1.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00542" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian A. Provencher</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Merrimack
College, North
Andover, Massachusetts 01845, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2607-9530" title="Orcid link">http://orcid.org/0000-0003-2607-9530</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e9b99b869f8c878a818c9baba9848c9b9b8084888a82c78c8d9c"><span class="__cf_email__" data-cfemail="2f7f5d40594a414c474a5d6d6f424a5d5d46424e4c44014a4b5a">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy J. Eshleman</span> - <span class="hlFld-Affiliation affiliation">Research
Service, VA Portland Health Care System, Portland, Oregon 97239, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert A. Johnson</span> - <span class="hlFld-Affiliation affiliation">Research
Service, VA Portland Health Care System, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Shi</span> - <span class="hlFld-Affiliation affiliation">Research
Service, VA Portland Health Care System, Portland, Oregon 97239, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Kryatova</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jared Nelson</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianhua Tian</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Gonzalez</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter C. Meltzer</span> - <span class="hlFld-Affiliation affiliation">Organix
Inc, 240 Salem Street, Woburn, Massachusetts 01801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Janowsky</span> - <span class="hlFld-Affiliation affiliation">Research
Service, VA Portland Health Care System, Portland, Oregon 97239, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">The
Methamphetamine Abuse Research Center, Oregon
Health and Science University, Portland, Oregon 97239, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. The authors contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank John F. Reed for technical assistance. This work was funded by the Department of Veterans Affairs Merit Review Program on Novel Pharmacotherapies for Psychostimulant Addiction (Grant I01 BX000939), Research Career Scientist Program, the National Institute on Drug Abuse (NIDA)-funded Methamphetamine Abuse Research Center (Grant P50 DA018165), and an NIH-VA interagency agreement (Grant ADA15001). The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">APQ</td><td class="NLM_def"><p class="first last">arylpiperidinylquinazoline</p></td></tr><tr><td class="NLM_term">CCR2</td><td class="NLM_def"><p class="first last">CC chemokine receptor 2</p></td></tr><tr><td class="NLM_term">CCL2</td><td class="NLM_def"><p class="first last">CC chemokine ligand 2</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">CC chemokine receptor 5</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DHTB</td><td class="NLM_def"><p class="first last">dihydrotetrabenazine</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">VMAT1</td><td class="NLM_def"><p class="first last">vesicular monoamine transporter 1</p></td></tr><tr><td class="NLM_term">VMAT2</td><td class="NLM_def"><p class="first last">vesicular monoamine transporter 2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbruscato, T. J.</span>; <span class="NLM_string-name">Tripper, P. C.</span></span> <span> </span><span class="NLM_article-title">DARK classics in chemical neuroscience: methamphetamine</span>.  <i>ACS Chem. Neurosci.</i> [Online Early Access] <span class="refDoi">Â DOI: 10.1021/acschemneuro.8b00123</span> . Published Online: March 30, <span class="NLM_year" style="font-weight: bold;">2018</span>. <a href="https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00123" class="extLink">https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00123</a> (accessed July 15, 2018).</span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=T.+J.+Abbruscato&author=P.+C.+Tripper&title=DARK+classics+in+chemical+neuroscience%3A+methamphetamine&doi=10.1021%2Facschemneuro.8b00123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00123%26sid%3Dliteratum%253Aachs%26aulast%3DAbbruscato%26aufirst%3DT.%2BJ.%26atitle%3DDARK%2520classics%2520in%2520chemical%2520neuroscience%253A%2520methamphetamine%26jtitle%3DACS%2520Chem.%2520Neurosci.%26doi%3D10.1021%2Facschemneuro.8b00123%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <i>The
DAWN Report: Emergency Department Visits Involving Methamphetamine:
2007 to 2011</i>; <span class="NLM_publisher-name">Substance Abuse and Mental
Health Services Administration, Center for Behavioral Health Statistics
and Quality</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, June 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The%0ADAWN+Report%3A+Emergency+Department+Visits+Involving+Methamphetamine%3A%0A2007+to+2011%3B+Substance+Abuse+and+Mental%0AHealth+Services+Administration%2C+Center+for+Behavioral+Health+Statistics%0Aand+Quality%3A+Rockville%2C+MD%2C+June+19%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%250ADAWN%2520Report%253A%2520Emergency%2520Department%2520Visits%2520Involving%2520Methamphetamine%253A%250A2007%2520to%25202011%26pub%3DSubstance%2520Abuse%2520and%2520Mental%250AHealth%2520Services%2520Administration%252C%2520Center%2520for%2520Behavioral%2520Health%2520Statistics%250Aand%2520Quality%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battki, S. L.</span></span> <span> </span><span class="NLM_article-title">Stimulant psychosis: symptom profile and acute clinical course</span>. <i>Am. J. Addict.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28</span>â <span class="NLM_lpage">37</span>, <span class="refDoi">Â DOI: 10.1080/10550490050172209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1080%2F10550490050172209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10914291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FksFSrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=28-37&author=D.+Harrisauthor=S.+L.+Battki&title=Stimulant+psychosis%3A+symptom+profile+and+acute+clinical+course&doi=10.1080%2F10550490050172209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulant psychosis: symptom profile and acute clinical course</span></div><div class="casAuthors">Harris D; Batki S L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal on addictions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>
        ISSN:<span class="NLM_cas:issn">1055-0496</span>.
    </div><div class="casAbstract">Nineteen patients seen at a psychiatric emergency service with amphetamine- or cocaine-induced psychotic disorder were assessed with structured interviews, chart review, and blood and urine testing.  All had a predominance of positive symptoms from the Positive and Negative Syndrome Scale (PANSS).  However, some subjects had substantial Negative Scale scores (26%), bizarre delusions (95%), and Schneiderian hallucinations (63%), mimicking a broad range of schizophrenic symptoms.  Several PANSS scores were correlated with treatment intensity: Positive score with seclusion hours, General Psychopathology and Negative scores with hospitalization length, and General Psychopathology score with neuroleptic dose.  Presenting symptoms may help in treatment planning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdQuKR6fS1aMNIRw0GKUoEfW6udTcc2eaLdpBieS6T3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FksFSrtw%253D%253D&md5=a483671c65ff39b967ddd644d24c490b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F10550490050172209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10550490050172209%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DBattki%26aufirst%3DS.%2BL.%26atitle%3DStimulant%2520psychosis%253A%2520symptom%2520profile%2520and%2520acute%2520clinical%2520course%26jtitle%3DAm.%2520J.%2520Addict.%26date%3D2000%26volume%3D9%26spage%3D28%26epage%3D37%26doi%3D10.1080%2F10550490050172209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dannals, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricaurte, G. A.</span></span> <span> </span><span class="NLM_article-title">Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">8417</span>â <span class="NLM_lpage">8422</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-20-08417.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1523%2FJNEUROSCI.18-20-08417.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9763484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK1cXms1ehurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=8417-8422&author=U.+D.+McCannauthor=D.+F.+Wongauthor=F.+Yokoiauthor=V.+Villemagneauthor=R.+F.+Dannalsauthor=G.+A.+Ricaurte&title=Reduced+striatal+dopamine+transporter+density+in+abstinent+methamphetamine+and+methcathinone+users%3A+evidence+from+positron+emission+tomography+studies+with+%5B11C%5DWIN-35%2C428&doi=10.1523%2FJNEUROSCI.18-20-08417.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428</span></div><div class="casAuthors">McCann, Una D.; Wong, Dean F.; Yokoi, Fuji; Villemagne, Victor; Dannals, Robert F.; Ricaurte, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8417-8422</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Methamphetamine and methcathinone are psychostimulant drugs with high potential for abuse.  In animals, methamphetamine and related drugs are known to damage brain dopamine (DA) neurons, and this damage has recently been shown to be detectable in living nonhuman primates by means of positron emission tomog. (PET) with [11C]WIN-35,428, a DA transporter (DAT) ligand.  The present studies detd. whether living humans with a history of methamphetamine or methcathinone abuse showed evidence of lasting decrements in brain DAT d.  PET studies were performed in 10 control subjects, six abstinent methamphetamine users, four abstinent methcathinone users, and three patients with Parkinson's disease (PD).  On av., subjects had abstained from amphetamine use for â¼3 yr.  Before PET studies, all subjects underwent urine and blood toxicol. screens to rule out recent drug use.  Compared with controls, abstinent methamphetamine and methcathinone users had significant decreases in DAT d. in the caudate nucleus (-23 and -24%, resp.) and putamen (-25 and -16%, resp.).  Larger decreases in DAT d. were evident in patients with PD (47 and 68% in caudate and putamen, resp.).  Neither methamphetamine nor methcathinone users showed clin. signs of parkinsonism.  Persistent redns. of DAT d. in methamphetamine and methcathinone users are suggestive of loss of DAT or loss of DA terminals and raise the possibility that as these individuals age, they may be at increased risk for the development of parkinsonism or neuropsychiatric conditions in which brain DA neurons have been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_HqZiJIwONbVg90H21EOLACvtfcHk0ljTiaPUccUDoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1ehurY%253D&md5=7ec1afd20873623076d37e228e7c7176</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-20-08417.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-20-08417.1998%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DU.%2BD.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DVillemagne%26aufirst%3DV.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRicaurte%26aufirst%3DG.%2BA.%26atitle%3DReduced%2520striatal%2520dopamine%2520transporter%2520density%2520in%2520abstinent%2520methamphetamine%2520and%2520methcathinone%2520users%253A%2520evidence%2520from%2520positron%2520emission%2520tomography%2520studies%2520with%2520%255B11C%255DWIN-35%252C428%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D8417%26epage%3D8422%26doi%3D10.1523%2FJNEUROSCI.18-20-08417.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freissmuth, M.</span></span> <span> </span><span class="NLM_article-title">Amphetamines, new psychoactive drugs and the monoamine transporter cycle</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">41</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.tips.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=25542076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVanug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=41-50&author=H.+Sitteauthor=M.+Freissmuth&title=Amphetamines%2C+new+psychoactive+drugs+and+the+monoamine+transporter+cycle&doi=10.1016%2Fj.tips.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amphetamines, new psychoactive drugs and the monoamine transporter cycle</span></div><div class="casAuthors">Sitte, Harald H.; Freissmuth, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-50</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In monoaminergic neurons, the vesicular transporters and the plasma membrane transporters operate in a relay.  Amphetamine and its congeners target this relay to elicit their actions: most amphetamines are substrates, which pervert the relay to elicit efflux of monoamines into the synaptic cleft.  However, some amphetamines act as transporter inhibitors.  Both compd. classes elicit profound psychostimulant effects, which render them liable to recreational abuse.  Currently, a surge of new psychoactive substances occurs on a global scale.  Chemists bypass drug bans by ingenuous structural variations, resulting in a rich pharmacol.  A credible transport model must account for their distinct mode of action and link this to subtle differences in activity and undesired, potentially deleterious effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjU1hFyvU8R7Vg90H21EOLACvtfcHk0ljTiaPUccUDoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVanug%253D%253D&md5=18de6ecc05000d320900885e41d97da2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DSitte%26aufirst%3DH.%26aulast%3DFreissmuth%26aufirst%3DM.%26atitle%3DAmphetamines%252C%2520new%2520psychoactive%2520drugs%2520and%2520the%2520monoamine%2520transporter%2520cycle%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D41%26epage%3D50%26doi%3D10.1016%2Fj.tips.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-420118-7.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FB978-0-12-420118-7.00002-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=71-106&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=A.+Vartakauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=The+vesicular+monoamine+transporter-2%3A+an+important+pharmacological+target+for+the+discovery+of+novel+therapeutics+to+treat+methamphetamine+abuse&doi=10.1016%2FB978-0-12-420118-7.00002-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DVartak%26aufirst%3DA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter-2%253A%2520an%2520important%2520pharmacological%2520target%2520for%2520the%2520discovery%2520of%2520novel%2520therapeutics%2520to%2520treat%2520methamphetamine%2520abuse%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D71%26epage%3D106%26doi%3D10.1016%2FB978-0-12-420118-7.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span> <span> </span><span class="NLM_article-title">VMAT2: A dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.2010.05906.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1111%2Fj.1749-6632.2010.05906.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2011&pages=86-98&author=L.+E.+Eidenauthor=E.+Weihe&title=VMAT2%3A+A+dynamic+regulator+of+brain+monoaminergic+neuronal+function+interacting+with+drugs+of+abuse&doi=10.1111%2Fj.1749-6632.2010.05906.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05906.x%26sid%3Dliteratum%253Aachs%26aulast%3DEiden%26aufirst%3DL.%2BE.%26aulast%3DWeihe%26aufirst%3DE.%26atitle%3DVMAT2%253A%2520A%2520dynamic%2520regulator%2520of%2520brain%2520monoaminergic%2520neuronal%2520function%2520interacting%2520with%2520drugs%2520of%2520abuse%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1216%26spage%3D86%26epage%3D98%26doi%3D10.1111%2Fj.1749-6632.2010.05906.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. W.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter 2: an underexplored pharmacological target</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2013.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=24398404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=89-97&author=A.+I.+Bernsteinauthor=K.+A.+Stoutauthor=G.+W.+Miller&title=The+vesicular+monoamine+transporter+2%3A+an+underexplored+pharmacological+target&doi=10.1016%2Fj.neuint.2013.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter 2: An underexplored pharmacological target</span></div><div class="casAuthors">Bernstein, Alison I.; Stout, Kristen A.; Miller, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Active transport of neurotransmitters into synaptic vesicles is required for their subsequent exocytotic release.  In the monoamine system, this process is carried out by the vesicular monoamine transporters (VMAT1 and VMAT2).  These proteins are responsible for vesicular packaging of dopamine, norepinephrine, serotonin, and histamine.  These proteins are essential for proper neuronal function; however, compared to their plasma membrane counterparts, there are few drugs available that target these vesicular proteins.  This is partly due to the added complexity of crossing the plasma membrane, but also to the tech. difficulty of assaying for vesicular uptake in high throughput.  Until recently, reagents to enable high throughput screening for function of these vesicular neurotransmitter transporters have not been available.  Fortunately, novel compds. and methods are now making such screening possible; thus, a renewed focus on these transporters as potential targets is timely and necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHcBYk8fojmbVg90H21EOLACvtfcHk0ljuqH6URxVD6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D&md5=f83b99eb743485ba5b44ec54e51228b2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DA.%2BI.%26aulast%3DStout%26aufirst%3DK.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BW.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%25202%253A%2520an%2520underexplored%2520pharmacological%2520target%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.neuint.2013.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumushima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arime, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span> <span> </span><span class="NLM_article-title">Monoamine transporter as a target molecule for psychostimulants</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">33</span>, <span class="refDoi">Â DOI: 10.1016/S0074-7742(09)85003-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FS0074-7742%2809%2985003-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=19607959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=29-33&author=I.+Soraauthor=B.+Liauthor=S.+Fumushimaauthor=A.+Fukuiauthor=Y.+Arimeauthor=Y.+Kasaharaauthor=H.+Tomitaauthor=K.+Ikeda&title=Monoamine+transporter+as+a+target+molecule+for+psychostimulants&doi=10.1016%2FS0074-7742%2809%2985003-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine transporter as a target molecule for psychostimulants</span></div><div class="casAuthors">Sora, Ichiro; Li, BingJin; Fumushima, Setsu; Fukui, Asami; Arime, Yosefu; Kasahara, Yoshiyuki; Tomita, Hiroaki; Ikeda, Kazutaka</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">Advances in Neuropharmacology</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Methamphetamine (MAP), a drug of abuse known worldwide for its addictive effects and neurotoxicity, causes somatic and psychiatric disorders.  MAP enters terminals/neurons via monoamine transporters, displaces both vesicular and intracellular monoamines, and facilitates the release of monoamines into the extraneuronal space through synaptic transport via the monoamine transporters.  Chronic psychostimulant abusers exhibit psychotic features, including delusions and auditory hallucinations.  The dopamine transporter (DAT) and the vesicular monoamine transporter 2 (VMAT2) play pivotal roles in the action of MAP, including locomotor effects.  The deletion of DAT attenuates the locomotor effects of MAP and may play larger role in behavioral responses to MAP compared to the deletion of VMAT2.  MAP produces hyperthermia and/or neuronal toxicity in most species.  The effects of MAP in DAT or serotonin transporter (SERT) single knockout (KO) mice and DAT/SERT double KO mice suggested that DAT and SERT are key mols. for hyperthermia and neuronal toxicity of MAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFVKV_H2UD-7Vg90H21EOLACvtfcHk0ljuqH6URxVD6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rJ&md5=9816fd35ca82f6e50905a1289f9a96bb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2985003-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252985003-4%26sid%3Dliteratum%253Aachs%26aulast%3DSora%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFumushima%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DA.%26aulast%3DArime%26aufirst%3DY.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DK.%26atitle%3DMonoamine%2520transporter%2520as%2520a%2520target%2520molecule%2520for%2520psychostimulants%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D85%26spage%3D29%26epage%3D33%26doi%3D10.1016%2FS0074-7742%2809%2985003-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">New scaffold for lead compounds to treat methamphetamine use disorders</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi">Â DOI: 10.1208/s12248-018-0192-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1208%2Fs12248-018-0192-y" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=29&author=N.-R.+Leeauthor=G.+Zhengauthor=P.+A.+Crooksauthor=M.+T.+Bardoauthor=L.+P.+Dwoskin&title=New+scaffold+for+lead+compounds+to+treat+methamphetamine+use+disorders&doi=10.1208%2Fs12248-018-0192-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1208%2Fs12248-018-0192-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-018-0192-y%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.-R.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DNew%2520scaffold%2520for%2520lead%2520compounds%2520to%2520treat%2520methamphetamine%2520use%2520disorders%26jtitle%3DAAPS%2520J.%26date%3D2018%26volume%3D20%26spage%3D29%26doi%3D10.1208%2Fs12248-018-0192-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grouleff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladefoged, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koldso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiott, B.</span></span> <span> </span><span class="NLM_article-title">Monoamine transporters: insights from molecular dynamics simulations</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">235</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2015.00235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.3389%2Ffphar.2015.00235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26528185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOnt7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=235&author=J.+Grouleffauthor=K.+Ladefogedauthor=H.+Koldsoauthor=B.+Schiott&title=Monoamine+transporters%3A+insights+from+molecular+dynamics+simulations&doi=10.3389%2Ffphar.2015.00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine transporters: insights from molecular dynamics simulations</span></div><div class="casAuthors">Grouleff, Julie; Ladefoged, Lucy Kate; Koldso, Heidi; Schiott, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235/1-235/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The human monoamine transporters (MATs) facilitate the reuptake of the neurotransmitters serotonin, dopamine, and norepinephrine from the synaptic cleft.  Imbalance in monoaminergic neurotransmission is linked to various diseases including major depression, attention deficit hyperactivity disorder, schizophrenia, and Parkinson's disease.  Inhibition of the MATs is thus an important strategy for treatment of such diseases.  The MATs are sodium-coupled transport proteins belonging to the neurotransmitter/Na+ symporter (NSS) family, and the publication of the first high-resoln. structure of a NSS family member, the bacterial leucine transporter LeuT, in 2005, proved to be a major stepping stone for understanding this family of transporters.  Structural data allows for the use of computational methods to study the MATs, which in turn has led to a no. of important discoveries.  The process of substrate translocation across the membrane is an intrinsically dynamic process.  Mol. dynamics simulations, which can provide atomistic details of mol. motion on ns to ms timescales, are therefore well-suited for studying transport processes.  In this review, we outline how mol. dynamics simulations have provided insight into the large scale motions assocd. with transport of the neurotransmitters, as well as the presence of external and internal gates, the coupling between ion and substrate transport, and differences in the conformational changes induced by substrates and inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh5v91itN1abVg90H21EOLACvtfcHk0ljuqH6URxVD6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOnt7nO&md5=15060d363db16b7c3a42f2c04063b5b2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00235%26sid%3Dliteratum%253Aachs%26aulast%3DGrouleff%26aufirst%3DJ.%26aulast%3DLadefoged%26aufirst%3DK.%26aulast%3DKoldso%26aufirst%3DH.%26aulast%3DSchiott%26aufirst%3DB.%26atitle%3DMonoamine%2520transporters%253A%2520insights%2520from%2520molecular%2520dynamics%2520simulations%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D235%26doi%3D10.3389%2Ffphar.2015.00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span> <span> </span><span class="NLM_article-title">New insights into the mechanism of action of amphetamines</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">681</span>â <span class="NLM_lpage">698</span>, <span class="refDoi">Â DOI: 10.1146/annurev.pharmtox.47.120505.105140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=17209801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=681-698&author=A.+E.+Fleckensteinauthor=T.+J.+Volzauthor=E.+L.+Riddleauthor=J.+W.+Gibbauthor=G.+R.+Hanson&title=New+insights+into+the+mechanism+of+action+of+amphetamines&doi=10.1146%2Fannurev.pharmtox.47.120505.105140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the mechanism of action of amphetamines</span></div><div class="casAuthors">Fleckenstein, Annette E.; Volz, Trent J.; Riddle, Evan L.; Gibb, James W.; Hanson, Glen R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">681-698</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Amphetamine is a psychostimulant commonly used to treat several disorders, including attention deficit, narcolepsy, and obesity.  Plasmalemmal and vesicular monoamine transporters, such as the neuronal dopamine transporter and the vesicular monoamine transporter-2, are two of its principal targets.  This review focuses on new insights, obtained from both in vivo and in vitro studies, into the mol. mechanisms whereby amphetamine, and the closely related compds. methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release.  These mechanisms include amphetamine-induced exchange diffusion, reverse transport, and channel-like transport phenomena as well as the weak base properties of amphetamine.  Addnl., amphetamine analogs may affect monoamine transporters through phosphorylation, transporter trafficking, and the prodn. of reactive oxygen and nitrogen species.  All of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraPle7JPAeKrVg90H21EOLACvtfcHk0liVi0eYEJwkgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D&md5=ead84eb20c530d952c181a79122a1971</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105140%26sid%3Dliteratum%253Aachs%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DGibb%26aufirst%3DJ.%2BW.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26atitle%3DNew%2520insights%2520into%2520the%2520mechanism%2520of%2520action%2520of%2520amphetamines%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D681%26epage%3D698%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Expression and function of the rat vesicular monoamine transporter 2</span>. <i>Am. J. Physiol.: Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">C1004</span>â <span class="NLM_lpage">C1011</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00348.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1152%2Fajpcell.00348.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=18287335" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=C1004-C1011&author=Y.+Adamauthor=R.+H.+Edwardsauthor=S.+Schuldiner&title=Expression+and+function+of+the+rat+vesicular+monoamine+transporter+2&doi=10.1152%2Fajpcell.00348.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00348.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00348.2007%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DExpression%2520and%2520function%2520of%2520the%2520rat%2520vesicular%2520monoamine%2520transporter%25202%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DC1004%26epage%3DC1011%26doi%3D10.1152%2Fajpcell.00348.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freyberg, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonders, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiranita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karam, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farino, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosharov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10652</span>, <span class="refDoi">Â DOI: 10.1038/ncomms10652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1038%2Fncomms10652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26879809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XislOqsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10652&author=Z.+Freybergauthor=M.+S.+Sondersauthor=J.+I.+Aguilarauthor=T.+Hiranitaauthor=C.+S.+Karamauthor=J.+Floresauthor=A.+B.+Pizzoauthor=Y.+Zhangauthor=Z.+J.+Farinoauthor=A.+Chenauthor=C.+A.+Martinauthor=T.+A.+Kopajticauthor=H.+Feiauthor=G.+Huauthor=Y.+Y.+Linauthor=E.+V.+Mosharovauthor=B.+D.+McCabeauthor=R.+Freybergauthor=K.+Wimalasenaauthor=L.+W.+Hsinauthor=D.+Samesauthor=D.+E.+Krantzauthor=J.+L.+Katzauthor=D.+Sulzerauthor=J.+A.+Javitch&title=Mechanisms+of+amphetamine+action+illuminated+through+optical+monitoring+of+dopamine+synaptic+vesicles+in+Drosophila+brain&doi=10.1038%2Fncomms10652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain</span></div><div class="casAuthors">Freyberg, Zachary; Sonders, Mark S.; Aguilar, Jenny I.; Hiranita, Takato; Karam, Caline S.; Flores, Jorge; Pizzo, Andrea B.; Zhang, Yuchao; Farino, Zachary J.; Chen, Audrey; Martin, Ciara A.; Kopajtic, Theresa A.; Fei, Hao; Hu, Gang; Lin, Yi-Ying; Mosharov, Eugene V.; McCabe, Brian D.; Freyberg, Robin; Wimalasena, Kandatege; Hsin, Ling-Wei; Sames, Dalibor; Krantz, David E.; Katz, Jonathan L.; Sulzer, David; Javitch, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10652</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amphetamines elevate extracellular dopamine, but the underlying mechanisms remain uncertain.  Here we show in rodents that acute pharmacol. inhibition of the vesicular monoamine transporter (VMAT) blocks amphetamine-induced locomotion and self-administration without impacting cocaine-induced behaviors.  To study VMAT's role in mediating amphetamine action in dopamine neurons, we have used novel genetic, pharmacol. and optical approaches in Drosophila melanogaster.  In an ex vivo whole-brain prepn., fluorescent reporters of vesicular cargo and of vesicular pH reveal that amphetamine redistributes vesicle contents and diminishes the vesicle pH-gradient responsible for dopamine uptake and retention.  This amphetamine-induced deacidification requires VMAT function and results from net H+ antiport by VMAT out of the vesicle lumen coupled to inward amphetamine transport.  Amphetamine-induced vesicle deacidification also requires functional dopamine transporter (DAT) at the plasma membrane.  Thus, we find that at pharmacol. relevant concns., amphetamines must be actively transported by DAT and VMAT in tandem to produce psychostimulant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW1al_k-lBf7Vg90H21EOLACvtfcHk0liVi0eYEJwkgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislOqsbo%253D&md5=b74452272c9a24baed52b15bca6f740d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms10652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10652%26sid%3Dliteratum%253Aachs%26aulast%3DFreyberg%26aufirst%3DZ.%26aulast%3DSonders%26aufirst%3DM.%2BS.%26aulast%3DAguilar%26aufirst%3DJ.%2BI.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DKaram%26aufirst%3DC.%2BS.%26aulast%3DFlores%26aufirst%3DJ.%26aulast%3DPizzo%26aufirst%3DA.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFarino%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DC.%2BA.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DFei%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%2BY.%26aulast%3DMosharov%26aufirst%3DE.%2BV.%26aulast%3DMcCabe%26aufirst%3DB.%2BD.%26aulast%3DFreyberg%26aufirst%3DR.%26aulast%3DWimalasena%26aufirst%3DK.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DKrantz%26aufirst%3DD.%2BE.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DSulzer%26aufirst%3DD.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DMechanisms%2520of%2520amphetamine%2520action%2520illuminated%2520through%2520optical%2520monitoring%2520of%2520dopamine%2520synaptic%2520vesicles%2520in%2520Drosophila%2520brain%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10652%26doi%3D10.1038%2Fncomms10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vocci, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appel, N. M.</span></span> <span> </span><span class="NLM_article-title">Approaches to the development of medications for the treatment of methamphetamine dependence</span>. <i>Addiction</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">96</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1111/j.1360-0443.2007.01772.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1111%2Fj.1360-0443.2007.01772.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=96-106&issue=Suppl.+1&author=F.+J.+Vocciauthor=N.+M.+Appel&title=Approaches+to+the+development+of+medications+for+the+treatment+of+methamphetamine+dependence&doi=10.1111%2Fj.1360-0443.2007.01772.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1360-0443.2007.01772.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1360-0443.2007.01772.x%26sid%3Dliteratum%253Aachs%26aulast%3DVocci%26aufirst%3DF.%2BJ.%26aulast%3DAppel%26aufirst%3DN.%2BM.%26atitle%3DApproaches%2520to%2520the%2520development%2520of%2520medications%2520for%2520the%2520treatment%2520of%2520methamphetamine%2520dependence%26jtitle%3DAddiction%26date%3D2007%26volume%3D102%26issue%3DSuppl.%25201%26spage%3D96%26epage%3D106%26doi%3D10.1111%2Fj.1360-0443.2007.01772.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span> <span> </span><span class="NLM_article-title">Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2613</span>â <span class="NLM_lpage">2616</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.04.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.bmcl.2015.04.105" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2613-2616&author=D.+Dingauthor=J.+R.+Nickellauthor=L.+P.+Dwoskinauthor=P.+A.+Crooks&title=Quinolyl+analogues+of+norlobelane%3A+novel+potent+inhibitors+of+%5B%283%29H%5Ddihydrotetrabenazine+binding+and+%5B%283%29H%5Ddopamine+uptake+at+the+vesicular+monoamine+transporter-2&doi=10.1016%2Fj.bmcl.2015.04.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.105%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DQuinolyl%2520analogues%2520of%2520norlobelane%253A%2520novel%2520potent%2520inhibitors%2520of%2520%255B%25283%2529H%255Ddihydrotetrabenazine%2520binding%2520and%2520%255B%25283%2529H%255Ddopamine%2520uptake%2520at%2520the%2520vesicular%2520monoamine%2520transporter-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2613%26epage%3D2616%26doi%3D10.1016%2Fj.bmcl.2015.04.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysko, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span> <span> </span><span class="NLM_article-title">Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1142</span>â <span class="NLM_lpage">1151</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.067314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.104.067314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15102929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1equr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=1142-1151&author=C.+J.+Wilhelmauthor=R.+A.+Johnsonauthor=P.+G.+Lyskoauthor=A.+J.+Eshlemanauthor=A.+Janowsky&title=Effects+of+methamphetamine+and+lobeline+on+vesicular+monoamine+and+dopamine+transporter-mediated+dopamine+release+in+a+cotransfected+model+system&doi=10.1124%2Fjpet.104.067314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system</span></div><div class="casAuthors">Wilhelm, Clare J.; Johnson, Robert A.; Lysko, Paul G.; Eshleman, Amy J.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine (DA) retention and drug-induced release kinetics were characterized in human embryonic kidney (HEK)-293 cells stably coexpressing the human DA transporter (hDAT) and human vesicular monoamine transporter (hVMAT2).  Cofunction of hDAT and hVMAT2 caused greater retention of [3H]DA at 20 min (37Â°), or 45 min (22Â°) compared with cells that were treated with dihydrotetrabenazene (DHTB) to block the hVMAT2.  In hDAT- and hVMAT2-coexpressing cells treated with DHTB during [3H]DA loading, methamphetamine (METH)-induced efflux was only 20% of preloaded [3H]DA, compared with 50 to 60% efflux in the absence of DHTB.  Interestingly, the presence of DHTB (during release only) increased the potency and efficacy of METH at inducing [3H]DA release (without DHTB: EC50 = 33.8 Î¼M, maximal release 51%; release with DHTB: EC50 = 3.2 Î¼M, maximal release 61%), suggesting that the effects of METH and DHTB on vesicular storage are additive.  High concns. of lobeline induced a statistically significant release of [3H]DA from HEK-hDAT-hVMAT2 cells, but only in the absence of DHTB, suggesting an hVMAT2-mediated effect.  Likewise, lobeline did not induce a significant release of [3H]DA from HEK-hDAT cells.  The substrates DA and p-tyramine induced robust release of preloaded [3H]DA from cotransfected cells.  Cocaine was somewhat effective at blocking substrate-induced [3H]DA efflux.  These results suggest that coexpression of the hDAT and hVMAT2 can be used as a model system to distinguish functional pools of DA and to quantify differences in drug effects on DA disposition.  In addn., cotransfected cells can be used to det. mechanisms of simultaneous drug interactions at multiple sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwzJUdZXee57Vg90H21EOLACvtfcHk0lhBeLBqgiE3VQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1equr8%253D&md5=6a9e98c873a8a1e7beea1e4cd50ba8d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.067314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.067314%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DLysko%26aufirst%3DP.%2BG.%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DEffects%2520of%2520methamphetamine%2520and%2520lobeline%2520on%2520vesicular%2520monoamine%2520and%2520dopamine%2520transporter-mediated%2520dopamine%2520release%2520in%2520a%2520cotransfected%2520model%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D1142%26epage%3D1151%26doi%3D10.1124%2Fjpet.104.067314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrholm, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hojahmat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrod, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaciuc, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">940</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1124/jpet.110.175117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.110.175117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=21177475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=940-951&author=D.+B.+Hortonauthor=K.+B.+Siripurapuauthor=S.+D.+Norrholmauthor=J.+P.+Culverauthor=M.+Hojahmatauthor=J.+S.+Beckmannauthor=S.+B.+Harrodauthor=A.+G.+Deaciucauthor=M.+T.+Bardoauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=meso-Transdiene+analogs+inhibit+vesicular+monoamine+transporter-2+function+and+methamphetamine-evoked+dopamine+release&doi=10.1124%2Fjpet.110.175117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release</span></div><div class="casAuthors">Horton, David B.; Siripurapu, Kiran B.; Norrholm, Seth D.; Culver, John P.; Hojahmat, Marhaba; Beckmann, Joshua S.; Harrod, Steven B.; Deaciuc, Agripina G.; Bardo, Michael T.; Crooks, Peter A.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">940-951</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lobeline, a nicotinic receptor antagonist and neurotransmitter transporter inhibitor, is a candidate pharmacotherapy for methamphetamine abuse.  Meso-Transdiene (MTD), a lobeline analog, lacks nicotinic receptor affinity, retains affinity for vesicular monoamine transporter 2 (VMAT2), and, surprisingly, has enhanced affinity for dopamine (DA) and serotonin transporters [DA transporter (DAT) and serotonin transporter (SERT), resp.].  In the current study, MTD was evaluated for its ability to decrease methamphetamine self-administration in rats relative to food-maintained responding.  MTD specifically decreased methamphetamine self-administration, extending our previous work.  Classical structure-activity relationships revealed that more conformationally restricted MTD analogs enhanced VMAT2 selectivity and drug likeness, whereas affinity at the dihydrotetrabenazine binding and DA uptake sites on VMAT2 was not altered.  Generally, MTD analogs exhibited 50- to 1000-fold lower affinity for DAT and were equipotent or had 10-fold higher affinity for SERT, compared with MTD.  Representative analogs from the series potently and competitively inhibited [3H]DA uptake at VMAT2.  (3Z,5Z)-3,5-bis(2,4-dichlorobenzylidene)-1-methylpiperidine (UKMH-106), the 3Z,5Z-2,4-dichlorophenyl MTD analog, had improved selectivity for VMAT2 over DAT and importantly inhibited methamphetamine-evoked DA release from striatal slices.  In contrast, (3Z,5E)-3,5-bis(2,4-dichlorobenzylidene)-1-methylpiperidine (UKMH-105), the 3Z,5E-geometrical isomer, inhibited DA uptake at VMAT2, but did not inhibit methamphetamine-evoked DA release.  Taken together, these results suggest that these geometrical isomers interact at alternate sites on VMAT2, which are assocd. with distinct pharmacophores.  Thus, structural modification of the MTD mol. resulted in analogs exhibiting improved drug likeness and improved selectivity for VMAT2, as well as the ability to decrease methamphetamine-evoked DA release, supporting the further evaluation of these analogs as treatments for methamphetamine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGX9DkPWAibVg90H21EOLACvtfcHk0lhBeLBqgiE3VQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqtLg%253D&md5=faf333ef46c1ade408fd30eaadf5df21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175117%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DD.%2BB.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DNorrholm%26aufirst%3DS.%2BD.%26aulast%3DCulver%26aufirst%3DJ.%2BP.%26aulast%3DHojahmat%26aufirst%3DM.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DHarrod%26aufirst%3DS.%2BB.%26aulast%3DDeaciuc%26aufirst%3DA.%2BG.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3Dmeso-Transdiene%2520analogs%2520inhibit%2520vesicular%2520monoamine%2520transporter-2%2520function%2520and%2520methamphetamine-evoked%2520dopamine%2520release%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D940%26epage%3D951%26doi%3D10.1124%2Fjpet.110.175117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-420118-7.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FB978-0-12-420118-7.00002-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=71-106&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=A.+Vartakauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=The+vesicular+monoamine+transporter-2%3A+an+important+pharmacological+target+for+the+discovery+of+novel+therapeutics+to+treat+methamphetamine+abuse&doi=10.1016%2FB978-0-12-420118-7.00002-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DVartak%26aufirst%3DA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter-2%253A%2520an%2520important%2520pharmacological%2520target%2520for%2520the%2520discovery%2520of%2520novel%2520therapeutics%2520to%2520treat%2520methamphetamine%2520abuse%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D71%26epage%3D106%26doi%3D10.1016%2FB978-0-12-420118-7.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>795</i></span>,  <span class="NLM_fpage">143</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.ejphar.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=27986625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsbrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=795&publication_year=2017&pages=143-149&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=D.+B.+Hortonauthor=G.+Zhengauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=GZ-793A+inhibits+the+neurochemical+effects+of+methamphetamine+via+a+selective+interaction+with+the+vesicular+monoamine+transporter-2&doi=10.1016%2Fj.ejphar.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2</span></div><div class="casAuthors">Nickell, Justin R.; Siripurapu, Kiran B.; Horton, David B.; Zheng, Guangrong; Crooks, Peter A.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">795</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lobeline and lobelane inhibit the behavioral and neurochem. effects of methamphetamine via an interaction with the vesicular monoamine transporter-2 (VMAT2).  However, lobeline has high affinity for nicotinic receptors, and tolerance develops to the behavioral effects of lobelane.  A water-sol. analog of lobelane, R-N-(1,2-dihydroxypropyl)-2,6-cis-di-(4-methoxyphenethyl)piperidine hydrochloride (GZ-793A), also interacts selectively with VMAT2 to inhibit the effects of methamphetamine, but does not produce behavioral tolerance.  The current study further evaluated the mechanism underlying the GZ-793A-mediated inhibition of the neurochem. effects of methamphetamine.  In contrast to lobeline, GZ-793A does not interact with the agonist recognition site on Î±4Î²2* and Î±7* nicotinic receptors.  GZ-793A (0.3-100 Î¼M) inhibited methamphetamine (5 Î¼M)-evoked fractional dopamine release from rat striatal slices, and did not evoke dopamine release in the absence of methamphetamine.  Furthermore, GZ-793A (1-100 Î¼M) inhibited neither nicotine (30 Î¼M)-evoked nor elec. field-stimulation-evoked (100 Hz/1 min) fractional dopamine release.  Unfortunately, GZ-793A inhibited [3H]dofetilide binding to human-ether-a-go-go related gene channels expressed on human embryonic kidney cells, and further, prolonged action potentials in rabbit cardiac Purkinje fibers, suggesting the potential for GZ-793A to induce ventricular arrhythmias.  Thus, GZ-793A selectively inhibits the neurochem. effects of methamphetamine and lacks nicotinic receptor interactions; however, development as a pharmacotherapy for methamphetamine use disorders will not be pursued due to its potential cardiac liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_QbTWv2cNtrVg90H21EOLACvtfcHk0ljOtD-s9hXovg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsbrK&md5=da9edd15288757516f17f6b700d770f0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DHorton%26aufirst%3DD.%2BB.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DGZ-793A%2520inhibits%2520the%2520neurochemical%2520effects%2520of%2520methamphetamine%2520via%2520a%2520selective%2520interaction%2520with%2520the%2520vesicular%2520monoamine%2520transporter-2%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D795%26spage%3D143%26epage%3D149%26doi%3D10.1016%2Fj.ejphar.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">For a comprehensive review see the following:</p></div><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">The role of vesicular transport proteins in synaptic transmission and neural degenerartion</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1146/annurev.neuro.20.1.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1146%2Fannurev.neuro.20.1.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9056710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2sXhs12qt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1997&pages=125-156&author=Y.+Liuauthor=R.+H.+Edwards&title=The+role+of+vesicular+transport+proteins+in+synaptic+transmission+and+neural+degenerartion&doi=10.1146%2Fannurev.neuro.20.1.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The role of vesicular transport proteins in synaptic transmission and neural degeneration</span></div><div class="casAuthors">Liu, Yongjian; Edwards, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-156</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with about 150 refs.  Classical neurotransmitters are synthesized in the cytoplasm, so they require transport into secretory vesicles for regulated exocytotic release.  Previous work had identified distinct vesicular transport activities for the different classical transmitters, and all depend on the H+-electrochem. gradient across the vesicle membrane but differ in the extent to which they rely on the chem. and elec. components of this gradient.  Drugs that interfere with vesicular amine transport have implicated this activity in psychiatric disease.  Selection for a cDNA encoding vesicular amine transport in the neurotoxin MPP+ also implicates the activity in Parkinson's disease.  Mol. cloning of vesicular monoamine transporters shows sequence similarity to bacterial antibiotic resistance proteins, supporting a role for transport in detoxification and defining a novel mammalian gene family that now also includes a transporter for acetylcholine.  Current work focuses on the mechanism of transport and the role that regulation of activity and its subcellular localization have in transmitter release, behavior, and neural degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75mx1c4Ir4LVg90H21EOLACvtfcHk0ljOtD-s9hXovg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhs12qt78%253D&md5=6e965648a05d49d7498572f4b6831685</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.20.1.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.20.1.125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DThe%2520role%2520of%2520vesicular%2520transport%2520proteins%2520in%2520synaptic%2520transmission%2520and%2520neural%2520degenerartion%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1997%26volume%3D20%26spage%3D125%26epage%3D156%26doi%3D10.1146%2Fannurev.neuro.20.1.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. W.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter 2: an underexplored pharmacological target</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2013.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=24398404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=89-97&author=A.+I.+Bernsteinauthor=K.+A.+Stoutauthor=G.+W.+Miller&title=The+vesicular+monoamine+transporter+2%3A+an+underexplored+pharmacological+target&doi=10.1016%2Fj.neuint.2013.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter 2: An underexplored pharmacological target</span></div><div class="casAuthors">Bernstein, Alison I.; Stout, Kristen A.; Miller, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Active transport of neurotransmitters into synaptic vesicles is required for their subsequent exocytotic release.  In the monoamine system, this process is carried out by the vesicular monoamine transporters (VMAT1 and VMAT2).  These proteins are responsible for vesicular packaging of dopamine, norepinephrine, serotonin, and histamine.  These proteins are essential for proper neuronal function; however, compared to their plasma membrane counterparts, there are few drugs available that target these vesicular proteins.  This is partly due to the added complexity of crossing the plasma membrane, but also to the tech. difficulty of assaying for vesicular uptake in high throughput.  Until recently, reagents to enable high throughput screening for function of these vesicular neurotransmitter transporters have not been available.  Fortunately, novel compds. and methods are now making such screening possible; thus, a renewed focus on these transporters as potential targets is timely and necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHcBYk8fojmbVg90H21EOLACvtfcHk0ljOtD-s9hXovg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D&md5=f83b99eb743485ba5b44ec54e51228b2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DA.%2BI.%26aulast%3DStout%26aufirst%3DK.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BW.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%25202%253A%2520an%2520underexplored%2520pharmacological%2520target%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.neuint.2013.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutt, D. J.</span></span> <span> </span><span class="NLM_article-title">The role of dopamine and norepinephrine in depression and antidepressant treatment</span>. <i>J. Clin. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 6</span>),  <span class="NLM_fpage">3</span>â <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=16848670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1CrtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=3-8&issue=Suppl.+6&author=D.+J.+Nutt&title=The+role+of+dopamine+and+norepinephrine+in+depression+and+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dopamine and norepinephrine in depression and antidepressant treatment</span></div><div class="casAuthors">Nutt, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Most antidepressants in use today are descendants of the monoamine oxidase inhibitor iproniazid and the tricyclic agent imipramine.  These agents were both originally developed for other indications but then were serendipitously detd. to have antidepressant effects.  Elucidation of the mechanisms of action of these first antidepressants, along with those of reserpine and amphetamine, led to the monoamine theories of depression.  Through the past several decades, approaches undertaken to clarify the roles of the neurotransmitters norepinephrine, dopamine, and serotonin in depression have included animal studies, human biol. and postmortem studies, inferences drawn from antidepressant drug actions, and challenge or depletion studies; most recently, brain imaging studies have proved to be esp. informative.  This research has identified novel potential targets, with the goal of developing new antidepressant drugs with better efficacy and faster onset of action than current "gold-std." treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMGf2-xYUD7Vg90H21EOLACvtfcHk0lheMQug5Uksyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1CrtrY%253D&md5=61db0885e6e5bde033e73a25a276ab14</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520role%2520of%2520dopamine%2520and%2520norepinephrine%2520in%2520depression%2520and%2520antidepressant%2520treatment%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2006%26volume%3D67%26issue%3DSuppl.%25206%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laduron, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">672</span>â <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=3380081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=672-677&author=F.+Darchenauthor=D.+Schermanauthor=P.+M.+Laduronauthor=J.+P.+Henry&title=Ketanserin+binds+to+the+monoamine+transporter+of+chromaffin+granules+and+of+synaptic+vesicles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles</span></div><div class="casAuthors">Darchen, Francois; Scherman, Daniel; Laduron, Pierre M.; Henry, Jean Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">672-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">[3H]Ketanserin binding studies were performed on purified chromaffin granule membranes.  Binding occurred on one class of sites and was temp.-dependent.  At 30Â° the equil. dissocn. const. KD was 45 nM.  At 0Â°, a KD value of 6 nM and a half-life of dissocn. of 40 s were measured.  Methysergide, an antagonist of 5-hydroxytryptamine2 receptors structurally unrelated to ketanserin, did not displace ketanserin binding.  Tetrabenazine, an inhibitor of the monoamine transport of chromaffin granules, displaced [3H]ketanserin binding.  Conversely, ketanserin inhibited the binding of [3H]dihydrotetrabenazine, a ligand that specifically binds to the monoamine transporter.  The inhibition was of the competitive type.  Ketanserin binding did not depend upon ATP-induced energization of chromaffin granules.  ATP-dependent 5-HT uptake by chromaffin granule ghosts was inhibited by ketanserin with an IC50 value of 70 nM.  A series of ketanserin derivs. was tested for the ability to displace [3H]dihydrotetrabenazine; EC50 values differed by >2 orders of magnitude and were not correlated to affinities on 5-HT2 receptors.  In mouse brain, [3H]ketanserin bound to methysergide-sensitive and to tetrabenazine-sensitive sites.  It is concluded that nonspecific displaceable binding sites of [3H]ketanserin previously described in the striatum are tetrabenazine binding sites assocd. with the synaptic vesicle monoamine transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEOVid7FYMkLVg90H21EOLACvtfcHk0lheMQug5Uksyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCmu74%253D&md5=35f87f54599f4b162e92211273c215e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarchen%26aufirst%3DF.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DKetanserin%2520binds%2520to%2520the%2520monoamine%2520transporter%2520of%2520chromaffin%2520granules%2520and%2520of%2520synaptic%2520vesicles%26jtitle%3DMol.%2520Pharmacol.%26date%3D1988%26volume%3D33%26spage%3D672%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankovic, J.</span></span> <span> </span><span class="NLM_article-title">Tetrabenazine in the treatment of hyperkinetic movement disorders</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1586/14737175.6.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1586%2F14737175.6.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=16466307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtl2ksLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=7-17&author=C.+Kenneyauthor=J.+Jankovic&title=Tetrabenazine+in+the+treatment+of+hyperkinetic+movement+disorders&doi=10.1586%2F14737175.6.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabenazine in the treatment of hyperkinetic movement disorders</span></div><div class="casAuthors">Kenney, Christopher; Jankovic, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Tetrabenazine, a dopamine-depleting agent first synthesized half a century ago, was initially developed for the treatment of schizophrenia.  Although psychotic disorders have since been treated more successfully with other neuroleptic medications, many studies have shown this drug to be effective in the treatment of hyperkinetic movement disorders (hyperkinesias).  Hyperkinesias are neurol. disorders characterized by abnormal involuntary movements such as chorea assocd. with Huntington's disease, tics in Tourette's syndrome and stereotypies in tardive dyskinesia.  Recently, clin. trials investigating tetrabenazine for the treatment of chorea assocd. with Huntington's disease found the drug to be safe and efficacious, making approval by the US Food and Drug Administration for this indication a distinct possibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcA5D5zq7trVg90H21EOLACvtfcHk0lheMQug5Uksyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtl2ksLg%253D&md5=1090a8b7c45bc4861672041731b03157</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DTetrabenazine%2520in%2520the%2520treatment%2520of%2520hyperkinetic%2520movement%2520disorders%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D7%26epage%3D17%26doi%3D10.1586%2F14737175.6.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, J. K.</span></span> <span> </span><span class="NLM_article-title">Functional reconstitution in situ of 5-hydroxytryptamine2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">22591</span>â <span class="NLM_lpage">22597</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.37.22591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.271.37.22591" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22591-22597&author=J.+L.+Hartmanauthor=J.+K.+Northup&title=Functional+reconstitution+in+situ+of+5-hydroxytryptamine2c+%285HT2c%29+receptors+with+alphaq+and+inverse+agonism+of+5HT2c+receptor+antagonists&doi=10.1074%2Fjbc.271.37.22591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.37.22591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.37.22591%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DJ.%2BL.%26aulast%3DNorthup%26aufirst%3DJ.%2BK.%26atitle%3DFunctional%2520reconstitution%2520in%2520situ%2520of%25205-hydroxytryptamine2c%2520%25285HT2c%2529%2520receptors%2520with%2520alphaq%2520and%2520inverse%2520agonism%2520of%25205HT2c%2520receptor%2520antagonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22591%26epage%3D22597%26doi%3D10.1074%2Fjbc.271.37.22591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nankai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toru, M.</span></span> <span> </span><span class="NLM_article-title">Acute immobilization stress reduces (Â±)DOI-induced 5-HT2A receptor-mediated head shakes in rats</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">14</span>, <span class="refDoi">Â DOI: 10.1007/BF02246047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1007%2FBF02246047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=7675955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFChtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1995&pages=9-14&author=S.+Yamadaauthor=A.+Watanabeauthor=M.+Nankaiauthor=M.+Toru&title=Acute+immobilization+stress+reduces+%28%C2%B1%29DOI-induced+5-HT2A+receptor-mediated+head+shakes+in+rats&doi=10.1007%2FBF02246047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Acute immobilization stress reduces (Â±)DOI-induced 5-HT2A receptor-mediated head shakes in rats</span></div><div class="casAuthors">Yamada, Satoru; Watanabe, Akiko; Nankai, Masahiro; Toru, Michio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acute immobilization stress induced by taping four limbs, applying tail pinch stress and elec. foot shock stress immediately reduced the frequency of head shakes induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ((Â±)DOI), a 5-HT2A agonist in rats.  Immobilization stress due to the use of cylinder restraint and forced swimming did not affect 5-HT2A-mediated behavior.  Acute immobilization stress did not affect [3H]ketanserin binding to the 5HT2A receptor in the prefrontal cortex and hippocampus.  Presynaptic serotonergic lesions with 5,7-dihydroxytryptamine (5,7-DHT) did not affect the redn. in 5-HT2A-mediated behavior after acute immobilization stress.  The decreases in head shake frequency after acute immobilization stress by taping were attenuated by pretreatment with diazepam (2.5 mg/kg, i.p.): this attenuation was reversed by pretreatment with flumazenil (10 mg/kg, i.p.).  The redn. in (Â±)DOI-induced 5-HT2A-mediated behavior caused by stress may be related to a change in agonist affinity to the receptor or to changes in other neurotransmitter systems or the effect of PI turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwrP-gc7LDbVg90H21EOLACvtfcHk0lheMQug5Uksyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFChtLs%253D&md5=cc8bb2366f7b8ecd46a1862978e17690</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FBF02246047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246047%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DNankai%26aufirst%3DM.%26aulast%3DToru%26aufirst%3DM.%26atitle%3DAcute%2520immobilization%2520stress%2520reduces%2520%2528%25C2%25B1%2529DOI-induced%25205-HT2A%2520receptor-mediated%2520head%2520shakes%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D1995%26volume%3D119%26spage%3D9%26epage%3D14%26doi%3D10.1007%2FBF02246047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schotte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, J. E.</span></span> <span> </span><span class="NLM_article-title">Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [<sup>125</sup>I]7-amino-8-iodo-ketanserin</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/0014-2999(88)90233-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2F0014-2999%2888%2990233-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=2832189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVKqsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1988&pages=213-216&author=A.+Schotteauthor=J.+E.+Leysen&title=Distinct+autoradiographic+labelling+of+serotonin+5-HT2+receptors%2C+alpha+1-adrenoceptors+and+histamine-H1+receptors+and+of+tetrabenazine-displaceable+ketanserin+binding+sites+in+rodent+brain+with+%5B125I%5D7-amino-8-iodo-ketanserin&doi=10.1016%2F0014-2999%2888%2990233-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct autoradiographic labeling of serotonin 5-HT2 receptors, Î±1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin</span></div><div class="casAuthors">Schotte, Alain; Leysen, Josee E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">[125I]7-Amino-8-iodo-ketanserin ([125I]AMIK) binding was assayed in rat and guinea pig horizontal brain sections and was analyzed by autoradiog.  The use of selective displacers allowed the identification of 4 distinct receptors in rat and guinea pig brain.  In rats, 5-HT2 receptors were detected in cortical areas and in caudate putamen, Î±1-adrenoceptors were found in cortical areas and several thalamic nuclei, tetrabenazine-displaceable ketanserin binding sites involved in the release of biogene amine metabolites occurred in caudate putamen, periaqueductal grey matter, and septal nuclei.  Histamine-H1 receptors were identified in the guinea pig cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARxh82qLiPrVg90H21EOLACvtfcHk0lhAWkKDL32B5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVKqsb4%253D&md5=83127ae4ebb111c79e3a2d24d9401d30</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990233-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990233-6%26sid%3Dliteratum%253Aachs%26aulast%3DSchotte%26aufirst%3DA.%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3DDistinct%2520autoradiographic%2520labelling%2520of%2520serotonin%25205-HT2%2520receptors%252C%2520alpha%25201-adrenoceptors%2520and%2520histamine-H1%2520receptors%2520and%2520of%2520tetrabenazine-displaceable%2520ketanserin%2520binding%2520sites%2520in%2520rodent%2520brain%2520with%2520%255B125I%255D7-amino-8-iodo-ketanserin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D145%26spage%3D213%26epage%3D216%26doi%3D10.1016%2F0014-2999%2888%2990233-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudnick, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner-Mordoch, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishkes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern-Bach, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">603</span>â <span class="NLM_lpage">608</span>, <span class="refDoi">Â DOI: 10.1021/bi00455a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00455a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=603-608&author=G.+Rudnickauthor=S.+S.+Steiner-Mordochauthor=H.+Fishkesauthor=Y.+Stern-Bachauthor=S.+Schuldiner&title=Energetics+of+reserpine+binding+and+occlusion+by+the+chromaffin+granule+biogenic+amine+transporter&doi=10.1021%2Fbi00455a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi00455a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00455a002%26sid%3Dliteratum%253Aachs%26aulast%3DRudnick%26aufirst%3DG.%26aulast%3DSteiner-Mordoch%26aufirst%3DS.%2BS.%26aulast%3DFishkes%26aufirst%3DH.%26aulast%3DStern-Bach%26aufirst%3DY.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DEnergetics%2520of%2520reserpine%2520binding%2520and%2520occlusion%2520by%2520the%2520chromaffin%2520granule%2520biogenic%2520amine%2520transporter%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D603%26epage%3D608%26doi%3D10.1021%2Fbi00455a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirvan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linial, M.</span></span> <span> </span><span class="NLM_article-title">Vesicular neurotransmitter transporters: from bacteria to humans</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">392</span>, <span class="refDoi">Â DOI: 10.1152/physrev.1995.75.2.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1152%2Fphysrev.1995.75.2.369" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1995&pages=369-392&author=S.+Schuldinerauthor=A.+Shirvanauthor=M.+Linial&title=Vesicular+neurotransmitter+transporters%3A+from+bacteria+to+humans&doi=10.1152%2Fphysrev.1995.75.2.369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1995.75.2.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1995.75.2.369%26sid%3Dliteratum%253Aachs%26aulast%3DSchuldiner%26aufirst%3DS.%26aulast%3DShirvan%26aufirst%3DA.%26aulast%3DLinial%26aufirst%3DM.%26atitle%3DVesicular%2520neurotransmitter%2520transporters%253A%2520from%2520bacteria%2520to%2520humans%26jtitle%3DPhysiol.%2520Rev.%26date%3D1995%26volume%3D75%26spage%3D369%26epage%3D392%26doi%3D10.1152%2Fphysrev.1995.75.2.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasnier, B.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter: from chromaffin granule to brain</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">227</span>â <span class="NLM_lpage">246</span>, <span class="refDoi">Â DOI: 10.1016/S0197-0186(97)00092-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FS0197-0186%2897%2900092-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9587917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK1cXisFShs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=227-246&author=J.+P.+Henryauthor=C.+Sagneauthor=C.+Bedetauthor=B.+Gasnier&title=The+vesicular+monoamine+transporter%3A+from+chromaffin+granule+to+brain&doi=10.1016%2FS0197-0186%2897%2900092-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter: from chromaffin granule to brain</span></div><div class="casAuthors">Henry, Jean-Pierre; Sagne, Corinne; Bedet, Cecile; Gasnier, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-246</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with â¼175 refs.  All characterized monoaminergic cells utilize the same transport system for the vesicular accumulation of monoamines prior to their release.  This system operates in neuronal (catecholaminergic, serotoninergic, or histaminergic) as well as in endocrine or neuroendocrine cells.  For several decades, chromaffin granules from bovine adrenal medulla have been used as a model system, allowing progress in the understanding of the biophysics, the biochem. and the pharmacol. of the monoamine vesicular transporter.  The transporters from rat, bovine, and man have been cloned.  Surprisingly, 2 genes encode different isoforms of the protein which are differentially expressed in monoaminergic systems.  The conjunction of recombinant DNA techniques and expression in secretory or non-secretory cells with the large body of data obtained on the chromaffin granule transporter has allowed rapid progress in the study of the protein.  But interestingly enough, this progress has open new possibilities in the study of biol. problems, esp. in the brain.  The transporter is useful for the detn. of the relationship between small and large dense core vesicles, for the understanding of the mechanism of drugs such as 1-methyl-4-phenylpyridinium (MPP+), tetrabenazine or amphetamines, and as a marker in brain development.  The possibility of regulations at the vesicular transporter level and of their effect on the quantum size has to be investigated.  The vesicular monoamine transporter is also an important target for brain imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94e--MH96tbVg90H21EOLACvtfcHk0lhAWkKDL32B5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFShs7c%253D&md5=cf9e339a99409866dc959f953cb8cff5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2897%2900092-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252897%252900092-2%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26aulast%3DSagne%26aufirst%3DC.%26aulast%3DBedet%26aufirst%3DC.%26aulast%3DGasnier%26aufirst%3DB.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%253A%2520from%2520chromaffin%2520granule%2520to%2520brain%26jtitle%3DNeurochem.%2520Int.%26date%3D1998%26volume%3D32%26spage%3D227%26epage%3D246%26doi%3D10.1016%2FS0197-0186%2897%2900092-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yaffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergara-Jaque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Emulating proton-induced conformational changes in the vesicular monoamine transprter VMAT2 by mutagenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E7390</span>â <span class="NLM_lpage">E7398</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1605162113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.1605162113" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7390-E7398&author=D.+Yaffeauthor=A.+Vergara-Jaqueauthor=L.+R.+Forrestauthor=S.+Schuldiner&title=Emulating+proton-induced+conformational+changes+in+the+vesicular+monoamine+transprter+VMAT2+by+mutagenesis&doi=10.1073%2Fpnas.1605162113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605162113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605162113%26sid%3Dliteratum%253Aachs%26aulast%3DYaffe%26aufirst%3DD.%26aulast%3DVergara-Jaque%26aufirst%3DA.%26aulast%3DForrest%26aufirst%3DL.%2BR.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DEmulating%2520proton-induced%2520conformational%2520changes%2520in%2520the%2520vesicular%2520monoamine%2520transprter%2520VMAT2%2520by%2520mutagenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE7390%26epage%3DE7398%26doi%3D10.1073%2Fpnas.1605162113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span>; <span class="NLM_string-name">Meltzer, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Quinazolinediones as VMAT Inhibitors</span>. <span class="NLM_patent">WO 2016019312 A2</span>, Feb 4, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Janowsky&author=P.+Meltzer&title=Preparation+of+Substituted+Quinazolinediones+as+VMAT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Substituted%2520Quinazolinediones%2520as%2520VMAT%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munster-Wandowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zander, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnert-Hilger, G.</span></span> <span> </span><span class="NLM_article-title">Co-existence of functionally different vesicular nerotransmitter transporters</span>. <i>Front. Synaptic Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">9</span>, <span class="refDoi">Â DOI: 10.3389/fnsyn.2016.00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.3389%2Ffnsyn.2016.00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26909036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A280%3ADC%252BC28jjs1eqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=4-9&author=A.+Munster-Wandowskiauthor=J.-F.+Zanderauthor=K.+Richterauthor=G.+Ahnert-Hilger&title=Co-existence+of+functionally+different+vesicular+nerotransmitter+transporters&doi=10.3389%2Ffnsyn.2016.00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Co-existence of Functionally Different Vesicular Neurotransmitter Transporters</span></div><div class="casAuthors">Munster-Wandowski Agnieszka; Zander Johannes-Friedrich; Richter Karin; Ahnert-Hilger Gudrun</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in synaptic neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4</span>
        ISSN:<span class="NLM_cas:issn">1663-3563</span>.
    </div><div class="casAbstract">The vesicular transmitter transporters VGLUT, VGAT, VMAT2 and VAChT, define phenotype and physiological properties of neuronal subtypes.  VGLUTs concentrate the excitatory amino acid glutamate, VGAT the inhibitory amino acid GABA, VMAT2 monoamines, and VAChT acetylcholine (ACh) into synaptic vesicle (SV).  Following membrane depolarization SV release their content into the synaptic cleft.  A strict segregation of vesicular transporters is mandatory for the precise functioning of synaptic communication and of neuronal circuits.  In the last years, evidence accumulates that subsets of neurons express more than one of these transporters leading to synaptic co-release of different and functionally opposing transmitters and modulation of synaptic plasticity.  Synaptic co-existence of transporters may change during pathological scenarios in order to ameliorate misbalances in neuronal activity.  In addition, evidence increases that transporters also co-exist on the same vesicle providing another layer of regulation.  Generally, vesicular transmitter loading relies on an electrochemical gradient ÎÎ¼H(+) driven by the proton ATPase rendering the lumen of the vesicle with respect to the cytosol positive (ÎÏ) and acidic (ÎpH).  While the activity of VGLUT mainly depends on the ÎÏ component, VMAT, VGAT and VAChT work best at a high ÎpH.  Thus, a vesicular synergy of transporters depending on the combination may increase or decrease the filling of SV with the principal transmitter.  We provide an overview on synaptic co-existence of vesicular transmitter transporters including changes in the excitatory/inhibitory balance under pathological conditions.  Additionally, we discuss functional aspects of vesicular synergy of transmitter transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXJIJUnooXF7P3FVUi_gf8fW6udTcc2ebcbu8cFvDXyrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jjs1eqsA%253D%253D&md5=fb2eee6354799df0916fa11612518145</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffnsyn.2016.00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsyn.2016.00004%26sid%3Dliteratum%253Aachs%26aulast%3DMunster-Wandowski%26aufirst%3DA.%26aulast%3DZander%26aufirst%3DJ.-F.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DAhnert-Hilger%26aufirst%3DG.%26atitle%3DCo-existence%2520of%2520functionally%2520different%2520vesicular%2520nerotransmitter%2520transporters%26jtitle%3DFront.%2520Synaptic%2520Neurosci.%26date%3D2016%26volume%3D8%26spage%3D4%26epage%3D9%26doi%3D10.3389%2Ffnsyn.2016.00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">584</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1073/pnas.80.2.584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.80.2.584" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=584-588&author=D.+Schermanauthor=P.+Jaudonauthor=J.+P.+Henry&title=Characterization+of+the+monoamine+carrier+of+chromaffin+granule+membrane+by+binding+of+%5B2-3H%5Ddihydrotetrabenazine&doi=10.1073%2Fpnas.80.2.584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.2.584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.2.584%26sid%3Dliteratum%253Aachs%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DJaudon%26aufirst%3DP.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520monoamine%2520carrier%2520of%2520chromaffin%2520granule%2520membrane%2520by%2520binding%2520of%2520%255B2-3H%255Ddihydrotetrabenazine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D584%26epage%3D588%26doi%3D10.1073%2Fpnas.80.2.584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lizpnNXn4jVnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>â <span class="NLM_lpage">775</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0ljNL4OM5Efysw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinevich, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrholm, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1035</span>â <span class="NLM_lpage">1045</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.068098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.104.068098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15121762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=1035-1045&author=D.+K.+Millerauthor=P.+A.+Crooksauthor=G.+Zhengauthor=V.+P.+Grinevichauthor=S.+D.+Norrholmauthor=L.+P.+Dwoskin&title=Lobeline+analogs+with+enhanced+affinity+and+selectivity+for+plasmalemma+and+vesicular+monoamine+transporters&doi=10.1124%2Fjpet.104.068098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters</span></div><div class="casAuthors">Miller, Dennis K.; Crooks, Peter A.; Zheng, Guangrong; Grinevich, Vladimir P.; Norrholm, Seth D.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lobeline attenuates the behavioral effects of psychostimulants in rodents and inhibits the function of nicotinic receptors (nAChRs), dopamine transporters (DATs), and vesicular monoamine transporters (VMAT2s).  Monoamine transporters are considered valid targets for drug development for the treatment of methamphetamine abuse.  In the current study, a series of lobeline analogs were evaluated for affinity and selectivity at these targets.  None of the analogs was more potent than nicotine at the [3H]methyllycaconitine binding site (Î±7* nAChR subtype).  Lobeline tosylate was equipotent with lobeline in inhibiting [3H]nicotine binding but 70-fold more potent in inhibiting nicotine-evoked 86Rb+ efflux, demonstrating antagonism of Î±4Î²2* nAChRs.  Compared with lobeline, the defunctionalized analogs lobelane, mesotransdiene, and (-)-trans-transdiene showed dramatically reduced affinity at Î±4Î²2* nAChRs and a 15- to 100-fold higher affinity (Ki = 1.95, 0.58, and 0.26 Î¼M, resp.) at DATs.  Mesotransdiene and (-)-trans-transdiene competitively inhibited DAT function, whereas lobelane and lobeline acted noncompetitively.  10S/10R-MEPP [N-methyl-2R-(2R/2S-hydroxy-2-phenylethyl)-6S-(2-phenylethyl)piperidine] and 10R-MESP [N-methyl-2R-(2R-hydroxy-2-phenylethyl)-6S-(2-phenylethen-1-yl)piperidine] were 2 to 3 orders of magnitude more potent (Ki = 0.01 and 0.04 Î¼M, resp.) than lobeline in inhibiting [3H]serotonin uptake; 10S/10R-MEPP showed a 600-fold selectivity for this transporter.  Uptake results using hDATs and human serotonin transporters expressed in human embryonic kidney-293 cells were consistent with native transporter assays.  Lobelane and ketoalkene were 5-fold more potent (Ki = 0.92 and 1.35 Î¼M, resp.) than lobeline (Ki = 5.46 Î¼M) in inhibiting [3H]methoxytetrabenazine binding to VMAT2 in vesicle prepns.  Thus, structural modification (defunctionalization) of the lobeline mol. markedly decreases affinity for Î±4Î²2* and Î±7* nAChRs while increasing affinity for neurotransmitter transporters, affording analogs with enhanced selectivity for these transporters and providing new leads for the treatment of psychostimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiZpZT4wLXbVg90H21EOLACvtfcHk0ljNL4OM5Efysw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtb4%253D&md5=588f10c8e544e8657d99e9d86eccf8ea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.068098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.068098%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DGrinevich%26aufirst%3DV.%2BP.%26aulast%3DNorrholm%26aufirst%3DS.%2BD.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DLobeline%2520analogs%2520with%2520enhanced%2520affinity%2520and%2520selectivity%2520for%2520plasmalemma%2520and%2520vesicular%2520monoamine%2520transporters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D1035%26epage%3D1045%26doi%3D10.1124%2Fjpet.104.068098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span> <span> </span><span class="NLM_article-title">Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">164</span>, <span class="refDoi">Â DOI: 10.1007/BF02736730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1007%2FBF02736730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=7654518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVejsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=149-164&author=E.+Weiheauthor=M.+K.+Schaferauthor=J.+E.+Ericksonauthor=L.+E.+Eiden&title=Localization+of+vesicular+monoamine+transporter+isoforms+%28VMAT1+and+VMAT2%29+to+endocrine+cells+and+neurons+in+rat&doi=10.1007%2FBF02736730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat</span></div><div class="casAuthors">Weihe, Eberhard; Schaefer, Martin K.-H.; Erickson, Jeffrey D.; Eiden, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-64</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana</span>)
        </div><div class="casAbstract">Polyclonal antipeptide antibodies have been raised against each of the two isoforms of the rat vesicular monoamine transporter, VMAT1 and VMAT2.  Antibody specificity was detd. by isoform-specific staining of monkey fibroblasts programmed to express either VMAT1 or VMAT2.  The expression of VMAT1 and VMAT2 in the diffuse neuroendocrine system of the rat has been examd. using these polyclonal antibodies specific for either VMAT1 or VMAT2.  VMAT1 is expressed exclusively in endocrine/paracrine cells assocd. with the intestine, stomach, and sympathetic nervous system.  VMAT2 is expressed in neurons of the sympathetic nervous system, and aminergic neurons in the enteric and central nervous systems.  VMAT2 is expressed in at least two endocrine cell populations in addn. to its expression in neurons.  A subpopulation of chromogranin A (CGA)-expressing chromaffin cells of the adrenal medulla also express VMAT2, and the oxyntic mucosa of the stomach contains a prominent population of CGA- and VMAT2-pos. endocrine cells.  The expression of VMAT2 in neurons, and the mutually exclusive expression of VMAT1 and VMAT2 in endocrine/paracrine cell populations of stomach, intestine, and sympathetic nervous system may provide a marker for, and insight into the ontogeny and monoamine-secreting capabilities of multiple neuroendocrine sublineages in the diffuse neuroendocrine system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol2jHaVzwxarVg90H21EOLACvtfcHk0ljNL4OM5Efysw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVejsLw%253D&md5=77c42fcbebab9cd6fa26c9389697ce42</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2FBF02736730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02736730%26sid%3Dliteratum%253Aachs%26aulast%3DWeihe%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DErickson%26aufirst%3DJ.%2BE.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DLocalization%2520of%2520vesicular%2520monoamine%2520transporter%2520isoforms%2520%2528VMAT1%2520and%2520VMAT2%2529%2520to%2520endocrine%2520cells%2520and%2520neurons%2520in%2520rat%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D1994%26volume%3D5%26spage%3D149%26epage%3D164%26doi%3D10.1007%2FBF02736730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span> <span> </span><span class="NLM_article-title">Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">5166</span>â <span class="NLM_lpage">5171</span>, <span class="refDoi">Â DOI: 10.1073/pnas.93.10.5166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.93.10.5166" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5166-5171&author=J.+D.+Ericksonauthor=M.+K.+Schaferauthor=T.+I.+Bonnerauthor=L.+E.+Eidenauthor=E.+Weihe&title=Distinct+pharmacological+properties+and+distribution+in+neurons+and+endocrine+cells+of+two+isoforms+of+the+human+vesicular+monoamine+transporter&doi=10.1073%2Fpnas.93.10.5166"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.10.5166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.10.5166%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DJ.%2BD.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26aulast%3DWeihe%26aufirst%3DE.%26atitle%3DDistinct%2520pharmacological%2520properties%2520and%2520distribution%2520in%2520neurons%2520and%2520endocrine%2520cells%2520of%2520two%2520isoforms%2520of%2520the%2520human%2520vesicular%2520monoamine%2520transporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D5166%26epage%3D5171%26doi%3D10.1073%2Fpnas.93.10.5166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1692</span>â <span class="NLM_lpage">1697</span>, <span class="refDoi">Â DOI: 10.1021/bi00430a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00430a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=1692-1697&author=F.+Darchenauthor=D.+Schermanauthor=J.+P.+Henry&title=Reserpine+binding+to+chromaffin+granules+suggests+the+existence+of+two+conformations+of+the+monoamine+transporter&doi=10.1021%2Fbi00430a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00430a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00430a040%26sid%3Dliteratum%253Aachs%26aulast%3DDarchen%26aufirst%3DF.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DReserpine%2520binding%2520to%2520chromaffin%2520granules%2520suggests%2520the%2520existence%2520of%2520two%2520conformations%2520of%2520the%2520monoamine%2520transporter%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D1692%26epage%3D1697%26doi%3D10.1021%2Fbi00430a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfrum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatfield, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span> <span> </span><span class="NLM_article-title">Substituted methcathinones differ in transporter and receptor interactions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1803</span>â <span class="NLM_lpage">1815</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2013.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.bcp.2013.04.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1803-1815&author=A.+J.+Eshlemanauthor=K.+M.+Wolfrumauthor=M.+G.+Hatfieldauthor=R.+A.+Johnsonauthor=K.+V.+Murphyauthor=A.+Janowsky&title=Substituted+methcathinones+differ+in+transporter+and+receptor+interactions&doi=10.1016%2Fj.bcp.2013.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DWolfrum%26aufirst%3DK.%2BM.%26aulast%3DHatfield%26aufirst%3DM.%2BG.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DK.%2BV.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DSubstituted%2520methcathinones%2520differ%2520in%2520transporter%2520and%2520receptor%2520interactions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1803%26epage%3D1815%26doi%3D10.1016%2Fj.bcp.2013.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. D.</span></span> <span> </span><span class="NLM_article-title">Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">16301</span>â <span class="NLM_lpage">16307</span>, <span class="refDoi">Â DOI: 10.1074/jbc.272.26.16301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.272.26.16301" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=16301-16307&author=J.+P.+Finnauthor=R.+D.+Edwards&title=Individual+residues+contribute+to+multiple+differences+in+ligand+recognition+between+vesicular+monoamine+transporters+1+and+2&doi=10.1074%2Fjbc.272.26.16301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.26.16301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.26.16301%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DEdwards%26aufirst%3DR.%2BD.%26atitle%3DIndividual%2520residues%2520contribute%2520to%2520multiple%2520differences%2520in%2520ligand%2520recognition%2520between%2520vesicular%2520monoamine%2520transporters%25201%2520and%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D16301%26epage%3D16307%26doi%3D10.1074%2Fjbc.272.26.16301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosandich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">Identification of residues involved in substrate recognition by a vesicular monoamine transporter</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">25798</span>â <span class="NLM_lpage">25804</span>, <span class="refDoi">Â DOI: 10.1074/jbc.270.43.25798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.270.43.25798" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=25798-25804&author=A.+Merickelauthor=P.+Rosandichauthor=D.+Peterauthor=R.+H.+Edwards&title=Identification+of+residues+involved+in+substrate+recognition+by+a+vesicular+monoamine+transporter&doi=10.1074%2Fjbc.270.43.25798"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.43.25798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.43.25798%26sid%3Dliteratum%253Aachs%26aulast%3DMerickel%26aufirst%3DA.%26aulast%3DRosandich%26aufirst%3DP.%26aulast%3DPeter%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520residues%2520involved%2520in%2520substrate%2520recognition%2520by%2520a%2520vesicular%2520monoamine%2520transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D25798%26epage%3D25804%26doi%3D10.1074%2Fjbc.270.43.25798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span> <span> </span><span class="NLM_article-title">N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>259</i></span>,  <span class="NLM_fpage">194</span>â <span class="NLM_lpage">202</span>, <span class="refDoi">Â DOI: 10.1016/j.neuroscience.2013.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuroscience.2013.11.059" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=2014&pages=194-202&author=B.+Torresauthor=A.+E.+Ruoho&title=N-terminus+regulation+of+VMAT2+mediates+methamphetamine-stimulated+efflux&doi=10.1016%2Fj.neuroscience.2013.11.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DN-terminus%2520regulation%2520of%2520VMAT2%2520mediates%2520methamphetamine-stimulated%2520efflux%26jtitle%3DNeuroscience%26date%3D2014%26volume%3D259%26spage%3D194%26epage%3D202%26doi%3D10.1016%2Fj.neuroscience.2013.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span> <span> </span><span class="NLM_article-title">Methamphetamine rapidly decreases vesicular dopamine uptake</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2221</span>â <span class="NLM_lpage">2223</span>, <span class="refDoi">Â DOI: 10.1046/j.1471-4159.2000.0742221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1046%2Fj.1471-4159.2000.0742221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10800970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis12qsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2221-2223&author=J.+M.+Brownauthor=G.+R.+Hansonauthor=A.+E.+Fleckenstein&title=Methamphetamine+rapidly+decreases+vesicular+dopamine+uptake&doi=10.1046%2Fj.1471-4159.2000.0742221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Methamphetamine rapidly decreases vesicular dopamine uptake</span></div><div class="casAuthors">Brown, Jeffrey M.; Hanson, Glen R.; Fleckenstein, Annette E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2221-2223</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Vesicular sequestration is important in the regulation of cytoplasmic concns. of monoamines such as dopamine.  Moreover, recent evidence suggests that increases in cytoplasmic dopamine levels, perhaps attributable to changes in vesicular monoamine transporter function, contribute to methamphetamine-induced dopaminergic deficits.  Hence, we examd. whether striatal vesicular uptake is altered following methamphetamine treatment.  Multiple administrations of methamphetamine rapidly (within 1 h) decreased vesicular dopamine uptake and dihydrotetrabenazine binding, an effect that (a) persisted at least 24 h, (b) was assocd. with dopamine and not serotonin neurons, and (c) was unrelated to residual drug introduced by the original methamphetamine treatment.  These data suggest that methamphetamine rapidly decreases vesicular monoamine transporter function in dopaminergic neurons, a phenomenon that may be assocd. with the long-term damage caused by this stimulant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS0qR0G-LAFLVg90H21EOLACvtfcHk0lhRVHWnhXc79g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis12qsrk%253D&md5=1271bdb61ab259752bd2fcc313206ddb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0742221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0742221.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26atitle%3DMethamphetamine%2520rapidly%2520decreases%2520vesicular%2520dopamine%2520uptake%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D2221%26epage%3D2223%26doi%3D10.1046%2Fj.1471-4159.2000.0742221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span> <span> </span><span class="NLM_article-title">Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">745</span>, <span class="refDoi">Â DOI: 10.1124/jpet.107.126888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.107.126888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=17693585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=738-745&author=T.+J.+Volzauthor=S.+J.+Farnsworthauthor=J.+L.+Kingauthor=E.+L.+Riddleauthor=G.+R.+Hansonauthor=A.+E.+Fleckenstein&title=Methylphenidate+administration+alters+vesicular+monoamine+transporter-2+function+in+cytoplasmic+and+membrane-associated+vesicles&doi=10.1124%2Fjpet.107.126888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles</span></div><div class="casAuthors">Volz, Trent J.; Farnsworth, Sarah J.; King, Jill L.; Riddle, Evan L.; Hanson, Glen R.; Fleckenstein, Annette E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-745</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In vivo methylphenidate (MPD) administration increases vesicular monoamine transporter-2 (VMAT-2) immunoreactivity, VMAT-2-mediated dopamine (DA) transport, and DA content in a nonmembrane-assocd. (referred to herein as cytoplasmic) vesicular subcellular fraction purified from rat striatum: a phenomenon attributed to a redistribution of VMAT-2-assocd. vesicles within nerve terminals.  In contrast, the present study elucidated the nature of, and the impact of MPD on, VMAT-2-assocd. vesicles that cofractionate with synaptosomal membranes after osmotic lysis (referred to herein as membrane-assocd. vesicles).  Results revealed that, in striking contrast to the cytoplasmic vesicles, DA transport velocity vs. substrate concn. curves in the membrane-assocd. vesicles were sigmoidal, suggesting pos. cooperativity with respect to DA transport.  Addnl., DA transport into membrane-assocd. vesicles was greater in total capacity in the presence of high DA concns. than transport into cytoplasmic vesicles.  Of potential therapeutic relevance, MPD increased DA transport into the membrane-assocd. vesicles despite rapidly decreasing (presumably by redistributing) VMAT-2 immunoreactivity in this fraction.  Functional relevance was suggested by findings that MPD treatment increased both the DA content of the membrane-assocd. vesicle fraction and K+-stimulated DA release from striatal suspensions.  In summary, the present data demonstrate the existence of a previously uncharacterized pool of membrane-assocd. VMAT-2-contg. vesicles that displays novel transport kinetics, has a large sequestration capacity, and responds to in vivo pharmacol. manipulation.  These findings provide insight into both the regulation of vesicular DA sequestration and the mechanism of action of MPD, and they may have implications regarding treatment of disorders involving abnormal DA disposition, including Parkinson's disease and substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaZrxRem8JirVg90H21EOLACvtfcHk0ljApque0BroAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzO&md5=8654232ba4679f09474f220b4f9defc9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.126888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.126888%26sid%3Dliteratum%253Aachs%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DFarnsworth%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DJ.%2BL.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26atitle%3DMethylphenidate%2520administration%2520alters%2520vesicular%2520monoamine%2520transporter-2%2520function%2520in%2520cytoplasmic%2520and%2520membrane-associated%2520vesicles%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D738%26epage%3D745%26doi%3D10.1124%2Fjpet.107.126888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=29-34&author=S.+Schuldinerauthor=Y.+Liuauthor=R.+H.+Edwards&title=Reserpine+binding+to+a+vesicular+amine+transporter+expressed+in+Chinese+hamster+ovary+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchuldiner%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DReserpine%2520binding%2520to%2520a%2520vesicular%2520amine%2520transporter%2520expressed%2520in%2520Chinese%2520hamster%2520ovary%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D29%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Stenger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. K.</span></span> <span> </span><span class="NLM_article-title">Peritoneal macrophages express the serotonin transporter</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">118</span>, <span class="refDoi">Â DOI: 10.1016/j.jneuroim.2004.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.jneuroim.2004.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15652409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisl2rtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2005&pages=113-118&author=M.+L.+Ruddauthor=A.+N.+Nicolasauthor=B.+L.+Brownauthor=K.+Fischer-Stengerauthor=J.+K.+Stewart&title=Peritoneal+macrophages+express+the+serotonin+transporter&doi=10.1016%2Fj.jneuroim.2004.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal macrophages express the serotonin transporter</span></div><div class="casAuthors">Rudd, M. L.; Nicolas, A. N.; Brown, B. L.; Fischer-Stenger, K.; Stewart, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although it is known that macrophages take up serotonin, a specific monoamine transporter has not been identified in macrophages.  In this study, mRNA coding for the serotonin transporter (SERT) was detected with the reverse transcription-polymerase chain reaction (RT-PCR) in recruited mouse peritoneal macrophages.  Sequencing confirmed the identity of the RT-PCR product to mouse SERT mRNA.  SERT protein was detected by Western blotting.  Macrophage activation with lipopolysaccharide had no effect on expression of SERT mRNA or protein.  Consistent with expression of a functional SERT, specific uptake of 3H-serotonin in macrophages was sodium dependent and inhibited by fluoxetine (IC50 6.9 nM) and desipramine (IC50 32 nM) but not by nisoxetine or reserpine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod8JGzaa5SobVg90H21EOLACvtfcHk0ljApque0BroAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisl2rtw%253D%253D&md5=0accfdd3bf933c7e645db53c2f34635e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2004.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2004.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BL.%26aulast%3DNicolas%26aufirst%3DA.%2BN.%26aulast%3DBrown%26aufirst%3DB.%2BL.%26aulast%3DFischer-Stenger%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26atitle%3DPeritoneal%2520macrophages%2520express%2520the%2520serotonin%2520transporter%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D159%26spage%3D113%26epage%3D118%26doi%3D10.1016%2Fj.jneuroim.2004.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordway, G. A.</span></span> <span> </span><span class="NLM_article-title">Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">760</span>â <span class="NLM_lpage">767</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2010.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2010.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=20176067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1aiu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=760-767&author=P.+Mandelaauthor=M.+Chandleyauthor=Y.-Y.+Xuauthor=M.-Y.+Zhuauthor=G.+A.+Ordway&title=Reserpine-induced+reduction+in+norepinephrine+transporter+function+requires+catecholamine+storage+vesicles&doi=10.1016%2Fj.neuint.2010.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles</span></div><div class="casAuthors">Mandela, Prashant; Chandley, Michelle; Xu, Yao-Yu; Zhu, Meng-Yang; Ordway, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">760-767</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Treatment of rats with reserpine, an inhibitor of the vesicular monoamine transporter (VMAT), depletes norepinephrine (NE) and regulates NE transporter (NET) expression.  The present study examd. the mol. mechanisms involved in regulation of the NET by reserpine using cultured cells.  Exposure of rat PC12 cells to reserpine for a period as short as 5 min decreased [3H]NE uptake capacity, an effect characterized by a robust decrease in the V max of the transport of [3H]NE.  As expected, reserpine did not displace the binding of [3H]nisoxetine from the NET in membrane homogenates.  The potency of reserpine for reducing [3H]NE uptake was dramatically lower in SK-N-SH cells that have reduced storage capacity for catecholamines.  Reserpine had no effect on [3H]NE uptake in HEK-293 cells transfected with the rat NET (293-hNET), cells that lack catecholamine storage vesicles.  NET regulation by reserpine was independent of trafficking of the NET from the cell surface.  Pre-exposure of cells to inhibitors of several intracellular signaling cascades known to regulate the NET, including Ca2+/Ca2+-calmodulin dependent kinase and protein kinases A, C and G, did not affect the ability of reserpine to reduce [3H]NE uptake.  Treatment of PC12 cells with the catecholamine depleting agent, Î±-methyl-p-tyrosine, increased [3H]NE uptake and eliminated the inhibitory effects of reserpine on [3H]NE uptake.  Reserpine non-competitively inhibits NET activity through a Ca2+-independent process that requires catecholamine storage vesicles, revealing a novel pharmacol. method to modify NET function.  Further characterization of the mol. nature of reserpine's action could lead to the development of alternative therapeutic strategies for treating disorders known to be benefitted by treatment with traditional competitive NET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aHcNIdnzgLVg90H21EOLACvtfcHk0ljApque0BroAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1aiu7k%253D&md5=387c34dff4e788fbcc2a9c25b0dd967e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DMandela%26aufirst%3DP.%26aulast%3DChandley%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.-Y.%26aulast%3DZhu%26aufirst%3DM.-Y.%26aulast%3DOrdway%26aufirst%3DG.%2BA.%26atitle%3DReserpine-induced%2520reduction%2520in%2520norepinephrine%2520transporter%2520function%2520requires%2520catecholamine%2520storage%2520vesicles%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D56%26spage%3D760%26epage%3D767%26doi%3D10.1016%2Fj.neuint.2010.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznick, H. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: Disassociation of the [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12935 Binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznick&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+Disassociation+of+the+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12935+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznick%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520Disassociation%2520of%2520the%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012935%2520Binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatch, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span> <span> </span><span class="NLM_article-title">Abuse liability profile of three substituted tryptamines</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">280</span>â <span class="NLM_lpage">289</span>, <span class="refDoi">Â DOI: 10.1124/jpet.111.179705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.111.179705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=21474568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFChsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=280-289&author=M.+B.+Gatchauthor=M.+J.+Forsterauthor=A.+Janowskyauthor=A.+J.+Eshleman&title=Abuse+liability+profile+of+three+substituted+tryptamines&doi=10.1124%2Fjpet.111.179705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Abuse liability profile of three substituted tryptamines</span></div><div class="casAuthors">Gatch, Michael B.; Forster, Michael J.; Janowsky, Aaron; Eshleman, Amy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">280-289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-Î±-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compds., including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD), (-)-2,5-dimethoxy-4-methylamphetamine (DOM), and dimethyltryptamine (DMT).  Because abused hallucinogens act at 5-hydroxytryptamine 1A (5-HT1A) and 5-HT2A receptors, and abused psychostimulants act at monoamine transporters, binding and functional activities of DIPT, 5-MeO-DET, and 5-MeO-AMT at these sites were also tested.  DIPT fully substituted in rats trained to discriminate DMT (ED50 = 1.71 mg/kg) and DOM (ED50 = 1.94 mg/kg), but produced only 68% LSD-appropriate responding.  5-MeO-DET fully substituted for DMT (ED50 = 0.41 mg/kg) and produced 59% MDMA-appropriate responding.  5-MeO-AMT did not fully substitute for any of the training drugs, but produced 67% LSD-appropriate responding.  None of the compds. produced substitution in rats trained to discriminate cocaine or methamphetamine.  All three compds. showed activity at 5-HT1A and 5-HT2A receptors as well as blockade of reuptake by the serotonin transporter.  In addn., 5-MeO-AMT produced low levels of serotonin release and low potency blockade of dopamine uptake.  DIPT, 5-MeO-DET, and 5-MeO-AMT produced behavioral and receptor effects similar to those of abused hallucinogens, but were not similar to those of psychostimulants.  DIPT and 5-MeO-DET may have abuse liability similar to known hallucinogens and may be hazardous because high doses produced activity and lethality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonSmqsIZk_grVg90H21EOLACvtfcHk0lhPJZ8BxuyV1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFChsrk%253D&md5=28594d307ac5d2d08ddab942ac1012a6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.179705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.179705%26sid%3Dliteratum%253Aachs%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DForster%26aufirst%3DM.%2BJ.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26atitle%3DAbuse%2520liability%2520profile%2520of%2520three%2520substituted%2520tryptamines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D280%26epage%3D289%26doi%3D10.1124%2Fjpet.111.179705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Kilbourn</span>. </span><span class="cited-content_cbyCitation_article-title">11C- and 18F-Radiotracers for In Vivo Imaging of the Dopamine System: Past, Present and Future. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (2)
                                     , 108. <a href="https://doi.org/10.3390/biomedicines9020108" title="DOI URL">https://doi.org/10.3390/biomedicines9020108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9020108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9020108%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3D11C-%252Band%252B18F-Radiotracers%252Bfor%252BIn%252BVivo%252BImaging%252Bof%252Bthe%252BDopamine%252BSystem%25253A%252BPast%25252C%252BPresent%252Band%252BFuture%26aulast%3DKilbourn%26aufirst%3DMichael%2BR.%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D2%26spage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Kilbourn</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of Vesicular Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1091-1132. <a href="https://doi.org/10.1007/978-3-030-53176-8_33" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_33</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_33%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bof%252BVesicular%252BMonoamine%252BTransporters%26aulast%3DKilbourn%26aufirst%3DMichael%2BR.%26date%3D2021%26date%3D2020%26spage%3D1091%26epage%3D1132%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Randy  Torralva</span>, <span class="hlFld-ContribAuthor ">Amy J.  Eshleman</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Swanson</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Schmachtenberg</span>, <span class="hlFld-ContribAuthor ">William E.  Schutzer</span>, <span class="hlFld-ContribAuthor ">Shelley H.  Bloom</span>, <span class="hlFld-ContribAuthor ">Katherine M.  Wolfrum</span>, <span class="hlFld-ContribAuthor ">John F.  Reed</span>, <span class="hlFld-ContribAuthor ">Aaron  Janowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>374 </em>
                                    (3)
                                     , 376-391. <a href="https://doi.org/10.1124/jpet.120.265561" title="DOI URL">https://doi.org/10.1124/jpet.120.265561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.120.265561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.120.265561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DFentanyl%252Bbut%252Bnot%252BMorphine%252BInteracts%252Bwith%252BNonopioid%252BRecombinant%252BHuman%252BNeurotransmitter%252BReceptors%252Band%252BTransporters%26aulast%3DTorralva%26aufirst%3DRandy%26date%3D2020%26date%3D2020%26volume%3D374%26issue%3D3%26spage%3D376%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>syn</i>-APQ Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (1) K<sub>2</sub>CO<sub>3</sub>, DCM; (2) NaH, PhN(Tf)<sub>2</sub>, DMF, 0Â° C; (b) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH, 85 Â°C; (c) Pd/C, H<sub>2</sub>, rt; (d) <b>6</b>, toluene or DMF/1,4-dioxane or CH<sub>3</sub>CN, 90â110 Â°C.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>anti</i>-APQ Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 60 Â°C; (b) EtONa, EtOH, 70 Â°C; (c) 4 M HCl; (d) <b>6</b>, toluene, 100 Â°C.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of Mg-ATP on (A) [<sup>3</sup>H]reserpine, (B) [<sup>3</sup>H](+)-<b>5b</b>, and (C) [<sup>3</sup>H]DHTB. The effects of Mg-ATP on radioligand binding were conducted as described in the Experimental Section. Error bars (SEMs) were derived from multiple experiments conducted with duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Kinetics of [<sup>3</sup>H]reserpine and [<sup>3</sup>H](+)-<b>5b</b> binding to human VMAT2. (A, B) [<sup>3</sup>H]Reserpine association and dissociation time curves, respectively. (C, D) [<sup>3</sup>H](+)-<b>5b</b> association and dissociation time curves, respectively. Note the different <i>X</i> axis time ranges in (B) and (D). Assays were conducted as described in theÂ <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, with excess concentration of respective nonradiolabeled ligand. <i>n</i> = 3â5 independent experiments conducted in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Saturation binding of [<sup>3</sup>H]reserpine, [<sup>3</sup>H](+)-<b>5b</b>, and [<sup>3</sup>H]DHTB binding to HEK-VMAT2 cell membranes: (A) [<sup>3</sup>H]reserpine, (B) [<sup>3</sup>H](+)-<b>5b</b>, and (C) [<sup>3</sup>H]DHTB saturation binding. Assays were conducted as described in theÂ <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Saturation curves are the average and SEM of 3â4 independent experiments each conducted in duplicate. A representative Scatchard plot is shown for each radioligand. In the Scatchard analysis, the (â) reciprocal of the slope of the line is an estimate of the <i>K</i><sub>d</sub> value for the radioligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentrationâresponse curves of inhibition of [<sup>3</sup>H]5-HT uptake into mouse striatal vesicular membranes. Six APQ compounds and three standards are shown. <i>n</i> = 3â6. All APQ compounds were more potent than ketanserin in this assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlations of binding affinities and uptake potencies for HEK-VMAT2 for select compounds: drug-induced inhibition of (A) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H](+)-<b>5b</b> binding versus log(IC<sub>50</sub>) for inhibition of [<sup>3</sup>H]5-HT uptake, (B) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H]reserpine binding versus log(IC<sub>50</sub>) for [<sup>3</sup>H]5-HT uptake, and (C) log(<i>K</i><sub>i</sub>) for inhibition of [<sup>3</sup>H]DHTB binding versus log(IC<sub>50</sub>) for [<sup>3</sup>H]5-HT uptake. Fourteen APQ compounds and seven standard compounds were included in the analysis. Data were analyzed using Spearmanâs nonparametric correlation analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/medium/jm-2018-00542z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of APQ compounds, standards, and staurosporine (SP) on cell viability in the MTT assay. APQ compounds, RO4-1284, ketanserin, METH, and DHTB were tested at 10 Î¼M, and reserpine was tested at 1 Î¼M. The positive control SP was tested at 0.1, 0.3, 1, and 3 Î¼M. Inset: test for linearity of HEK-hVMAT2 cell number vs OD at 590 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00542/20181019/images/large/jm-2018-00542z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00542&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbruscato, T. J.</span>; <span class="NLM_string-name">Tripper, P. C.</span></span> <span> </span><span class="NLM_article-title">DARK classics in chemical neuroscience: methamphetamine</span>.  <i>ACS Chem. Neurosci.</i> [Online Early Access] <span class="refDoi">Â DOI: 10.1021/acschemneuro.8b00123</span> . Published Online: March 30, <span class="NLM_year" style="font-weight: bold;">2018</span>. <a href="https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00123" class="extLink">https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00123</a> (accessed July 15, 2018).</span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=T.+J.+Abbruscato&author=P.+C.+Tripper&title=DARK+classics+in+chemical+neuroscience%3A+methamphetamine&doi=10.1021%2Facschemneuro.8b00123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00123%26sid%3Dliteratum%253Aachs%26aulast%3DAbbruscato%26aufirst%3DT.%2BJ.%26atitle%3DDARK%2520classics%2520in%2520chemical%2520neuroscience%253A%2520methamphetamine%26jtitle%3DACS%2520Chem.%2520Neurosci.%26doi%3D10.1021%2Facschemneuro.8b00123%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <i>The
DAWN Report: Emergency Department Visits Involving Methamphetamine:
2007 to 2011</i>; <span class="NLM_publisher-name">Substance Abuse and Mental
Health Services Administration, Center for Behavioral Health Statistics
and Quality</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, June 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The%0ADAWN+Report%3A+Emergency+Department+Visits+Involving+Methamphetamine%3A%0A2007+to+2011%3B+Substance+Abuse+and+Mental%0AHealth+Services+Administration%2C+Center+for+Behavioral+Health+Statistics%0Aand+Quality%3A+Rockville%2C+MD%2C+June+19%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%250ADAWN%2520Report%253A%2520Emergency%2520Department%2520Visits%2520Involving%2520Methamphetamine%253A%250A2007%2520to%25202011%26pub%3DSubstance%2520Abuse%2520and%2520Mental%250AHealth%2520Services%2520Administration%252C%2520Center%2520for%2520Behavioral%2520Health%2520Statistics%250Aand%2520Quality%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battki, S. L.</span></span> <span> </span><span class="NLM_article-title">Stimulant psychosis: symptom profile and acute clinical course</span>. <i>Am. J. Addict.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28</span>â <span class="NLM_lpage">37</span>, <span class="refDoi">Â DOI: 10.1080/10550490050172209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1080%2F10550490050172209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10914291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FksFSrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=28-37&author=D.+Harrisauthor=S.+L.+Battki&title=Stimulant+psychosis%3A+symptom+profile+and+acute+clinical+course&doi=10.1080%2F10550490050172209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulant psychosis: symptom profile and acute clinical course</span></div><div class="casAuthors">Harris D; Batki S L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal on addictions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>
        ISSN:<span class="NLM_cas:issn">1055-0496</span>.
    </div><div class="casAbstract">Nineteen patients seen at a psychiatric emergency service with amphetamine- or cocaine-induced psychotic disorder were assessed with structured interviews, chart review, and blood and urine testing.  All had a predominance of positive symptoms from the Positive and Negative Syndrome Scale (PANSS).  However, some subjects had substantial Negative Scale scores (26%), bizarre delusions (95%), and Schneiderian hallucinations (63%), mimicking a broad range of schizophrenic symptoms.  Several PANSS scores were correlated with treatment intensity: Positive score with seclusion hours, General Psychopathology and Negative scores with hospitalization length, and General Psychopathology score with neuroleptic dose.  Presenting symptoms may help in treatment planning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdQuKR6fS1aMNIRw0GKUoEfW6udTcc2eYPXwb-QEp2mLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FksFSrtw%253D%253D&md5=a483671c65ff39b967ddd644d24c490b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F10550490050172209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10550490050172209%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DBattki%26aufirst%3DS.%2BL.%26atitle%3DStimulant%2520psychosis%253A%2520symptom%2520profile%2520and%2520acute%2520clinical%2520course%26jtitle%3DAm.%2520J.%2520Addict.%26date%3D2000%26volume%3D9%26spage%3D28%26epage%3D37%26doi%3D10.1080%2F10550490050172209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dannals, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricaurte, G. A.</span></span> <span> </span><span class="NLM_article-title">Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">8417</span>â <span class="NLM_lpage">8422</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-20-08417.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1523%2FJNEUROSCI.18-20-08417.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9763484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK1cXms1ehurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=8417-8422&author=U.+D.+McCannauthor=D.+F.+Wongauthor=F.+Yokoiauthor=V.+Villemagneauthor=R.+F.+Dannalsauthor=G.+A.+Ricaurte&title=Reduced+striatal+dopamine+transporter+density+in+abstinent+methamphetamine+and+methcathinone+users%3A+evidence+from+positron+emission+tomography+studies+with+%5B11C%5DWIN-35%2C428&doi=10.1523%2FJNEUROSCI.18-20-08417.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428</span></div><div class="casAuthors">McCann, Una D.; Wong, Dean F.; Yokoi, Fuji; Villemagne, Victor; Dannals, Robert F.; Ricaurte, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8417-8422</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Methamphetamine and methcathinone are psychostimulant drugs with high potential for abuse.  In animals, methamphetamine and related drugs are known to damage brain dopamine (DA) neurons, and this damage has recently been shown to be detectable in living nonhuman primates by means of positron emission tomog. (PET) with [11C]WIN-35,428, a DA transporter (DAT) ligand.  The present studies detd. whether living humans with a history of methamphetamine or methcathinone abuse showed evidence of lasting decrements in brain DAT d.  PET studies were performed in 10 control subjects, six abstinent methamphetamine users, four abstinent methcathinone users, and three patients with Parkinson's disease (PD).  On av., subjects had abstained from amphetamine use for â¼3 yr.  Before PET studies, all subjects underwent urine and blood toxicol. screens to rule out recent drug use.  Compared with controls, abstinent methamphetamine and methcathinone users had significant decreases in DAT d. in the caudate nucleus (-23 and -24%, resp.) and putamen (-25 and -16%, resp.).  Larger decreases in DAT d. were evident in patients with PD (47 and 68% in caudate and putamen, resp.).  Neither methamphetamine nor methcathinone users showed clin. signs of parkinsonism.  Persistent redns. of DAT d. in methamphetamine and methcathinone users are suggestive of loss of DAT or loss of DA terminals and raise the possibility that as these individuals age, they may be at increased risk for the development of parkinsonism or neuropsychiatric conditions in which brain DA neurons have been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_HqZiJIwONbVg90H21EOLACvtfcHk0li8_wObr9Bhjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1ehurY%253D&md5=7ec1afd20873623076d37e228e7c7176</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-20-08417.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-20-08417.1998%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DU.%2BD.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DVillemagne%26aufirst%3DV.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRicaurte%26aufirst%3DG.%2BA.%26atitle%3DReduced%2520striatal%2520dopamine%2520transporter%2520density%2520in%2520abstinent%2520methamphetamine%2520and%2520methcathinone%2520users%253A%2520evidence%2520from%2520positron%2520emission%2520tomography%2520studies%2520with%2520%255B11C%255DWIN-35%252C428%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D8417%26epage%3D8422%26doi%3D10.1523%2FJNEUROSCI.18-20-08417.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freissmuth, M.</span></span> <span> </span><span class="NLM_article-title">Amphetamines, new psychoactive drugs and the monoamine transporter cycle</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">41</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.tips.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=25542076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVanug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=41-50&author=H.+Sitteauthor=M.+Freissmuth&title=Amphetamines%2C+new+psychoactive+drugs+and+the+monoamine+transporter+cycle&doi=10.1016%2Fj.tips.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amphetamines, new psychoactive drugs and the monoamine transporter cycle</span></div><div class="casAuthors">Sitte, Harald H.; Freissmuth, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-50</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In monoaminergic neurons, the vesicular transporters and the plasma membrane transporters operate in a relay.  Amphetamine and its congeners target this relay to elicit their actions: most amphetamines are substrates, which pervert the relay to elicit efflux of monoamines into the synaptic cleft.  However, some amphetamines act as transporter inhibitors.  Both compd. classes elicit profound psychostimulant effects, which render them liable to recreational abuse.  Currently, a surge of new psychoactive substances occurs on a global scale.  Chemists bypass drug bans by ingenuous structural variations, resulting in a rich pharmacol.  A credible transport model must account for their distinct mode of action and link this to subtle differences in activity and undesired, potentially deleterious effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjU1hFyvU8R7Vg90H21EOLACvtfcHk0ljYDgScxt3_-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVanug%253D%253D&md5=18de6ecc05000d320900885e41d97da2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DSitte%26aufirst%3DH.%26aulast%3DFreissmuth%26aufirst%3DM.%26atitle%3DAmphetamines%252C%2520new%2520psychoactive%2520drugs%2520and%2520the%2520monoamine%2520transporter%2520cycle%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D41%26epage%3D50%26doi%3D10.1016%2Fj.tips.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-420118-7.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FB978-0-12-420118-7.00002-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=71-106&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=A.+Vartakauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=The+vesicular+monoamine+transporter-2%3A+an+important+pharmacological+target+for+the+discovery+of+novel+therapeutics+to+treat+methamphetamine+abuse&doi=10.1016%2FB978-0-12-420118-7.00002-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DVartak%26aufirst%3DA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter-2%253A%2520an%2520important%2520pharmacological%2520target%2520for%2520the%2520discovery%2520of%2520novel%2520therapeutics%2520to%2520treat%2520methamphetamine%2520abuse%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D71%26epage%3D106%26doi%3D10.1016%2FB978-0-12-420118-7.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span> <span> </span><span class="NLM_article-title">VMAT2: A dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.2010.05906.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1111%2Fj.1749-6632.2010.05906.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2011&pages=86-98&author=L.+E.+Eidenauthor=E.+Weihe&title=VMAT2%3A+A+dynamic+regulator+of+brain+monoaminergic+neuronal+function+interacting+with+drugs+of+abuse&doi=10.1111%2Fj.1749-6632.2010.05906.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05906.x%26sid%3Dliteratum%253Aachs%26aulast%3DEiden%26aufirst%3DL.%2BE.%26aulast%3DWeihe%26aufirst%3DE.%26atitle%3DVMAT2%253A%2520A%2520dynamic%2520regulator%2520of%2520brain%2520monoaminergic%2520neuronal%2520function%2520interacting%2520with%2520drugs%2520of%2520abuse%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1216%26spage%3D86%26epage%3D98%26doi%3D10.1111%2Fj.1749-6632.2010.05906.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. W.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter 2: an underexplored pharmacological target</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2013.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=24398404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=89-97&author=A.+I.+Bernsteinauthor=K.+A.+Stoutauthor=G.+W.+Miller&title=The+vesicular+monoamine+transporter+2%3A+an+underexplored+pharmacological+target&doi=10.1016%2Fj.neuint.2013.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter 2: An underexplored pharmacological target</span></div><div class="casAuthors">Bernstein, Alison I.; Stout, Kristen A.; Miller, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Active transport of neurotransmitters into synaptic vesicles is required for their subsequent exocytotic release.  In the monoamine system, this process is carried out by the vesicular monoamine transporters (VMAT1 and VMAT2).  These proteins are responsible for vesicular packaging of dopamine, norepinephrine, serotonin, and histamine.  These proteins are essential for proper neuronal function; however, compared to their plasma membrane counterparts, there are few drugs available that target these vesicular proteins.  This is partly due to the added complexity of crossing the plasma membrane, but also to the tech. difficulty of assaying for vesicular uptake in high throughput.  Until recently, reagents to enable high throughput screening for function of these vesicular neurotransmitter transporters have not been available.  Fortunately, novel compds. and methods are now making such screening possible; thus, a renewed focus on these transporters as potential targets is timely and necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHcBYk8fojmbVg90H21EOLACvtfcHk0ljYDgScxt3_-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D&md5=f83b99eb743485ba5b44ec54e51228b2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DA.%2BI.%26aulast%3DStout%26aufirst%3DK.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BW.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%25202%253A%2520an%2520underexplored%2520pharmacological%2520target%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.neuint.2013.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumushima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arime, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span> <span> </span><span class="NLM_article-title">Monoamine transporter as a target molecule for psychostimulants</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">33</span>, <span class="refDoi">Â DOI: 10.1016/S0074-7742(09)85003-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FS0074-7742%2809%2985003-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=19607959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=29-33&author=I.+Soraauthor=B.+Liauthor=S.+Fumushimaauthor=A.+Fukuiauthor=Y.+Arimeauthor=Y.+Kasaharaauthor=H.+Tomitaauthor=K.+Ikeda&title=Monoamine+transporter+as+a+target+molecule+for+psychostimulants&doi=10.1016%2FS0074-7742%2809%2985003-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine transporter as a target molecule for psychostimulants</span></div><div class="casAuthors">Sora, Ichiro; Li, BingJin; Fumushima, Setsu; Fukui, Asami; Arime, Yosefu; Kasahara, Yoshiyuki; Tomita, Hiroaki; Ikeda, Kazutaka</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">Advances in Neuropharmacology</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Methamphetamine (MAP), a drug of abuse known worldwide for its addictive effects and neurotoxicity, causes somatic and psychiatric disorders.  MAP enters terminals/neurons via monoamine transporters, displaces both vesicular and intracellular monoamines, and facilitates the release of monoamines into the extraneuronal space through synaptic transport via the monoamine transporters.  Chronic psychostimulant abusers exhibit psychotic features, including delusions and auditory hallucinations.  The dopamine transporter (DAT) and the vesicular monoamine transporter 2 (VMAT2) play pivotal roles in the action of MAP, including locomotor effects.  The deletion of DAT attenuates the locomotor effects of MAP and may play larger role in behavioral responses to MAP compared to the deletion of VMAT2.  MAP produces hyperthermia and/or neuronal toxicity in most species.  The effects of MAP in DAT or serotonin transporter (SERT) single knockout (KO) mice and DAT/SERT double KO mice suggested that DAT and SERT are key mols. for hyperthermia and neuronal toxicity of MAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFVKV_H2UD-7Vg90H21EOLACvtfcHk0ljYDgScxt3_-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rJ&md5=9816fd35ca82f6e50905a1289f9a96bb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2985003-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252985003-4%26sid%3Dliteratum%253Aachs%26aulast%3DSora%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFumushima%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DA.%26aulast%3DArime%26aufirst%3DY.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DK.%26atitle%3DMonoamine%2520transporter%2520as%2520a%2520target%2520molecule%2520for%2520psychostimulants%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D85%26spage%3D29%26epage%3D33%26doi%3D10.1016%2FS0074-7742%2809%2985003-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">New scaffold for lead compounds to treat methamphetamine use disorders</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi">Â DOI: 10.1208/s12248-018-0192-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1208%2Fs12248-018-0192-y" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=29&author=N.-R.+Leeauthor=G.+Zhengauthor=P.+A.+Crooksauthor=M.+T.+Bardoauthor=L.+P.+Dwoskin&title=New+scaffold+for+lead+compounds+to+treat+methamphetamine+use+disorders&doi=10.1208%2Fs12248-018-0192-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1208%2Fs12248-018-0192-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-018-0192-y%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.-R.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DNew%2520scaffold%2520for%2520lead%2520compounds%2520to%2520treat%2520methamphetamine%2520use%2520disorders%26jtitle%3DAAPS%2520J.%26date%3D2018%26volume%3D20%26spage%3D29%26doi%3D10.1208%2Fs12248-018-0192-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grouleff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladefoged, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koldso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiott, B.</span></span> <span> </span><span class="NLM_article-title">Monoamine transporters: insights from molecular dynamics simulations</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">235</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2015.00235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.3389%2Ffphar.2015.00235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26528185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOnt7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=235&author=J.+Grouleffauthor=K.+Ladefogedauthor=H.+Koldsoauthor=B.+Schiott&title=Monoamine+transporters%3A+insights+from+molecular+dynamics+simulations&doi=10.3389%2Ffphar.2015.00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine transporters: insights from molecular dynamics simulations</span></div><div class="casAuthors">Grouleff, Julie; Ladefoged, Lucy Kate; Koldso, Heidi; Schiott, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235/1-235/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The human monoamine transporters (MATs) facilitate the reuptake of the neurotransmitters serotonin, dopamine, and norepinephrine from the synaptic cleft.  Imbalance in monoaminergic neurotransmission is linked to various diseases including major depression, attention deficit hyperactivity disorder, schizophrenia, and Parkinson's disease.  Inhibition of the MATs is thus an important strategy for treatment of such diseases.  The MATs are sodium-coupled transport proteins belonging to the neurotransmitter/Na+ symporter (NSS) family, and the publication of the first high-resoln. structure of a NSS family member, the bacterial leucine transporter LeuT, in 2005, proved to be a major stepping stone for understanding this family of transporters.  Structural data allows for the use of computational methods to study the MATs, which in turn has led to a no. of important discoveries.  The process of substrate translocation across the membrane is an intrinsically dynamic process.  Mol. dynamics simulations, which can provide atomistic details of mol. motion on ns to ms timescales, are therefore well-suited for studying transport processes.  In this review, we outline how mol. dynamics simulations have provided insight into the large scale motions assocd. with transport of the neurotransmitters, as well as the presence of external and internal gates, the coupling between ion and substrate transport, and differences in the conformational changes induced by substrates and inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh5v91itN1abVg90H21EOLACvtfcHk0li2J1z47TYb_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOnt7nO&md5=15060d363db16b7c3a42f2c04063b5b2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00235%26sid%3Dliteratum%253Aachs%26aulast%3DGrouleff%26aufirst%3DJ.%26aulast%3DLadefoged%26aufirst%3DK.%26aulast%3DKoldso%26aufirst%3DH.%26aulast%3DSchiott%26aufirst%3DB.%26atitle%3DMonoamine%2520transporters%253A%2520insights%2520from%2520molecular%2520dynamics%2520simulations%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D235%26doi%3D10.3389%2Ffphar.2015.00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span> <span> </span><span class="NLM_article-title">New insights into the mechanism of action of amphetamines</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">681</span>â <span class="NLM_lpage">698</span>, <span class="refDoi">Â DOI: 10.1146/annurev.pharmtox.47.120505.105140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=17209801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=681-698&author=A.+E.+Fleckensteinauthor=T.+J.+Volzauthor=E.+L.+Riddleauthor=J.+W.+Gibbauthor=G.+R.+Hanson&title=New+insights+into+the+mechanism+of+action+of+amphetamines&doi=10.1146%2Fannurev.pharmtox.47.120505.105140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the mechanism of action of amphetamines</span></div><div class="casAuthors">Fleckenstein, Annette E.; Volz, Trent J.; Riddle, Evan L.; Gibb, James W.; Hanson, Glen R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">681-698</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Amphetamine is a psychostimulant commonly used to treat several disorders, including attention deficit, narcolepsy, and obesity.  Plasmalemmal and vesicular monoamine transporters, such as the neuronal dopamine transporter and the vesicular monoamine transporter-2, are two of its principal targets.  This review focuses on new insights, obtained from both in vivo and in vitro studies, into the mol. mechanisms whereby amphetamine, and the closely related compds. methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release.  These mechanisms include amphetamine-induced exchange diffusion, reverse transport, and channel-like transport phenomena as well as the weak base properties of amphetamine.  Addnl., amphetamine analogs may affect monoamine transporters through phosphorylation, transporter trafficking, and the prodn. of reactive oxygen and nitrogen species.  All of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraPle7JPAeKrVg90H21EOLACvtfcHk0li2J1z47TYb_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D&md5=ead84eb20c530d952c181a79122a1971</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105140%26sid%3Dliteratum%253Aachs%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DGibb%26aufirst%3DJ.%2BW.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26atitle%3DNew%2520insights%2520into%2520the%2520mechanism%2520of%2520action%2520of%2520amphetamines%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D681%26epage%3D698%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Expression and function of the rat vesicular monoamine transporter 2</span>. <i>Am. J. Physiol.: Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">C1004</span>â <span class="NLM_lpage">C1011</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00348.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1152%2Fajpcell.00348.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=18287335" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=C1004-C1011&author=Y.+Adamauthor=R.+H.+Edwardsauthor=S.+Schuldiner&title=Expression+and+function+of+the+rat+vesicular+monoamine+transporter+2&doi=10.1152%2Fajpcell.00348.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00348.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00348.2007%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DExpression%2520and%2520function%2520of%2520the%2520rat%2520vesicular%2520monoamine%2520transporter%25202%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DC1004%26epage%3DC1011%26doi%3D10.1152%2Fajpcell.00348.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freyberg, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonders, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiranita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karam, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farino, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosharov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10652</span>, <span class="refDoi">Â DOI: 10.1038/ncomms10652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1038%2Fncomms10652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26879809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XislOqsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10652&author=Z.+Freybergauthor=M.+S.+Sondersauthor=J.+I.+Aguilarauthor=T.+Hiranitaauthor=C.+S.+Karamauthor=J.+Floresauthor=A.+B.+Pizzoauthor=Y.+Zhangauthor=Z.+J.+Farinoauthor=A.+Chenauthor=C.+A.+Martinauthor=T.+A.+Kopajticauthor=H.+Feiauthor=G.+Huauthor=Y.+Y.+Linauthor=E.+V.+Mosharovauthor=B.+D.+McCabeauthor=R.+Freybergauthor=K.+Wimalasenaauthor=L.+W.+Hsinauthor=D.+Samesauthor=D.+E.+Krantzauthor=J.+L.+Katzauthor=D.+Sulzerauthor=J.+A.+Javitch&title=Mechanisms+of+amphetamine+action+illuminated+through+optical+monitoring+of+dopamine+synaptic+vesicles+in+Drosophila+brain&doi=10.1038%2Fncomms10652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain</span></div><div class="casAuthors">Freyberg, Zachary; Sonders, Mark S.; Aguilar, Jenny I.; Hiranita, Takato; Karam, Caline S.; Flores, Jorge; Pizzo, Andrea B.; Zhang, Yuchao; Farino, Zachary J.; Chen, Audrey; Martin, Ciara A.; Kopajtic, Theresa A.; Fei, Hao; Hu, Gang; Lin, Yi-Ying; Mosharov, Eugene V.; McCabe, Brian D.; Freyberg, Robin; Wimalasena, Kandatege; Hsin, Ling-Wei; Sames, Dalibor; Krantz, David E.; Katz, Jonathan L.; Sulzer, David; Javitch, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10652</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amphetamines elevate extracellular dopamine, but the underlying mechanisms remain uncertain.  Here we show in rodents that acute pharmacol. inhibition of the vesicular monoamine transporter (VMAT) blocks amphetamine-induced locomotion and self-administration without impacting cocaine-induced behaviors.  To study VMAT's role in mediating amphetamine action in dopamine neurons, we have used novel genetic, pharmacol. and optical approaches in Drosophila melanogaster.  In an ex vivo whole-brain prepn., fluorescent reporters of vesicular cargo and of vesicular pH reveal that amphetamine redistributes vesicle contents and diminishes the vesicle pH-gradient responsible for dopamine uptake and retention.  This amphetamine-induced deacidification requires VMAT function and results from net H+ antiport by VMAT out of the vesicle lumen coupled to inward amphetamine transport.  Amphetamine-induced vesicle deacidification also requires functional dopamine transporter (DAT) at the plasma membrane.  Thus, we find that at pharmacol. relevant concns., amphetamines must be actively transported by DAT and VMAT in tandem to produce psychostimulant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW1al_k-lBf7Vg90H21EOLACvtfcHk0lhRexD4Us8Opw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislOqsbo%253D&md5=b74452272c9a24baed52b15bca6f740d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms10652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10652%26sid%3Dliteratum%253Aachs%26aulast%3DFreyberg%26aufirst%3DZ.%26aulast%3DSonders%26aufirst%3DM.%2BS.%26aulast%3DAguilar%26aufirst%3DJ.%2BI.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DKaram%26aufirst%3DC.%2BS.%26aulast%3DFlores%26aufirst%3DJ.%26aulast%3DPizzo%26aufirst%3DA.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFarino%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DC.%2BA.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DFei%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%2BY.%26aulast%3DMosharov%26aufirst%3DE.%2BV.%26aulast%3DMcCabe%26aufirst%3DB.%2BD.%26aulast%3DFreyberg%26aufirst%3DR.%26aulast%3DWimalasena%26aufirst%3DK.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DKrantz%26aufirst%3DD.%2BE.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DSulzer%26aufirst%3DD.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DMechanisms%2520of%2520amphetamine%2520action%2520illuminated%2520through%2520optical%2520monitoring%2520of%2520dopamine%2520synaptic%2520vesicles%2520in%2520Drosophila%2520brain%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10652%26doi%3D10.1038%2Fncomms10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vocci, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appel, N. M.</span></span> <span> </span><span class="NLM_article-title">Approaches to the development of medications for the treatment of methamphetamine dependence</span>. <i>Addiction</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">96</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1111/j.1360-0443.2007.01772.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1111%2Fj.1360-0443.2007.01772.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=96-106&issue=Suppl.+1&author=F.+J.+Vocciauthor=N.+M.+Appel&title=Approaches+to+the+development+of+medications+for+the+treatment+of+methamphetamine+dependence&doi=10.1111%2Fj.1360-0443.2007.01772.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1360-0443.2007.01772.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1360-0443.2007.01772.x%26sid%3Dliteratum%253Aachs%26aulast%3DVocci%26aufirst%3DF.%2BJ.%26aulast%3DAppel%26aufirst%3DN.%2BM.%26atitle%3DApproaches%2520to%2520the%2520development%2520of%2520medications%2520for%2520the%2520treatment%2520of%2520methamphetamine%2520dependence%26jtitle%3DAddiction%26date%3D2007%26volume%3D102%26issue%3DSuppl.%25201%26spage%3D96%26epage%3D106%26doi%3D10.1111%2Fj.1360-0443.2007.01772.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span> <span> </span><span class="NLM_article-title">Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2613</span>â <span class="NLM_lpage">2616</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.04.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.bmcl.2015.04.105" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2613-2616&author=D.+Dingauthor=J.+R.+Nickellauthor=L.+P.+Dwoskinauthor=P.+A.+Crooks&title=Quinolyl+analogues+of+norlobelane%3A+novel+potent+inhibitors+of+%5B%283%29H%5Ddihydrotetrabenazine+binding+and+%5B%283%29H%5Ddopamine+uptake+at+the+vesicular+monoamine+transporter-2&doi=10.1016%2Fj.bmcl.2015.04.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.105%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DQuinolyl%2520analogues%2520of%2520norlobelane%253A%2520novel%2520potent%2520inhibitors%2520of%2520%255B%25283%2529H%255Ddihydrotetrabenazine%2520binding%2520and%2520%255B%25283%2529H%255Ddopamine%2520uptake%2520at%2520the%2520vesicular%2520monoamine%2520transporter-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2613%26epage%3D2616%26doi%3D10.1016%2Fj.bmcl.2015.04.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysko, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span> <span> </span><span class="NLM_article-title">Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1142</span>â <span class="NLM_lpage">1151</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.067314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.104.067314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15102929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1equr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=1142-1151&author=C.+J.+Wilhelmauthor=R.+A.+Johnsonauthor=P.+G.+Lyskoauthor=A.+J.+Eshlemanauthor=A.+Janowsky&title=Effects+of+methamphetamine+and+lobeline+on+vesicular+monoamine+and+dopamine+transporter-mediated+dopamine+release+in+a+cotransfected+model+system&doi=10.1124%2Fjpet.104.067314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system</span></div><div class="casAuthors">Wilhelm, Clare J.; Johnson, Robert A.; Lysko, Paul G.; Eshleman, Amy J.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine (DA) retention and drug-induced release kinetics were characterized in human embryonic kidney (HEK)-293 cells stably coexpressing the human DA transporter (hDAT) and human vesicular monoamine transporter (hVMAT2).  Cofunction of hDAT and hVMAT2 caused greater retention of [3H]DA at 20 min (37Â°), or 45 min (22Â°) compared with cells that were treated with dihydrotetrabenazene (DHTB) to block the hVMAT2.  In hDAT- and hVMAT2-coexpressing cells treated with DHTB during [3H]DA loading, methamphetamine (METH)-induced efflux was only 20% of preloaded [3H]DA, compared with 50 to 60% efflux in the absence of DHTB.  Interestingly, the presence of DHTB (during release only) increased the potency and efficacy of METH at inducing [3H]DA release (without DHTB: EC50 = 33.8 Î¼M, maximal release 51%; release with DHTB: EC50 = 3.2 Î¼M, maximal release 61%), suggesting that the effects of METH and DHTB on vesicular storage are additive.  High concns. of lobeline induced a statistically significant release of [3H]DA from HEK-hDAT-hVMAT2 cells, but only in the absence of DHTB, suggesting an hVMAT2-mediated effect.  Likewise, lobeline did not induce a significant release of [3H]DA from HEK-hDAT cells.  The substrates DA and p-tyramine induced robust release of preloaded [3H]DA from cotransfected cells.  Cocaine was somewhat effective at blocking substrate-induced [3H]DA efflux.  These results suggest that coexpression of the hDAT and hVMAT2 can be used as a model system to distinguish functional pools of DA and to quantify differences in drug effects on DA disposition.  In addn., cotransfected cells can be used to det. mechanisms of simultaneous drug interactions at multiple sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwzJUdZXee57Vg90H21EOLACvtfcHk0lhRexD4Us8Opw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1equr8%253D&md5=6a9e98c873a8a1e7beea1e4cd50ba8d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.067314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.067314%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DLysko%26aufirst%3DP.%2BG.%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DEffects%2520of%2520methamphetamine%2520and%2520lobeline%2520on%2520vesicular%2520monoamine%2520and%2520dopamine%2520transporter-mediated%2520dopamine%2520release%2520in%2520a%2520cotransfected%2520model%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D1142%26epage%3D1151%26doi%3D10.1124%2Fjpet.104.067314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrholm, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hojahmat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrod, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaciuc, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">940</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1124/jpet.110.175117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.110.175117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=21177475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=940-951&author=D.+B.+Hortonauthor=K.+B.+Siripurapuauthor=S.+D.+Norrholmauthor=J.+P.+Culverauthor=M.+Hojahmatauthor=J.+S.+Beckmannauthor=S.+B.+Harrodauthor=A.+G.+Deaciucauthor=M.+T.+Bardoauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=meso-Transdiene+analogs+inhibit+vesicular+monoamine+transporter-2+function+and+methamphetamine-evoked+dopamine+release&doi=10.1124%2Fjpet.110.175117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release</span></div><div class="casAuthors">Horton, David B.; Siripurapu, Kiran B.; Norrholm, Seth D.; Culver, John P.; Hojahmat, Marhaba; Beckmann, Joshua S.; Harrod, Steven B.; Deaciuc, Agripina G.; Bardo, Michael T.; Crooks, Peter A.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">940-951</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lobeline, a nicotinic receptor antagonist and neurotransmitter transporter inhibitor, is a candidate pharmacotherapy for methamphetamine abuse.  Meso-Transdiene (MTD), a lobeline analog, lacks nicotinic receptor affinity, retains affinity for vesicular monoamine transporter 2 (VMAT2), and, surprisingly, has enhanced affinity for dopamine (DA) and serotonin transporters [DA transporter (DAT) and serotonin transporter (SERT), resp.].  In the current study, MTD was evaluated for its ability to decrease methamphetamine self-administration in rats relative to food-maintained responding.  MTD specifically decreased methamphetamine self-administration, extending our previous work.  Classical structure-activity relationships revealed that more conformationally restricted MTD analogs enhanced VMAT2 selectivity and drug likeness, whereas affinity at the dihydrotetrabenazine binding and DA uptake sites on VMAT2 was not altered.  Generally, MTD analogs exhibited 50- to 1000-fold lower affinity for DAT and were equipotent or had 10-fold higher affinity for SERT, compared with MTD.  Representative analogs from the series potently and competitively inhibited [3H]DA uptake at VMAT2.  (3Z,5Z)-3,5-bis(2,4-dichlorobenzylidene)-1-methylpiperidine (UKMH-106), the 3Z,5Z-2,4-dichlorophenyl MTD analog, had improved selectivity for VMAT2 over DAT and importantly inhibited methamphetamine-evoked DA release from striatal slices.  In contrast, (3Z,5E)-3,5-bis(2,4-dichlorobenzylidene)-1-methylpiperidine (UKMH-105), the 3Z,5E-geometrical isomer, inhibited DA uptake at VMAT2, but did not inhibit methamphetamine-evoked DA release.  Taken together, these results suggest that these geometrical isomers interact at alternate sites on VMAT2, which are assocd. with distinct pharmacophores.  Thus, structural modification of the MTD mol. resulted in analogs exhibiting improved drug likeness and improved selectivity for VMAT2, as well as the ability to decrease methamphetamine-evoked DA release, supporting the further evaluation of these analogs as treatments for methamphetamine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGX9DkPWAibVg90H21EOLACvtfcHk0lhAzwALNilkvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqtLg%253D&md5=faf333ef46c1ade408fd30eaadf5df21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175117%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DD.%2BB.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DNorrholm%26aufirst%3DS.%2BD.%26aulast%3DCulver%26aufirst%3DJ.%2BP.%26aulast%3DHojahmat%26aufirst%3DM.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DHarrod%26aufirst%3DS.%2BB.%26aulast%3DDeaciuc%26aufirst%3DA.%2BG.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3Dmeso-Transdiene%2520analogs%2520inhibit%2520vesicular%2520monoamine%2520transporter-2%2520function%2520and%2520methamphetamine-evoked%2520dopamine%2520release%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D940%26epage%3D951%26doi%3D10.1124%2Fjpet.110.175117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-420118-7.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FB978-0-12-420118-7.00002-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=71-106&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=A.+Vartakauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=The+vesicular+monoamine+transporter-2%3A+an+important+pharmacological+target+for+the+discovery+of+novel+therapeutics+to+treat+methamphetamine+abuse&doi=10.1016%2FB978-0-12-420118-7.00002-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DVartak%26aufirst%3DA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter-2%253A%2520an%2520important%2520pharmacological%2520target%2520for%2520the%2520discovery%2520of%2520novel%2520therapeutics%2520to%2520treat%2520methamphetamine%2520abuse%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D71%26epage%3D106%26doi%3D10.1016%2FB978-0-12-420118-7.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripurapu, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>795</i></span>,  <span class="NLM_fpage">143</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.ejphar.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=27986625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsbrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=795&publication_year=2017&pages=143-149&author=J.+R.+Nickellauthor=K.+B.+Siripurapuauthor=D.+B.+Hortonauthor=G.+Zhengauthor=P.+A.+Crooksauthor=L.+P.+Dwoskin&title=GZ-793A+inhibits+the+neurochemical+effects+of+methamphetamine+via+a+selective+interaction+with+the+vesicular+monoamine+transporter-2&doi=10.1016%2Fj.ejphar.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2</span></div><div class="casAuthors">Nickell, Justin R.; Siripurapu, Kiran B.; Horton, David B.; Zheng, Guangrong; Crooks, Peter A.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">795</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lobeline and lobelane inhibit the behavioral and neurochem. effects of methamphetamine via an interaction with the vesicular monoamine transporter-2 (VMAT2).  However, lobeline has high affinity for nicotinic receptors, and tolerance develops to the behavioral effects of lobelane.  A water-sol. analog of lobelane, R-N-(1,2-dihydroxypropyl)-2,6-cis-di-(4-methoxyphenethyl)piperidine hydrochloride (GZ-793A), also interacts selectively with VMAT2 to inhibit the effects of methamphetamine, but does not produce behavioral tolerance.  The current study further evaluated the mechanism underlying the GZ-793A-mediated inhibition of the neurochem. effects of methamphetamine.  In contrast to lobeline, GZ-793A does not interact with the agonist recognition site on Î±4Î²2* and Î±7* nicotinic receptors.  GZ-793A (0.3-100 Î¼M) inhibited methamphetamine (5 Î¼M)-evoked fractional dopamine release from rat striatal slices, and did not evoke dopamine release in the absence of methamphetamine.  Furthermore, GZ-793A (1-100 Î¼M) inhibited neither nicotine (30 Î¼M)-evoked nor elec. field-stimulation-evoked (100 Hz/1 min) fractional dopamine release.  Unfortunately, GZ-793A inhibited [3H]dofetilide binding to human-ether-a-go-go related gene channels expressed on human embryonic kidney cells, and further, prolonged action potentials in rabbit cardiac Purkinje fibers, suggesting the potential for GZ-793A to induce ventricular arrhythmias.  Thus, GZ-793A selectively inhibits the neurochem. effects of methamphetamine and lacks nicotinic receptor interactions; however, development as a pharmacotherapy for methamphetamine use disorders will not be pursued due to its potential cardiac liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_QbTWv2cNtrVg90H21EOLACvtfcHk0lhAzwALNilkvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsbrK&md5=da9edd15288757516f17f6b700d770f0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DNickell%26aufirst%3DJ.%2BR.%26aulast%3DSiripurapu%26aufirst%3DK.%2BB.%26aulast%3DHorton%26aufirst%3DD.%2BB.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DGZ-793A%2520inhibits%2520the%2520neurochemical%2520effects%2520of%2520methamphetamine%2520via%2520a%2520selective%2520interaction%2520with%2520the%2520vesicular%2520monoamine%2520transporter-2%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D795%26spage%3D143%26epage%3D149%26doi%3D10.1016%2Fj.ejphar.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">For a comprehensive review see the following:</p></div><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">The role of vesicular transport proteins in synaptic transmission and neural degenerartion</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1146/annurev.neuro.20.1.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1146%2Fannurev.neuro.20.1.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9056710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2sXhs12qt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1997&pages=125-156&author=Y.+Liuauthor=R.+H.+Edwards&title=The+role+of+vesicular+transport+proteins+in+synaptic+transmission+and+neural+degenerartion&doi=10.1146%2Fannurev.neuro.20.1.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The role of vesicular transport proteins in synaptic transmission and neural degeneration</span></div><div class="casAuthors">Liu, Yongjian; Edwards, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-156</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with about 150 refs.  Classical neurotransmitters are synthesized in the cytoplasm, so they require transport into secretory vesicles for regulated exocytotic release.  Previous work had identified distinct vesicular transport activities for the different classical transmitters, and all depend on the H+-electrochem. gradient across the vesicle membrane but differ in the extent to which they rely on the chem. and elec. components of this gradient.  Drugs that interfere with vesicular amine transport have implicated this activity in psychiatric disease.  Selection for a cDNA encoding vesicular amine transport in the neurotoxin MPP+ also implicates the activity in Parkinson's disease.  Mol. cloning of vesicular monoamine transporters shows sequence similarity to bacterial antibiotic resistance proteins, supporting a role for transport in detoxification and defining a novel mammalian gene family that now also includes a transporter for acetylcholine.  Current work focuses on the mechanism of transport and the role that regulation of activity and its subcellular localization have in transmitter release, behavior, and neural degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75mx1c4Ir4LVg90H21EOLACvtfcHk0lhAzwALNilkvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhs12qt78%253D&md5=6e965648a05d49d7498572f4b6831685</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.20.1.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.20.1.125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DThe%2520role%2520of%2520vesicular%2520transport%2520proteins%2520in%2520synaptic%2520transmission%2520and%2520neural%2520degenerartion%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1997%26volume%3D20%26spage%3D125%26epage%3D156%26doi%3D10.1146%2Fannurev.neuro.20.1.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. W.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter 2: an underexplored pharmacological target</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2013.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=24398404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=89-97&author=A.+I.+Bernsteinauthor=K.+A.+Stoutauthor=G.+W.+Miller&title=The+vesicular+monoamine+transporter+2%3A+an+underexplored+pharmacological+target&doi=10.1016%2Fj.neuint.2013.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter 2: An underexplored pharmacological target</span></div><div class="casAuthors">Bernstein, Alison I.; Stout, Kristen A.; Miller, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Active transport of neurotransmitters into synaptic vesicles is required for their subsequent exocytotic release.  In the monoamine system, this process is carried out by the vesicular monoamine transporters (VMAT1 and VMAT2).  These proteins are responsible for vesicular packaging of dopamine, norepinephrine, serotonin, and histamine.  These proteins are essential for proper neuronal function; however, compared to their plasma membrane counterparts, there are few drugs available that target these vesicular proteins.  This is partly due to the added complexity of crossing the plasma membrane, but also to the tech. difficulty of assaying for vesicular uptake in high throughput.  Until recently, reagents to enable high throughput screening for function of these vesicular neurotransmitter transporters have not been available.  Fortunately, novel compds. and methods are now making such screening possible; thus, a renewed focus on these transporters as potential targets is timely and necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHcBYk8fojmbVg90H21EOLACvtfcHk0lhOi5dBkIOxwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKms7g%253D&md5=f83b99eb743485ba5b44ec54e51228b2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DA.%2BI.%26aulast%3DStout%26aufirst%3DK.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BW.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%25202%253A%2520an%2520underexplored%2520pharmacological%2520target%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.neuint.2013.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutt, D. J.</span></span> <span> </span><span class="NLM_article-title">The role of dopamine and norepinephrine in depression and antidepressant treatment</span>. <i>J. Clin. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 6</span>),  <span class="NLM_fpage">3</span>â <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=16848670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1CrtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=3-8&issue=Suppl.+6&author=D.+J.+Nutt&title=The+role+of+dopamine+and+norepinephrine+in+depression+and+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dopamine and norepinephrine in depression and antidepressant treatment</span></div><div class="casAuthors">Nutt, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Most antidepressants in use today are descendants of the monoamine oxidase inhibitor iproniazid and the tricyclic agent imipramine.  These agents were both originally developed for other indications but then were serendipitously detd. to have antidepressant effects.  Elucidation of the mechanisms of action of these first antidepressants, along with those of reserpine and amphetamine, led to the monoamine theories of depression.  Through the past several decades, approaches undertaken to clarify the roles of the neurotransmitters norepinephrine, dopamine, and serotonin in depression have included animal studies, human biol. and postmortem studies, inferences drawn from antidepressant drug actions, and challenge or depletion studies; most recently, brain imaging studies have proved to be esp. informative.  This research has identified novel potential targets, with the goal of developing new antidepressant drugs with better efficacy and faster onset of action than current "gold-std." treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMGf2-xYUD7Vg90H21EOLACvtfcHk0lhOi5dBkIOxwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1CrtrY%253D&md5=61db0885e6e5bde033e73a25a276ab14</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520role%2520of%2520dopamine%2520and%2520norepinephrine%2520in%2520depression%2520and%2520antidepressant%2520treatment%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2006%26volume%3D67%26issue%3DSuppl.%25206%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laduron, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">672</span>â <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=3380081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=672-677&author=F.+Darchenauthor=D.+Schermanauthor=P.+M.+Laduronauthor=J.+P.+Henry&title=Ketanserin+binds+to+the+monoamine+transporter+of+chromaffin+granules+and+of+synaptic+vesicles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles</span></div><div class="casAuthors">Darchen, Francois; Scherman, Daniel; Laduron, Pierre M.; Henry, Jean Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">672-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">[3H]Ketanserin binding studies were performed on purified chromaffin granule membranes.  Binding occurred on one class of sites and was temp.-dependent.  At 30Â° the equil. dissocn. const. KD was 45 nM.  At 0Â°, a KD value of 6 nM and a half-life of dissocn. of 40 s were measured.  Methysergide, an antagonist of 5-hydroxytryptamine2 receptors structurally unrelated to ketanserin, did not displace ketanserin binding.  Tetrabenazine, an inhibitor of the monoamine transport of chromaffin granules, displaced [3H]ketanserin binding.  Conversely, ketanserin inhibited the binding of [3H]dihydrotetrabenazine, a ligand that specifically binds to the monoamine transporter.  The inhibition was of the competitive type.  Ketanserin binding did not depend upon ATP-induced energization of chromaffin granules.  ATP-dependent 5-HT uptake by chromaffin granule ghosts was inhibited by ketanserin with an IC50 value of 70 nM.  A series of ketanserin derivs. was tested for the ability to displace [3H]dihydrotetrabenazine; EC50 values differed by >2 orders of magnitude and were not correlated to affinities on 5-HT2 receptors.  In mouse brain, [3H]ketanserin bound to methysergide-sensitive and to tetrabenazine-sensitive sites.  It is concluded that nonspecific displaceable binding sites of [3H]ketanserin previously described in the striatum are tetrabenazine binding sites assocd. with the synaptic vesicle monoamine transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEOVid7FYMkLVg90H21EOLACvtfcHk0lhOi5dBkIOxwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCmu74%253D&md5=35f87f54599f4b162e92211273c215e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarchen%26aufirst%3DF.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DKetanserin%2520binds%2520to%2520the%2520monoamine%2520transporter%2520of%2520chromaffin%2520granules%2520and%2520of%2520synaptic%2520vesicles%26jtitle%3DMol.%2520Pharmacol.%26date%3D1988%26volume%3D33%26spage%3D672%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankovic, J.</span></span> <span> </span><span class="NLM_article-title">Tetrabenazine in the treatment of hyperkinetic movement disorders</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1586/14737175.6.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1586%2F14737175.6.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=16466307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtl2ksLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=7-17&author=C.+Kenneyauthor=J.+Jankovic&title=Tetrabenazine+in+the+treatment+of+hyperkinetic+movement+disorders&doi=10.1586%2F14737175.6.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabenazine in the treatment of hyperkinetic movement disorders</span></div><div class="casAuthors">Kenney, Christopher; Jankovic, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Tetrabenazine, a dopamine-depleting agent first synthesized half a century ago, was initially developed for the treatment of schizophrenia.  Although psychotic disorders have since been treated more successfully with other neuroleptic medications, many studies have shown this drug to be effective in the treatment of hyperkinetic movement disorders (hyperkinesias).  Hyperkinesias are neurol. disorders characterized by abnormal involuntary movements such as chorea assocd. with Huntington's disease, tics in Tourette's syndrome and stereotypies in tardive dyskinesia.  Recently, clin. trials investigating tetrabenazine for the treatment of chorea assocd. with Huntington's disease found the drug to be safe and efficacious, making approval by the US Food and Drug Administration for this indication a distinct possibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcA5D5zq7trVg90H21EOLACvtfcHk0lhOi5dBkIOxwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtl2ksLg%253D&md5=1090a8b7c45bc4861672041731b03157</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DTetrabenazine%2520in%2520the%2520treatment%2520of%2520hyperkinetic%2520movement%2520disorders%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D7%26epage%3D17%26doi%3D10.1586%2F14737175.6.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, J. K.</span></span> <span> </span><span class="NLM_article-title">Functional reconstitution in situ of 5-hydroxytryptamine2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">22591</span>â <span class="NLM_lpage">22597</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.37.22591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.271.37.22591" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22591-22597&author=J.+L.+Hartmanauthor=J.+K.+Northup&title=Functional+reconstitution+in+situ+of+5-hydroxytryptamine2c+%285HT2c%29+receptors+with+alphaq+and+inverse+agonism+of+5HT2c+receptor+antagonists&doi=10.1074%2Fjbc.271.37.22591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.37.22591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.37.22591%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DJ.%2BL.%26aulast%3DNorthup%26aufirst%3DJ.%2BK.%26atitle%3DFunctional%2520reconstitution%2520in%2520situ%2520of%25205-hydroxytryptamine2c%2520%25285HT2c%2529%2520receptors%2520with%2520alphaq%2520and%2520inverse%2520agonism%2520of%25205HT2c%2520receptor%2520antagonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22591%26epage%3D22597%26doi%3D10.1074%2Fjbc.271.37.22591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nankai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toru, M.</span></span> <span> </span><span class="NLM_article-title">Acute immobilization stress reduces (Â±)DOI-induced 5-HT2A receptor-mediated head shakes in rats</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">14</span>, <span class="refDoi">Â DOI: 10.1007/BF02246047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1007%2FBF02246047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=7675955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFChtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1995&pages=9-14&author=S.+Yamadaauthor=A.+Watanabeauthor=M.+Nankaiauthor=M.+Toru&title=Acute+immobilization+stress+reduces+%28%C2%B1%29DOI-induced+5-HT2A+receptor-mediated+head+shakes+in+rats&doi=10.1007%2FBF02246047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Acute immobilization stress reduces (Â±)DOI-induced 5-HT2A receptor-mediated head shakes in rats</span></div><div class="casAuthors">Yamada, Satoru; Watanabe, Akiko; Nankai, Masahiro; Toru, Michio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acute immobilization stress induced by taping four limbs, applying tail pinch stress and elec. foot shock stress immediately reduced the frequency of head shakes induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ((Â±)DOI), a 5-HT2A agonist in rats.  Immobilization stress due to the use of cylinder restraint and forced swimming did not affect 5-HT2A-mediated behavior.  Acute immobilization stress did not affect [3H]ketanserin binding to the 5HT2A receptor in the prefrontal cortex and hippocampus.  Presynaptic serotonergic lesions with 5,7-dihydroxytryptamine (5,7-DHT) did not affect the redn. in 5-HT2A-mediated behavior after acute immobilization stress.  The decreases in head shake frequency after acute immobilization stress by taping were attenuated by pretreatment with diazepam (2.5 mg/kg, i.p.): this attenuation was reversed by pretreatment with flumazenil (10 mg/kg, i.p.).  The redn. in (Â±)DOI-induced 5-HT2A-mediated behavior caused by stress may be related to a change in agonist affinity to the receptor or to changes in other neurotransmitter systems or the effect of PI turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwrP-gc7LDbVg90H21EOLACvtfcHk0lgFj7uZEfQIPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFChtLs%253D&md5=cc8bb2366f7b8ecd46a1862978e17690</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FBF02246047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246047%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DNankai%26aufirst%3DM.%26aulast%3DToru%26aufirst%3DM.%26atitle%3DAcute%2520immobilization%2520stress%2520reduces%2520%2528%25C2%25B1%2529DOI-induced%25205-HT2A%2520receptor-mediated%2520head%2520shakes%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D1995%26volume%3D119%26spage%3D9%26epage%3D14%26doi%3D10.1007%2FBF02246047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schotte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, J. E.</span></span> <span> </span><span class="NLM_article-title">Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [<sup>125</sup>I]7-amino-8-iodo-ketanserin</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/0014-2999(88)90233-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2F0014-2999%2888%2990233-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=2832189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVKqsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1988&pages=213-216&author=A.+Schotteauthor=J.+E.+Leysen&title=Distinct+autoradiographic+labelling+of+serotonin+5-HT2+receptors%2C+alpha+1-adrenoceptors+and+histamine-H1+receptors+and+of+tetrabenazine-displaceable+ketanserin+binding+sites+in+rodent+brain+with+%5B125I%5D7-amino-8-iodo-ketanserin&doi=10.1016%2F0014-2999%2888%2990233-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct autoradiographic labeling of serotonin 5-HT2 receptors, Î±1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin</span></div><div class="casAuthors">Schotte, Alain; Leysen, Josee E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">[125I]7-Amino-8-iodo-ketanserin ([125I]AMIK) binding was assayed in rat and guinea pig horizontal brain sections and was analyzed by autoradiog.  The use of selective displacers allowed the identification of 4 distinct receptors in rat and guinea pig brain.  In rats, 5-HT2 receptors were detected in cortical areas and in caudate putamen, Î±1-adrenoceptors were found in cortical areas and several thalamic nuclei, tetrabenazine-displaceable ketanserin binding sites involved in the release of biogene amine metabolites occurred in caudate putamen, periaqueductal grey matter, and septal nuclei.  Histamine-H1 receptors were identified in the guinea pig cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARxh82qLiPrVg90H21EOLACvtfcHk0lgFj7uZEfQIPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVKqsb4%253D&md5=83127ae4ebb111c79e3a2d24d9401d30</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990233-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990233-6%26sid%3Dliteratum%253Aachs%26aulast%3DSchotte%26aufirst%3DA.%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3DDistinct%2520autoradiographic%2520labelling%2520of%2520serotonin%25205-HT2%2520receptors%252C%2520alpha%25201-adrenoceptors%2520and%2520histamine-H1%2520receptors%2520and%2520of%2520tetrabenazine-displaceable%2520ketanserin%2520binding%2520sites%2520in%2520rodent%2520brain%2520with%2520%255B125I%255D7-amino-8-iodo-ketanserin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D145%26spage%3D213%26epage%3D216%26doi%3D10.1016%2F0014-2999%2888%2990233-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudnick, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner-Mordoch, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishkes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern-Bach, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">603</span>â <span class="NLM_lpage">608</span>, <span class="refDoi">Â DOI: 10.1021/bi00455a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00455a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=603-608&author=G.+Rudnickauthor=S.+S.+Steiner-Mordochauthor=H.+Fishkesauthor=Y.+Stern-Bachauthor=S.+Schuldiner&title=Energetics+of+reserpine+binding+and+occlusion+by+the+chromaffin+granule+biogenic+amine+transporter&doi=10.1021%2Fbi00455a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi00455a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00455a002%26sid%3Dliteratum%253Aachs%26aulast%3DRudnick%26aufirst%3DG.%26aulast%3DSteiner-Mordoch%26aufirst%3DS.%2BS.%26aulast%3DFishkes%26aufirst%3DH.%26aulast%3DStern-Bach%26aufirst%3DY.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DEnergetics%2520of%2520reserpine%2520binding%2520and%2520occlusion%2520by%2520the%2520chromaffin%2520granule%2520biogenic%2520amine%2520transporter%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D603%26epage%3D608%26doi%3D10.1021%2Fbi00455a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirvan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linial, M.</span></span> <span> </span><span class="NLM_article-title">Vesicular neurotransmitter transporters: from bacteria to humans</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">392</span>, <span class="refDoi">Â DOI: 10.1152/physrev.1995.75.2.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1152%2Fphysrev.1995.75.2.369" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1995&pages=369-392&author=S.+Schuldinerauthor=A.+Shirvanauthor=M.+Linial&title=Vesicular+neurotransmitter+transporters%3A+from+bacteria+to+humans&doi=10.1152%2Fphysrev.1995.75.2.369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1995.75.2.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1995.75.2.369%26sid%3Dliteratum%253Aachs%26aulast%3DSchuldiner%26aufirst%3DS.%26aulast%3DShirvan%26aufirst%3DA.%26aulast%3DLinial%26aufirst%3DM.%26atitle%3DVesicular%2520neurotransmitter%2520transporters%253A%2520from%2520bacteria%2520to%2520humans%26jtitle%3DPhysiol.%2520Rev.%26date%3D1995%26volume%3D75%26spage%3D369%26epage%3D392%26doi%3D10.1152%2Fphysrev.1995.75.2.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasnier, B.</span></span> <span> </span><span class="NLM_article-title">The vesicular monoamine transporter: from chromaffin granule to brain</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">227</span>â <span class="NLM_lpage">246</span>, <span class="refDoi">Â DOI: 10.1016/S0197-0186(97)00092-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2FS0197-0186%2897%2900092-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=9587917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK1cXisFShs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=227-246&author=J.+P.+Henryauthor=C.+Sagneauthor=C.+Bedetauthor=B.+Gasnier&title=The+vesicular+monoamine+transporter%3A+from+chromaffin+granule+to+brain&doi=10.1016%2FS0197-0186%2897%2900092-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The vesicular monoamine transporter: from chromaffin granule to brain</span></div><div class="casAuthors">Henry, Jean-Pierre; Sagne, Corinne; Bedet, Cecile; Gasnier, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-246</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with â¼175 refs.  All characterized monoaminergic cells utilize the same transport system for the vesicular accumulation of monoamines prior to their release.  This system operates in neuronal (catecholaminergic, serotoninergic, or histaminergic) as well as in endocrine or neuroendocrine cells.  For several decades, chromaffin granules from bovine adrenal medulla have been used as a model system, allowing progress in the understanding of the biophysics, the biochem. and the pharmacol. of the monoamine vesicular transporter.  The transporters from rat, bovine, and man have been cloned.  Surprisingly, 2 genes encode different isoforms of the protein which are differentially expressed in monoaminergic systems.  The conjunction of recombinant DNA techniques and expression in secretory or non-secretory cells with the large body of data obtained on the chromaffin granule transporter has allowed rapid progress in the study of the protein.  But interestingly enough, this progress has open new possibilities in the study of biol. problems, esp. in the brain.  The transporter is useful for the detn. of the relationship between small and large dense core vesicles, for the understanding of the mechanism of drugs such as 1-methyl-4-phenylpyridinium (MPP+), tetrabenazine or amphetamines, and as a marker in brain development.  The possibility of regulations at the vesicular transporter level and of their effect on the quantum size has to be investigated.  The vesicular monoamine transporter is also an important target for brain imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94e--MH96tbVg90H21EOLACvtfcHk0liRhCihCVAmYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFShs7c%253D&md5=cf9e339a99409866dc959f953cb8cff5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2897%2900092-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252897%252900092-2%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26aulast%3DSagne%26aufirst%3DC.%26aulast%3DBedet%26aufirst%3DC.%26aulast%3DGasnier%26aufirst%3DB.%26atitle%3DThe%2520vesicular%2520monoamine%2520transporter%253A%2520from%2520chromaffin%2520granule%2520to%2520brain%26jtitle%3DNeurochem.%2520Int.%26date%3D1998%26volume%3D32%26spage%3D227%26epage%3D246%26doi%3D10.1016%2FS0197-0186%2897%2900092-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yaffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergara-Jaque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span> <span> </span><span class="NLM_article-title">Emulating proton-induced conformational changes in the vesicular monoamine transprter VMAT2 by mutagenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E7390</span>â <span class="NLM_lpage">E7398</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1605162113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.1605162113" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7390-E7398&author=D.+Yaffeauthor=A.+Vergara-Jaqueauthor=L.+R.+Forrestauthor=S.+Schuldiner&title=Emulating+proton-induced+conformational+changes+in+the+vesicular+monoamine+transprter+VMAT2+by+mutagenesis&doi=10.1073%2Fpnas.1605162113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605162113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605162113%26sid%3Dliteratum%253Aachs%26aulast%3DYaffe%26aufirst%3DD.%26aulast%3DVergara-Jaque%26aufirst%3DA.%26aulast%3DForrest%26aufirst%3DL.%2BR.%26aulast%3DSchuldiner%26aufirst%3DS.%26atitle%3DEmulating%2520proton-induced%2520conformational%2520changes%2520in%2520the%2520vesicular%2520monoamine%2520transprter%2520VMAT2%2520by%2520mutagenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE7390%26epage%3DE7398%26doi%3D10.1073%2Fpnas.1605162113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span>; <span class="NLM_string-name">Meltzer, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Quinazolinediones as VMAT Inhibitors</span>. <span class="NLM_patent">WO 2016019312 A2</span>, Feb 4, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Janowsky&author=P.+Meltzer&title=Preparation+of+Substituted+Quinazolinediones+as+VMAT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Substituted%2520Quinazolinediones%2520as%2520VMAT%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munster-Wandowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zander, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnert-Hilger, G.</span></span> <span> </span><span class="NLM_article-title">Co-existence of functionally different vesicular nerotransmitter transporters</span>. <i>Front. Synaptic Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">9</span>, <span class="refDoi">Â DOI: 10.3389/fnsyn.2016.00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.3389%2Ffnsyn.2016.00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=26909036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A280%3ADC%252BC28jjs1eqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=4-9&author=A.+Munster-Wandowskiauthor=J.-F.+Zanderauthor=K.+Richterauthor=G.+Ahnert-Hilger&title=Co-existence+of+functionally+different+vesicular+nerotransmitter+transporters&doi=10.3389%2Ffnsyn.2016.00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Co-existence of Functionally Different Vesicular Neurotransmitter Transporters</span></div><div class="casAuthors">Munster-Wandowski Agnieszka; Zander Johannes-Friedrich; Richter Karin; Ahnert-Hilger Gudrun</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in synaptic neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4</span>
        ISSN:<span class="NLM_cas:issn">1663-3563</span>.
    </div><div class="casAbstract">The vesicular transmitter transporters VGLUT, VGAT, VMAT2 and VAChT, define phenotype and physiological properties of neuronal subtypes.  VGLUTs concentrate the excitatory amino acid glutamate, VGAT the inhibitory amino acid GABA, VMAT2 monoamines, and VAChT acetylcholine (ACh) into synaptic vesicle (SV).  Following membrane depolarization SV release their content into the synaptic cleft.  A strict segregation of vesicular transporters is mandatory for the precise functioning of synaptic communication and of neuronal circuits.  In the last years, evidence accumulates that subsets of neurons express more than one of these transporters leading to synaptic co-release of different and functionally opposing transmitters and modulation of synaptic plasticity.  Synaptic co-existence of transporters may change during pathological scenarios in order to ameliorate misbalances in neuronal activity.  In addition, evidence increases that transporters also co-exist on the same vesicle providing another layer of regulation.  Generally, vesicular transmitter loading relies on an electrochemical gradient ÎÎ¼H(+) driven by the proton ATPase rendering the lumen of the vesicle with respect to the cytosol positive (ÎÏ) and acidic (ÎpH).  While the activity of VGLUT mainly depends on the ÎÏ component, VMAT, VGAT and VAChT work best at a high ÎpH.  Thus, a vesicular synergy of transporters depending on the combination may increase or decrease the filling of SV with the principal transmitter.  We provide an overview on synaptic co-existence of vesicular transmitter transporters including changes in the excitatory/inhibitory balance under pathological conditions.  Additionally, we discuss functional aspects of vesicular synergy of transmitter transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXJIJUnooXF7P3FVUi_gf8fW6udTcc2ebO2iVDIgTkcLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jjs1eqsA%253D%253D&md5=fb2eee6354799df0916fa11612518145</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffnsyn.2016.00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsyn.2016.00004%26sid%3Dliteratum%253Aachs%26aulast%3DMunster-Wandowski%26aufirst%3DA.%26aulast%3DZander%26aufirst%3DJ.-F.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DAhnert-Hilger%26aufirst%3DG.%26atitle%3DCo-existence%2520of%2520functionally%2520different%2520vesicular%2520nerotransmitter%2520transporters%26jtitle%3DFront.%2520Synaptic%2520Neurosci.%26date%3D2016%26volume%3D8%26spage%3D4%26epage%3D9%26doi%3D10.3389%2Ffnsyn.2016.00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">584</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1073/pnas.80.2.584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.80.2.584" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=584-588&author=D.+Schermanauthor=P.+Jaudonauthor=J.+P.+Henry&title=Characterization+of+the+monoamine+carrier+of+chromaffin+granule+membrane+by+binding+of+%5B2-3H%5Ddihydrotetrabenazine&doi=10.1073%2Fpnas.80.2.584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.2.584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.2.584%26sid%3Dliteratum%253Aachs%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DJaudon%26aufirst%3DP.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520monoamine%2520carrier%2520of%2520chromaffin%2520granule%2520membrane%2520by%2520binding%2520of%2520%255B2-3H%255Ddihydrotetrabenazine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D584%26epage%3D588%26doi%3D10.1073%2Fpnas.80.2.584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lg9vULM7LIn0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>â <span class="NLM_lpage">775</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0lg9vULM7LIn0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinevich, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrholm, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwoskin, L. P.</span></span> <span> </span><span class="NLM_article-title">Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1035</span>â <span class="NLM_lpage">1045</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.068098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.104.068098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15121762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=1035-1045&author=D.+K.+Millerauthor=P.+A.+Crooksauthor=G.+Zhengauthor=V.+P.+Grinevichauthor=S.+D.+Norrholmauthor=L.+P.+Dwoskin&title=Lobeline+analogs+with+enhanced+affinity+and+selectivity+for+plasmalemma+and+vesicular+monoamine+transporters&doi=10.1124%2Fjpet.104.068098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters</span></div><div class="casAuthors">Miller, Dennis K.; Crooks, Peter A.; Zheng, Guangrong; Grinevich, Vladimir P.; Norrholm, Seth D.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lobeline attenuates the behavioral effects of psychostimulants in rodents and inhibits the function of nicotinic receptors (nAChRs), dopamine transporters (DATs), and vesicular monoamine transporters (VMAT2s).  Monoamine transporters are considered valid targets for drug development for the treatment of methamphetamine abuse.  In the current study, a series of lobeline analogs were evaluated for affinity and selectivity at these targets.  None of the analogs was more potent than nicotine at the [3H]methyllycaconitine binding site (Î±7* nAChR subtype).  Lobeline tosylate was equipotent with lobeline in inhibiting [3H]nicotine binding but 70-fold more potent in inhibiting nicotine-evoked 86Rb+ efflux, demonstrating antagonism of Î±4Î²2* nAChRs.  Compared with lobeline, the defunctionalized analogs lobelane, mesotransdiene, and (-)-trans-transdiene showed dramatically reduced affinity at Î±4Î²2* nAChRs and a 15- to 100-fold higher affinity (Ki = 1.95, 0.58, and 0.26 Î¼M, resp.) at DATs.  Mesotransdiene and (-)-trans-transdiene competitively inhibited DAT function, whereas lobelane and lobeline acted noncompetitively.  10S/10R-MEPP [N-methyl-2R-(2R/2S-hydroxy-2-phenylethyl)-6S-(2-phenylethyl)piperidine] and 10R-MESP [N-methyl-2R-(2R-hydroxy-2-phenylethyl)-6S-(2-phenylethen-1-yl)piperidine] were 2 to 3 orders of magnitude more potent (Ki = 0.01 and 0.04 Î¼M, resp.) than lobeline in inhibiting [3H]serotonin uptake; 10S/10R-MEPP showed a 600-fold selectivity for this transporter.  Uptake results using hDATs and human serotonin transporters expressed in human embryonic kidney-293 cells were consistent with native transporter assays.  Lobelane and ketoalkene were 5-fold more potent (Ki = 0.92 and 1.35 Î¼M, resp.) than lobeline (Ki = 5.46 Î¼M) in inhibiting [3H]methoxytetrabenazine binding to VMAT2 in vesicle prepns.  Thus, structural modification (defunctionalization) of the lobeline mol. markedly decreases affinity for Î±4Î²2* and Î±7* nAChRs while increasing affinity for neurotransmitter transporters, affording analogs with enhanced selectivity for these transporters and providing new leads for the treatment of psychostimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiZpZT4wLXbVg90H21EOLACvtfcHk0lg9vULM7LIn0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtb4%253D&md5=588f10c8e544e8657d99e9d86eccf8ea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.068098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.068098%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DGrinevich%26aufirst%3DV.%2BP.%26aulast%3DNorrholm%26aufirst%3DS.%2BD.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DLobeline%2520analogs%2520with%2520enhanced%2520affinity%2520and%2520selectivity%2520for%2520plasmalemma%2520and%2520vesicular%2520monoamine%2520transporters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D1035%26epage%3D1045%26doi%3D10.1124%2Fjpet.104.068098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span> <span> </span><span class="NLM_article-title">Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">164</span>, <span class="refDoi">Â DOI: 10.1007/BF02736730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1007%2FBF02736730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=7654518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVejsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=149-164&author=E.+Weiheauthor=M.+K.+Schaferauthor=J.+E.+Ericksonauthor=L.+E.+Eiden&title=Localization+of+vesicular+monoamine+transporter+isoforms+%28VMAT1+and+VMAT2%29+to+endocrine+cells+and+neurons+in+rat&doi=10.1007%2FBF02736730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat</span></div><div class="casAuthors">Weihe, Eberhard; Schaefer, Martin K.-H.; Erickson, Jeffrey D.; Eiden, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-64</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana</span>)
        </div><div class="casAbstract">Polyclonal antipeptide antibodies have been raised against each of the two isoforms of the rat vesicular monoamine transporter, VMAT1 and VMAT2.  Antibody specificity was detd. by isoform-specific staining of monkey fibroblasts programmed to express either VMAT1 or VMAT2.  The expression of VMAT1 and VMAT2 in the diffuse neuroendocrine system of the rat has been examd. using these polyclonal antibodies specific for either VMAT1 or VMAT2.  VMAT1 is expressed exclusively in endocrine/paracrine cells assocd. with the intestine, stomach, and sympathetic nervous system.  VMAT2 is expressed in neurons of the sympathetic nervous system, and aminergic neurons in the enteric and central nervous systems.  VMAT2 is expressed in at least two endocrine cell populations in addn. to its expression in neurons.  A subpopulation of chromogranin A (CGA)-expressing chromaffin cells of the adrenal medulla also express VMAT2, and the oxyntic mucosa of the stomach contains a prominent population of CGA- and VMAT2-pos. endocrine cells.  The expression of VMAT2 in neurons, and the mutually exclusive expression of VMAT1 and VMAT2 in endocrine/paracrine cell populations of stomach, intestine, and sympathetic nervous system may provide a marker for, and insight into the ontogeny and monoamine-secreting capabilities of multiple neuroendocrine sublineages in the diffuse neuroendocrine system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol2jHaVzwxarVg90H21EOLACvtfcHk0lgVe3eUlXc3iA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVejsLw%253D&md5=77c42fcbebab9cd6fa26c9389697ce42</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2FBF02736730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02736730%26sid%3Dliteratum%253Aachs%26aulast%3DWeihe%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DErickson%26aufirst%3DJ.%2BE.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DLocalization%2520of%2520vesicular%2520monoamine%2520transporter%2520isoforms%2520%2528VMAT1%2520and%2520VMAT2%2529%2520to%2520endocrine%2520cells%2520and%2520neurons%2520in%2520rat%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D1994%26volume%3D5%26spage%3D149%26epage%3D164%26doi%3D10.1007%2FBF02736730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihe, E.</span></span> <span> </span><span class="NLM_article-title">Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">5166</span>â <span class="NLM_lpage">5171</span>, <span class="refDoi">Â DOI: 10.1073/pnas.93.10.5166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1073%2Fpnas.93.10.5166" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5166-5171&author=J.+D.+Ericksonauthor=M.+K.+Schaferauthor=T.+I.+Bonnerauthor=L.+E.+Eidenauthor=E.+Weihe&title=Distinct+pharmacological+properties+and+distribution+in+neurons+and+endocrine+cells+of+two+isoforms+of+the+human+vesicular+monoamine+transporter&doi=10.1073%2Fpnas.93.10.5166"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.10.5166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.10.5166%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DJ.%2BD.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26aulast%3DWeihe%26aufirst%3DE.%26atitle%3DDistinct%2520pharmacological%2520properties%2520and%2520distribution%2520in%2520neurons%2520and%2520endocrine%2520cells%2520of%2520two%2520isoforms%2520of%2520the%2520human%2520vesicular%2520monoamine%2520transporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D5166%26epage%3D5171%26doi%3D10.1073%2Fpnas.93.10.5166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. P.</span></span> <span> </span><span class="NLM_article-title">Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1692</span>â <span class="NLM_lpage">1697</span>, <span class="refDoi">Â DOI: 10.1021/bi00430a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00430a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=1692-1697&author=F.+Darchenauthor=D.+Schermanauthor=J.+P.+Henry&title=Reserpine+binding+to+chromaffin+granules+suggests+the+existence+of+two+conformations+of+the+monoamine+transporter&doi=10.1021%2Fbi00430a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00430a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00430a040%26sid%3Dliteratum%253Aachs%26aulast%3DDarchen%26aufirst%3DF.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DHenry%26aufirst%3DJ.%2BP.%26atitle%3DReserpine%2520binding%2520to%2520chromaffin%2520granules%2520suggests%2520the%2520existence%2520of%2520two%2520conformations%2520of%2520the%2520monoamine%2520transporter%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D1692%26epage%3D1697%26doi%3D10.1021%2Fbi00430a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfrum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatfield, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span> <span> </span><span class="NLM_article-title">Substituted methcathinones differ in transporter and receptor interactions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1803</span>â <span class="NLM_lpage">1815</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2013.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.bcp.2013.04.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1803-1815&author=A.+J.+Eshlemanauthor=K.+M.+Wolfrumauthor=M.+G.+Hatfieldauthor=R.+A.+Johnsonauthor=K.+V.+Murphyauthor=A.+Janowsky&title=Substituted+methcathinones+differ+in+transporter+and+receptor+interactions&doi=10.1016%2Fj.bcp.2013.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DWolfrum%26aufirst%3DK.%2BM.%26aulast%3DHatfield%26aufirst%3DM.%2BG.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DK.%2BV.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DSubstituted%2520methcathinones%2520differ%2520in%2520transporter%2520and%2520receptor%2520interactions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1803%26epage%3D1815%26doi%3D10.1016%2Fj.bcp.2013.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. D.</span></span> <span> </span><span class="NLM_article-title">Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">16301</span>â <span class="NLM_lpage">16307</span>, <span class="refDoi">Â DOI: 10.1074/jbc.272.26.16301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.272.26.16301" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=16301-16307&author=J.+P.+Finnauthor=R.+D.+Edwards&title=Individual+residues+contribute+to+multiple+differences+in+ligand+recognition+between+vesicular+monoamine+transporters+1+and+2&doi=10.1074%2Fjbc.272.26.16301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.26.16301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.26.16301%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DEdwards%26aufirst%3DR.%2BD.%26atitle%3DIndividual%2520residues%2520contribute%2520to%2520multiple%2520differences%2520in%2520ligand%2520recognition%2520between%2520vesicular%2520monoamine%2520transporters%25201%2520and%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D16301%26epage%3D16307%26doi%3D10.1074%2Fjbc.272.26.16301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosandich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">Identification of residues involved in substrate recognition by a vesicular monoamine transporter</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">25798</span>â <span class="NLM_lpage">25804</span>, <span class="refDoi">Â DOI: 10.1074/jbc.270.43.25798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1074%2Fjbc.270.43.25798" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=25798-25804&author=A.+Merickelauthor=P.+Rosandichauthor=D.+Peterauthor=R.+H.+Edwards&title=Identification+of+residues+involved+in+substrate+recognition+by+a+vesicular+monoamine+transporter&doi=10.1074%2Fjbc.270.43.25798"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.43.25798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.43.25798%26sid%3Dliteratum%253Aachs%26aulast%3DMerickel%26aufirst%3DA.%26aulast%3DRosandich%26aufirst%3DP.%26aulast%3DPeter%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520residues%2520involved%2520in%2520substrate%2520recognition%2520by%2520a%2520vesicular%2520monoamine%2520transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D25798%26epage%3D25804%26doi%3D10.1074%2Fjbc.270.43.25798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span> <span> </span><span class="NLM_article-title">N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>259</i></span>,  <span class="NLM_fpage">194</span>â <span class="NLM_lpage">202</span>, <span class="refDoi">Â DOI: 10.1016/j.neuroscience.2013.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuroscience.2013.11.059" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=2014&pages=194-202&author=B.+Torresauthor=A.+E.+Ruoho&title=N-terminus+regulation+of+VMAT2+mediates+methamphetamine-stimulated+efflux&doi=10.1016%2Fj.neuroscience.2013.11.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DN-terminus%2520regulation%2520of%2520VMAT2%2520mediates%2520methamphetamine-stimulated%2520efflux%26jtitle%3DNeuroscience%26date%3D2014%26volume%3D259%26spage%3D194%26epage%3D202%26doi%3D10.1016%2Fj.neuroscience.2013.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span> <span> </span><span class="NLM_article-title">Methamphetamine rapidly decreases vesicular dopamine uptake</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2221</span>â <span class="NLM_lpage">2223</span>, <span class="refDoi">Â DOI: 10.1046/j.1471-4159.2000.0742221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1046%2Fj.1471-4159.2000.0742221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10800970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis12qsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2221-2223&author=J.+M.+Brownauthor=G.+R.+Hansonauthor=A.+E.+Fleckenstein&title=Methamphetamine+rapidly+decreases+vesicular+dopamine+uptake&doi=10.1046%2Fj.1471-4159.2000.0742221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Methamphetamine rapidly decreases vesicular dopamine uptake</span></div><div class="casAuthors">Brown, Jeffrey M.; Hanson, Glen R.; Fleckenstein, Annette E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2221-2223</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Vesicular sequestration is important in the regulation of cytoplasmic concns. of monoamines such as dopamine.  Moreover, recent evidence suggests that increases in cytoplasmic dopamine levels, perhaps attributable to changes in vesicular monoamine transporter function, contribute to methamphetamine-induced dopaminergic deficits.  Hence, we examd. whether striatal vesicular uptake is altered following methamphetamine treatment.  Multiple administrations of methamphetamine rapidly (within 1 h) decreased vesicular dopamine uptake and dihydrotetrabenazine binding, an effect that (a) persisted at least 24 h, (b) was assocd. with dopamine and not serotonin neurons, and (c) was unrelated to residual drug introduced by the original methamphetamine treatment.  These data suggest that methamphetamine rapidly decreases vesicular monoamine transporter function in dopaminergic neurons, a phenomenon that may be assocd. with the long-term damage caused by this stimulant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS0qR0G-LAFLVg90H21EOLACvtfcHk0li54t2Ydd2qfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis12qsrk%253D&md5=1271bdb61ab259752bd2fcc313206ddb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0742221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0742221.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26atitle%3DMethamphetamine%2520rapidly%2520decreases%2520vesicular%2520dopamine%2520uptake%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D2221%26epage%3D2223%26doi%3D10.1046%2Fj.1471-4159.2000.0742221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleckenstein, A. E.</span></span> <span> </span><span class="NLM_article-title">Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">745</span>, <span class="refDoi">Â DOI: 10.1124/jpet.107.126888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.107.126888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=17693585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=738-745&author=T.+J.+Volzauthor=S.+J.+Farnsworthauthor=J.+L.+Kingauthor=E.+L.+Riddleauthor=G.+R.+Hansonauthor=A.+E.+Fleckenstein&title=Methylphenidate+administration+alters+vesicular+monoamine+transporter-2+function+in+cytoplasmic+and+membrane-associated+vesicles&doi=10.1124%2Fjpet.107.126888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles</span></div><div class="casAuthors">Volz, Trent J.; Farnsworth, Sarah J.; King, Jill L.; Riddle, Evan L.; Hanson, Glen R.; Fleckenstein, Annette E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-745</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In vivo methylphenidate (MPD) administration increases vesicular monoamine transporter-2 (VMAT-2) immunoreactivity, VMAT-2-mediated dopamine (DA) transport, and DA content in a nonmembrane-assocd. (referred to herein as cytoplasmic) vesicular subcellular fraction purified from rat striatum: a phenomenon attributed to a redistribution of VMAT-2-assocd. vesicles within nerve terminals.  In contrast, the present study elucidated the nature of, and the impact of MPD on, VMAT-2-assocd. vesicles that cofractionate with synaptosomal membranes after osmotic lysis (referred to herein as membrane-assocd. vesicles).  Results revealed that, in striking contrast to the cytoplasmic vesicles, DA transport velocity vs. substrate concn. curves in the membrane-assocd. vesicles were sigmoidal, suggesting pos. cooperativity with respect to DA transport.  Addnl., DA transport into membrane-assocd. vesicles was greater in total capacity in the presence of high DA concns. than transport into cytoplasmic vesicles.  Of potential therapeutic relevance, MPD increased DA transport into the membrane-assocd. vesicles despite rapidly decreasing (presumably by redistributing) VMAT-2 immunoreactivity in this fraction.  Functional relevance was suggested by findings that MPD treatment increased both the DA content of the membrane-assocd. vesicle fraction and K+-stimulated DA release from striatal suspensions.  In summary, the present data demonstrate the existence of a previously uncharacterized pool of membrane-assocd. VMAT-2-contg. vesicles that displays novel transport kinetics, has a large sequestration capacity, and responds to in vivo pharmacol. manipulation.  These findings provide insight into both the regulation of vesicular DA sequestration and the mechanism of action of MPD, and they may have implications regarding treatment of disorders involving abnormal DA disposition, including Parkinson's disease and substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaZrxRem8JirVg90H21EOLACvtfcHk0li54t2Ydd2qfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzO&md5=8654232ba4679f09474f220b4f9defc9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.126888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.126888%26sid%3Dliteratum%253Aachs%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DFarnsworth%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DJ.%2BL.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26atitle%3DMethylphenidate%2520administration%2520alters%2520vesicular%2520monoamine%2520transporter-2%2520function%2520in%2520cytoplasmic%2520and%2520membrane-associated%2520vesicles%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D738%26epage%3D745%26doi%3D10.1124%2Fjpet.107.126888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuldiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. H.</span></span> <span> </span><span class="NLM_article-title">Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=29-34&author=S.+Schuldinerauthor=Y.+Liuauthor=R.+H.+Edwards&title=Reserpine+binding+to+a+vesicular+amine+transporter+expressed+in+Chinese+hamster+ovary+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchuldiner%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DR.%2BH.%26atitle%3DReserpine%2520binding%2520to%2520a%2520vesicular%2520amine%2520transporter%2520expressed%2520in%2520Chinese%2520hamster%2520ovary%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D29%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Stenger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. K.</span></span> <span> </span><span class="NLM_article-title">Peritoneal macrophages express the serotonin transporter</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">118</span>, <span class="refDoi">Â DOI: 10.1016/j.jneuroim.2004.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.jneuroim.2004.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=15652409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisl2rtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2005&pages=113-118&author=M.+L.+Ruddauthor=A.+N.+Nicolasauthor=B.+L.+Brownauthor=K.+Fischer-Stengerauthor=J.+K.+Stewart&title=Peritoneal+macrophages+express+the+serotonin+transporter&doi=10.1016%2Fj.jneuroim.2004.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal macrophages express the serotonin transporter</span></div><div class="casAuthors">Rudd, M. L.; Nicolas, A. N.; Brown, B. L.; Fischer-Stenger, K.; Stewart, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although it is known that macrophages take up serotonin, a specific monoamine transporter has not been identified in macrophages.  In this study, mRNA coding for the serotonin transporter (SERT) was detected with the reverse transcription-polymerase chain reaction (RT-PCR) in recruited mouse peritoneal macrophages.  Sequencing confirmed the identity of the RT-PCR product to mouse SERT mRNA.  SERT protein was detected by Western blotting.  Macrophage activation with lipopolysaccharide had no effect on expression of SERT mRNA or protein.  Consistent with expression of a functional SERT, specific uptake of 3H-serotonin in macrophages was sodium dependent and inhibited by fluoxetine (IC50 6.9 nM) and desipramine (IC50 32 nM) but not by nisoxetine or reserpine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod8JGzaa5SobVg90H21EOLACvtfcHk0lgvCwA0xaY7og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisl2rtw%253D%253D&md5=0accfdd3bf933c7e645db53c2f34635e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2004.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2004.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BL.%26aulast%3DNicolas%26aufirst%3DA.%2BN.%26aulast%3DBrown%26aufirst%3DB.%2BL.%26aulast%3DFischer-Stenger%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26atitle%3DPeritoneal%2520macrophages%2520express%2520the%2520serotonin%2520transporter%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D159%26spage%3D113%26epage%3D118%26doi%3D10.1016%2Fj.jneuroim.2004.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordway, G. A.</span></span> <span> </span><span class="NLM_article-title">Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">760</span>â <span class="NLM_lpage">767</span>, <span class="refDoi">Â DOI: 10.1016/j.neuint.2010.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1016%2Fj.neuint.2010.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=20176067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1aiu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=760-767&author=P.+Mandelaauthor=M.+Chandleyauthor=Y.-Y.+Xuauthor=M.-Y.+Zhuauthor=G.+A.+Ordway&title=Reserpine-induced+reduction+in+norepinephrine+transporter+function+requires+catecholamine+storage+vesicles&doi=10.1016%2Fj.neuint.2010.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles</span></div><div class="casAuthors">Mandela, Prashant; Chandley, Michelle; Xu, Yao-Yu; Zhu, Meng-Yang; Ordway, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">760-767</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Treatment of rats with reserpine, an inhibitor of the vesicular monoamine transporter (VMAT), depletes norepinephrine (NE) and regulates NE transporter (NET) expression.  The present study examd. the mol. mechanisms involved in regulation of the NET by reserpine using cultured cells.  Exposure of rat PC12 cells to reserpine for a period as short as 5 min decreased [3H]NE uptake capacity, an effect characterized by a robust decrease in the V max of the transport of [3H]NE.  As expected, reserpine did not displace the binding of [3H]nisoxetine from the NET in membrane homogenates.  The potency of reserpine for reducing [3H]NE uptake was dramatically lower in SK-N-SH cells that have reduced storage capacity for catecholamines.  Reserpine had no effect on [3H]NE uptake in HEK-293 cells transfected with the rat NET (293-hNET), cells that lack catecholamine storage vesicles.  NET regulation by reserpine was independent of trafficking of the NET from the cell surface.  Pre-exposure of cells to inhibitors of several intracellular signaling cascades known to regulate the NET, including Ca2+/Ca2+-calmodulin dependent kinase and protein kinases A, C and G, did not affect the ability of reserpine to reduce [3H]NE uptake.  Treatment of PC12 cells with the catecholamine depleting agent, Î±-methyl-p-tyrosine, increased [3H]NE uptake and eliminated the inhibitory effects of reserpine on [3H]NE uptake.  Reserpine non-competitively inhibits NET activity through a Ca2+-independent process that requires catecholamine storage vesicles, revealing a novel pharmacol. method to modify NET function.  Further characterization of the mol. nature of reserpine's action could lead to the development of alternative therapeutic strategies for treating disorders known to be benefitted by treatment with traditional competitive NET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aHcNIdnzgLVg90H21EOLACvtfcHk0lgvCwA0xaY7og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1aiu7k%253D&md5=387c34dff4e788fbcc2a9c25b0dd967e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DMandela%26aufirst%3DP.%26aulast%3DChandley%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.-Y.%26aulast%3DZhu%26aufirst%3DM.-Y.%26aulast%3DOrdway%26aufirst%3DG.%2BA.%26atitle%3DReserpine-induced%2520reduction%2520in%2520norepinephrine%2520transporter%2520function%2520requires%2520catecholamine%2520storage%2520vesicles%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D56%26spage%3D760%26epage%3D767%26doi%3D10.1016%2Fj.neuint.2010.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznick, H. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: Disassociation of the [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12935 Binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznick&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+Disassociation+of+the+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12935+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznick%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520Disassociation%2520of%2520the%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012935%2520Binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatch, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, A. J.</span></span> <span> </span><span class="NLM_article-title">Abuse liability profile of three substituted tryptamines</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">280</span>â <span class="NLM_lpage">289</span>, <span class="refDoi">Â DOI: 10.1124/jpet.111.179705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=10.1124%2Fjpet.111.179705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=21474568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFChsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=280-289&author=M.+B.+Gatchauthor=M.+J.+Forsterauthor=A.+Janowskyauthor=A.+J.+Eshleman&title=Abuse+liability+profile+of+three+substituted+tryptamines&doi=10.1124%2Fjpet.111.179705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Abuse liability profile of three substituted tryptamines</span></div><div class="casAuthors">Gatch, Michael B.; Forster, Michael J.; Janowsky, Aaron; Eshleman, Amy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">280-289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-Î±-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compds., including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD), (-)-2,5-dimethoxy-4-methylamphetamine (DOM), and dimethyltryptamine (DMT).  Because abused hallucinogens act at 5-hydroxytryptamine 1A (5-HT1A) and 5-HT2A receptors, and abused psychostimulants act at monoamine transporters, binding and functional activities of DIPT, 5-MeO-DET, and 5-MeO-AMT at these sites were also tested.  DIPT fully substituted in rats trained to discriminate DMT (ED50 = 1.71 mg/kg) and DOM (ED50 = 1.94 mg/kg), but produced only 68% LSD-appropriate responding.  5-MeO-DET fully substituted for DMT (ED50 = 0.41 mg/kg) and produced 59% MDMA-appropriate responding.  5-MeO-AMT did not fully substitute for any of the training drugs, but produced 67% LSD-appropriate responding.  None of the compds. produced substitution in rats trained to discriminate cocaine or methamphetamine.  All three compds. showed activity at 5-HT1A and 5-HT2A receptors as well as blockade of reuptake by the serotonin transporter.  In addn., 5-MeO-AMT produced low levels of serotonin release and low potency blockade of dopamine uptake.  DIPT, 5-MeO-DET, and 5-MeO-AMT produced behavioral and receptor effects similar to those of abused hallucinogens, but were not similar to those of psychostimulants.  DIPT and 5-MeO-DET may have abuse liability similar to known hallucinogens and may be hazardous because high doses produced activity and lethality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonSmqsIZk_grVg90H21EOLACvtfcHk0livAFQ5H8X80A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFChsrk%253D&md5=28594d307ac5d2d08ddab942ac1012a6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.179705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.179705%26sid%3Dliteratum%253Aachs%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DForster%26aufirst%3DM.%2BJ.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26atitle%3DAbuse%2520liability%2520profile%2520of%2520three%2520substituted%2520tryptamines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D280%26epage%3D289%26doi%3D10.1124%2Fjpet.111.179705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00542">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40624"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00542">10.1021/acs.jmedchem.8b00542</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed experimental procedures,Â spectroscopic data (<sup>1</sup>H NMR) and MPO calculations for the APQ ligands (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_001.pdf">jm8b00542_si_001.pdf (4.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00542/suppl_file/jm8b00542_si_002.csv">jm8b00542_si_002.csv (1.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00542&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-20%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00542%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00542" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799420d3d5d3c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
